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introduction
The worldwide lifetime incidence of mental illness is nearly 50% (1). Overall, the 
lifetime incidence of mental illness is similar in men and women (1). However, for a 
variety of mental health diagnoses, there are notable sex-associated distinctions. For 
example, mood disorders and psychological distress disproportionately affect women 
(2). Although it has been widely acknowledged that sex is an important marker of 
individual variability, sex-specific factors and the underlying biological mechanisms 
that impact resilience to stress and mental health, have not been sufficiently studied. 
Especially in women, this knowledge is very limited. Women, to a much greater 
extent than men, undergo hormonal fluctuations associated with the reproductive 
cycle. These fluctuations influence numerous bodily and mental functions, and have 
been suggested to be responsible for increased susceptibility to stress and stress-
related disorders in women (1,2). This thesis focuses on hormonal factors involved in 
the physiological responses to acute psychosocial stress of women in the presence 
or absence of personality psychopathology, while also considering the influence of 
cognitive and genetic factors.
Psychosocial stress
Many of the stressors we experience in our daily lives are psychological in nature 
and often socially oriented. Such stressors can include threat to social esteem, re-
spect and self-worth, and/or acceptance within a group, or a threat that we feel we 
have no control over. Psychosocial stress has been defined as a real or interpreted 
socially-oriented conditioned threat to the psychological integrity of an individual, 
which induces biochemical, physiological, cognitive and behavioral changes (3). 
This response to stress represents an integrated reaction to stressors and is essential 
to adapt to various homeostatic challenges. Effective adaptation to stress requires a 
complex interplay of several factors, which include a dynamic interaction between 
environmental demands, the individual’s capacity to cope with those demands, and 
the individual’s appraisal of that relationship (3,4). Subsequently, cognitive appraisal 
is considered a central concept in explaining psychological stress (4). 
It is widely accepted that individuals vary significantly in the way they react to 
a demanding natural environment, or complex social interactions. It is also ac-
knowledged that these individual differences might be associated with behavior and 
health outcomes (5,6). Given the significant variability in the strength and valence 
of emotional reactions and biological system activity, the identification and mecha-
nistic understanding of individual differences has become an important challenge 
for psychiatric research (7). The capacity to properly contextualize and monitor a 
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situation has been shown to be essential to ascertain whether specific situations are 
threatening for an individual’s well-being.
cognitive stress appraisal
Already decades ago, the transactional stress model postulated that cognitive ap-
praisal processes are key concepts in determining appropriate coping mechanisms 
and enable adaptation to the environment (2). Which coping mechanism is selected 
to be employed is determined by how an individual appraises a stressful event, 
and his or her adaptive reaction to stress. In other words, appraisal mediates the 
stressfulness of events. The cognitive appraisal of stressors is a process of evaluation 
comprising two stages. Primary appraisal is concerned with the subjective assess-
ment of the demands of the environment, for example, whether there is potential for 
harm or benefit. Secondary appraisal involves an individual’s determination of his 
or her resources that can be applied to the situation as coping options. These stages 
interact to produce an overall perception, management, and optimally, termination 
of stress (8). Thus, a stress reaction takes place when the individual concludes that 
environmental stimuli are exceeding his or her personal coping capacities. 
These cognitive stress appraisals are an effortless and automatic interpretation of the 
perceived situation that creates an emotional experience and allows the individual 
to respond adaptively. Hence, the motivation to adapt to environmental demands 
involves complex and dynamic interaction networks among emotions, cognitive 
appraisals, physiological responses and behavioral experiences (4,9). Additionally, 
events appraised as highly significant are more likely to result in psychophysiological 
stress reactions (10–12). From a developmental perspective, temperament and at-
tachment are thought to be major organizers of early social-emotional development 
and are important factors in an individual’s psychosocial functioning. It has been 
suggested that both attachment and temperamental factors can make unique and 
interactive contributions to how an individual deals with a demanding environment 
(13,14). However, knowledge of the role of attachment and temperament on the 
cognitive processing of psychosocial stress in women, and in particular with regard-
ing to the influence of personality psychopathology, has remained limited.
Personality Psychopathology
Personality disorders are ‘pervasive, inflexible, maladaptive’ collections of traits that 
impact an individual across a broad range of situations (15). Personality disorders 
exhibit high comorbidity with Axis I pathology (16,17). Personality disorders are 
heterogeneous regarding their clinical features and etiology. The symptoms of per-
sonality disorders are caused by multiple factors such as inborn temperamental traits, 
as well as environmental and developmental events (18). Therefore, the common 
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traits of chronic, inflexible styles of perceiving oneself and interacting with others 
vary widely in presentation. There are ten categories of personality disorders defined 
within the DSM 5 (19,20). Of those, Borderline Personality Disorder (BPD) and Clus-
ter C (avoidant/dependent) Personality Disorder (CPD) are among the most common 
in clinical samples (21,22).
Borderline Personality disorder (BPd)
BPD is considered to be the most complex, and certainly one of the most devastating, 
personality disorder categories (23,24). It is also by far the most intensively studied. 
Approximately 2-4% of the general population suffers from BPD (25). However, BPD 
is more common in Axis I clinical populations, with estimated prevalence rates of 9 
to 23% in psychiatric outpatients (25) and up to 44% in psychiatric inpatients (26). 
Female patients predominate within psychiatric settings (about 75%), however men 
are more commonly diagnosed with BPD in substance abuse or forensic settings 
(27,28).
Patients with Borderline personality disorder (BPD) have long been recognized as 
creating considerable challenges for clinicians who diagnose and treat them (29). The 
main reasons for the treatment difficulties encountered are patterns of intense affec-
tivity, destructive relationships, impulsive behavior, and problems with mentalization 
that make it difficult for patients to reflect upon these patterns (30). There is growing 
evidence that emotional dysregulation is a core feature in BPD (31). Ever-changing 
emotions, together with poor social cognition, contributes to an unstable sense of 
the self and unsteady social interactions (32). In turn, psychosocial deficits reinforce 
emotional dysregulation, in this way creating a circular mechanism.
cluster c Personality disorder (cPd)
All patients with CPD exhibit anxiety in some form (33). Cluster C personality 
disorders, including avoidant, dependent, and obsessive-compulsive personality dis-
orders, are reported to be among the most common mental disorders in the general 
population (34). Whether caused by fear of judgement by others, or abandonment, 
patients with CPD suffer from uncomfortable beliefs and sensations that cause dis-
tress and interfere with their functioning (35). Patients with CPD usually have a less 
problematic course in therapy than patients with BPD and are considered clinically 
less disruptive (33). However, they also often remain in a passive patient role, without 
making the necessary efforts to succeed in treatment (35). Furthermore, cluster C 
disorders (dependent and avoidant) generally have been regarded as disorders of 
medium severity (33). However, this assumption has not been thoroughly studied in 
empirical studies. 
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dysfunctional affect regulation as a common feature of BPd and cPd
Despite the amount of research on the benefits of successfully regulating affect for our 
mental and somatic well-being (36), research on the effects of dysfunctional affect 
regulation in psychiatric patients remains inconclusive. Yet, it has been established 
that affect dysregulation is involved in the etiology and maintenance of psychopa-
thology (37). In addition, dysfunctional affect regulation is often described in patients 
with complex psychopathology, such as the presence of a combination of DSM Axis 
I and Axis II symptoms. People with BPD and/ or CPD are not capable of establishing 
and maintaining interpersonal relationships, which require sufficient affect regulation 
(38). 
Whereas BPD is a classic example of a global dysregulation of negative affect, 
primarily involving fear and anger, patients with CPD exhibit avoidant behavior 
and unmodulated affect accompanied by severe anxiety, shame and panic (39,40). 
Individuals with BPD and CPD are considered to have a reduced capacity to relax 
after stressful situations, which subsequently reinforces their hyper-aroused state in a 
dysregulated manner (41,42). As a consequence, the perception of threat is usually 
elevated and the symptoms of BPD and CPD is typically exacerbated by stress. The 
limited ability to process information consequently contributes to poor self-perception 
and coping, and reduces control over affect and impulses.
Although there is ample evidence that patients with BPD and CPD experience emo-
tional dysregulation, the evidence for biological sensitivity is more ambiguous (43). 
Data about the concomitant circumstances and mechanisms that underlie emotional 
dysregulation is sparse and inconclusive. Distinct studies using psychobiological 
markers of emotion have thus far failed to identify a consistent physiological pattern 
of affect dysregulation in BPD versus CPD (44,45).
Affect dysregulation and developmental components
Although multiple interdependent processes are involved in the regulation of emo-
tions, dysfunctional affect regulation has been hypothesized to result from childhood 
adversity and the quality of early-life attachment, most notably neglect or abuse by 
primary caregivers (46–48). Such adverse events during early-life development have 
been suggested to result in an insecure attachment style. A healthy attachment bond 
has been suggested to be of vital importance for developing adaptive emotional 
control (46,47). Whereas a secure attachment style is theorized to be related to a 
more adaptive regulation of affect, an insecure attachment style is thought to impair 
the development of affect regulation, cognition and coping in emotional relationships 
(24,47,49). 
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the biological stress systems
The ability to respond to the demands of a situation with a general alarm response 
is one of the essential elements in the global adaptive and self-regulating systems of 
biological organisms (50). Over the course of evolution, overlapping mechanisms 
have developed, to deal with environmental demands. In mammals, the autonomic 
nervous system (ANS) and the Hypothalamic-pituitary-adrenal (HPA) axis are con-
sidered to be the most important systems, but many other endogenous stress-reactive 
systems contribute. There are also several other systemic processes, such as prolactin 
release (51) and/or circulating IL-6 levels (52) that have temporal links to stressful 
stimuli. Another important system is the Hypothalamic-Pituitary-gonadal (HPG), 
which regulates the release of gonadal steroid hormones (53). This thesis work focuses 
on the two major stress regulating systems (ANS and HPA axis), and the functionally 
interconnected reproductive system (HPG axis) (Figure 1). 
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figure 1. A schematic diagram of the hypothalamic-pituitary-adrenal (hPA) and hypothalamic-pitu-
itary-gonadal (hPG) axes. The autonomic nervous system (ANS) is also an important modulating factor. 
The HPA and HPG axes share a common bipartite composition, with both central (hypothalamic stimu-
lation of the pituitary in both) and peripheral (gonads and adrenals, respectively) components.
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the hypothalamic-Pituitary-Adrenal axis
The HPA axis is the primary neuroendocrine system governing how mammals cope 
with and adapt to stressors. Activation of the HPA axis represents a primary hormonal 
response to a homeostatic challenge. Thus, the exposure to a stressful situation results 
in a wide spectrum of central and peripheral responses starting with corticotrophin 
releasing hormone (CRH), which is secreted by the paraventricular nucleus of the 
hypothalamus. Released CRH triggers the pituitary gland to secrete the adrenocor-
ticotropic hormone (ACTH). In turn, ACTH triggers the adrenal cortex to produce 
the glucocorticoid cortisol. Released cortisol, via negative feedback, suppresses CRH 
and ACTH secretion from the hypothalamus and the pituitary gland (53). Cortisol is 
the final output of the HPA axis and therefore an important dynamic index of the state 
of the HPA axis.
Cortisol acts principally in two different ways: basally through support of normal 
metabolic and diurnal functions, and dynamically in response to stress (53,54). 
The basal function is driven by hypothalamic input and is very sensitive to negative 
feedback control. The stress regulatory function of cortisol secretion is influenced by 
the amygdala and hypothalamus, but is notably less sensitive to negative feedback 
(52,53).
Although the majority of cortisol, up to 90 percent, is bound to the proteins 
corticosteroid-binding globulin and albumin, the remaining unbound cortisol consti-
tutes the biologically active fraction (55,56). Saliva sampling is a reliable indicator of 
free unbound cortisol concentration in the blood (55), as only free unbound cortisol 
passes into the saliva. Analogously, only free unbound cortisol is capable of passing 
through the blood-brain barrier to mediate effects within the central nervous system 
(54). Although cortisol has many well-demonstrated benefits during acute periods of 
threat and stress, chronically elevated cortisol levels have considerably deleterious 
systemic consequences (57). Therefore, a tightly-regulated stress response is very 
important, as inappropriate or prolonged HPA axis activation has been associated 
with numerous pathophysiological and psychopathological disease states (58,59).
the Autonomic nervous system
The ANS functions importantly in regulating physiological arousal and inhibition dur-
ing stress. The ANS consists of two main branches: the sympathetic and parasympa-
thetic nervous system. When exposed to a stressor, the sympathetic branch is rapidly 
activated and endows an individual with a readiness to respond. This rapid response 
is mostly involved in regulating arousal by release of adrenaline and noradrenaline, 
which in turn stimulate heart rate and blood pressure, dilate the pupils, and activate the 
sweat glands. This branch is often referred to as the “fight-or-flight’ system. Although 
adrenaline and noradrenaline are unable to cross blood-brain barrier, they directly 
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stimulate the vagal nerve, a primary component of the parasympathetic system that 
innervates the sinoatrial node of the heart. The parasympathetic branch of the ANS 
is responsible for conservation of energy and regulating organ functions when the 
body is at rest. Both branches are constantly active, operate independently of one 
another, and exert reciprocal influences on the heart (60). The magnitude of activity 
varies depending upon internal and environmental conditions. When active coping 
of the individual is required, the sympathetic system inhibits vagal tone to support an 
increase in heart rate. Afterwards, vagal tone is restored, thereby regulating heart rate 
back to resting levels. 
These responses are meant to help the body to adapt to and protect against stressful 
stimuli (61), but chronic excessive (sympathetic) activation can produce neurochemi-
cal imbalances that may contribute to the development of psychiatric disorders (62). 
These physiological responses have been suggested to be an important physiological 
marker of psychological states, such as the subjective feeling of anxiety or emotional 
dysregulation (63). Heart rate and skin conductance level (SCL) are reliable typical 
indices of ANS activity. Whereas SCL is an established biomarker of sympathetic 
nervous system activity, mean heart rate reflects innervation of both sympathetic and 
parasympathetic systems.
the hypothalamic-Pituitary-Gonadal axis
The HPG axis is a neuroendocrine axis that functions parallel to the HPA axis and 
regulates reproduction. The reproductive and stress systems have an analogous 
bipartite composition, with both central (hypothalamic stimulation of the pituitary 
in both) and peripheral (gonad and adrenal glands, respectively) components (53). 
The hypothalamus directs many of its actions through the pulsatile secretion of 
gonadotropin-releasing hormone (GnRH), which in turn acts on the pituitary gland to 
stimulate the synthesis and release of gonadotropins, luteinizing hormone (LH) and 
follicle-stimulating hormone (FSH) (64,65). 
In men, gonadotropins circulate systemically and constitutively. Circulating go-
nadotropins act on the testes to release testosterone, which in turn, together with 
gonadotropins, negatively regulates hypothalamic function to maintain homeostasis. 
The female reproductive system is undoubtedly more complex. The hypothalamus 
releases GnRH, and secreted gonadotropins trigger the ovaries to release estradiol 
and progesterone (64,66). To initiate the ovulatory cascade, women experience hor-
monal surges, a uniquely sex-specific physiological phenomenon, in which estrogen 
switches from exerting negative feedback to positive feedback (64). Following ovu-
lation, progesterone levels rise higher than estradiol, and then both estrogen and 
progesterone levels slowly decrease together. The declining levels of estrogen then 
reverse the negative feedback on GnRH, initiating the cycle to begin anew (64).
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hPA and hPG axis interactions during stress
Studies on interactions between the stress and reproductive axes have primarily 
focused on the mechanisms by which stress impacts the reproductive system. Stress, 
whether psychological or physical, has been suggested to disturb the reproductive 
axis at every level of the axis, from the hypothalamus to the ovaries or testes (64,67). 
However, the relationship between these two endocrine systems is not unidirectional. 
Recently, a reciprocal relationship between the HPA and HPG axes has been shown, 
suggesting a functionally interconnected reciprocal co-regulation between them (68). 
Consequently, changes in sex steroid levels modulate the magnitude of the stress 
response. 
A consistent finding is that men exhibit two-fold higher cortisol responses to 
psychosocial stress compared to women (69), when menstrual cycle phase or oral 
contraceptive use is not included as a confounding factor. Therefore, it has been 
suggested that the internal sex-specific endocrine milieu is related to variation in 
responses to stress. Endogenous levels of sex steroids and exogenous administration 
of sex hormones have been shown to affect HPA axis responses (70). Several studies 
have shown that the salivary cortisol response to psychosocial stress in women is 
modulated by the phase of the menstrual cycle. Women in the luteal phase have 
salivary cortisol stress responses comparable to those of men, whereas women in the 
follicular phase exhibit significantly lower salivary cortisol responses, comparable to 
those of women using oral contraceptives (71–75). Furthermore, although estradiol 
seems to have the most potent effects on HPA axis-mediated stress regulation, pro-
gesterone was also observed to be an important regulator of HPA axis function by 
enhancing stimulated HPA axis function in women (76,77). Remarkably, however, 
despite the potency by which sex steroids regulate glucocorticoid release, knowledge 
of how sex steroids operate to regulate the HPA axis is not well established. The 
effects of HPA axis activation on sex steroid levels also remain to be investigated. 
determinants of psychophysiological stress reactivity
Genetic factors
It is assumed that genetic factors are among the most important factors in determining 
an individual’s adaptive response to stress. Various studies imply that the serotonin 
(5-hydroxytryptamine; 5-HT) neurotransmission system and the HPA axis are closely 
interrelated, and that both function importantly in the mediating responses to stress 
(78,79). The serotonin transporter (5-HTT) regulates the concentration of 5-HT in the 
synaptic cleft and has been shown to contribute to many physiological functions 
(80). 5-HTT is encoded by a single gene (SLC6A4), within which the 5-HTT-linked 
polymorphic region (5-HTTLPR) regulates the SLC6A4 transcriptional activity (80). 
There are two major variants of the 5-HTTLPR, which differ significantly in their 
General introduction
17
functional efficiency. The long (L) allele of the 5-HTTLPR is related to higher tran-
scriptional efficiency and higher 5-HTT expression, compared to the short (S) allele 
(80). Previous studies have suggested that 5-HTTLPR variations moderate the stress 
response, with dominance of the S allele over the L allele (81). However, there are 
conflicting results (82). Therefore, further clarification of the impact of 5-HTTLPR 
variant on stress reactivity is needed.
Gene and environment interaction
Following the diathesis-stress theory, some studies have suggested that HPA axis and 
stress reactivity might be modulated by the interaction of genetic vulnerability and ma-
jor life stressors (81,83,84). The majority of these studies imply that 5-HTTLPR genotype 
modulates HPA axis reactivity to social stress. However, the direction of this interaction 
remains inconclusive. Many factors such as gender, age, and cumulative exposure to 
stressful life events, have been suggested to contribute to the magnitude and direction 
of SLC6A4 gene 5-HTTLPR x environment interactions on HPA axis responsivity (82).
In addition, research has shown that childhood trauma exposure such as physical and 
sexual abuse, emotional neglect, and early relationship losses can have detrimental ef-
fects on the developing brain. Specifically in early childhood, the developing HPA axis 
is under strong social regulation and vulnerable to environmental disturbances (85). 
Various studies have postulated that early life adversities have long-lasting effects on 
the activity of the HPA axis (86–88). Furthermore, childhood trauma is considered an 
important precursor to many forms of pathology in adulthood (89) and is prospectively 
related to a range of personality psychopathology symptoms and diagnoses (90).
Hormonal contraceptives
Currently, psychoneuroendocrine research takes into account the potential impact of 
the menstrual cycle on salivary cortisol responses to stress (74). However, adjusting 
for the effects of hormonal contraceptives on cortisol responses remains difficult, is 
sometimes overlooked, and often simply established as an exclusion criterion. 
Worldwide, more than 70 million women of reproductive age are estimated to use 
some form of hormonal contraception. Remarkably however, the effects of synthetic 
steroids – the active component of hormonal contraceptives – on the physiological 
response to stress have scarcely been investigated. These studies have demonstrated 
that women using oral hormonal contraceptives (typically containing estrogen and 
progestin) displayed a blunted salivary cortisol response following acute stress 
(73,92,93), or following pharmacological stimulation (75), compared to women in 
the luteal phase of menstrual cycle. 
More recently, women have been increasingly expressing preference for long-
lasting reversible contraceptives such as progestin releasing intrauterine devices 
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(IUD) (94), making them the fastest-growing method of hormonal contraception. 
However despite their widespread and increasingly frequent use, data on the im-
pact of progestin-only contraception on the functioning of the HPA axis in women 
is almost entirely unknown. Obviously, given our increasing understanding of the 
physiologically important co-regulation of the HPA and HPG axes, knowledge of 
the corresponding influence of hormonal contraceptives on female physiology is of 
compelling importance, to women themselves, to their clinicians, as well as for clini-
cal and fundamental research.
rationale and aims of the thesis
Women are particularly susceptible to stress-related disorders, and the impact of 
hormones, natural or synthetic, could be a crucial factor to include when study-
ing women’s mental health. Yet, both natural hormonal fluctuations and the use of 
hormonal contraceptives have long been considered valid scientific arguments to 
exclude women from studies regarding stress physiology. Therefore, we explicitly 
focused our studies of stress regulation to include women, by directly considering 
the influence of the menstrual cycle and contraceptive use. Furthermore, given that 
maladaptive emotional control is a significant burden to women affected by personal-
ity disorders, this thesis also aimed to investigate stress regulation in women with 
personality psychopathology by examining psychophysiological responses to acute 
psychosocial stress in relation to its cognitive and genetic determinants. In a cohort of 
women recruited among outpatients with personality disorder and matched healthy 
controls, we assessed cognitive appraisal, genetic factors, subjective mood, cortisol, 
and autonomic nervous system responses during a standardized psychosocial stress 
procedure. In addition, we aimed to explore biological determinants of physiological 
stress reactivity in women by performing an ACTH challenge test in healthy women. 
Aims of the thesis
The specific aims of this thesis are as follows:
- Given the potential of cognitive appraisal to either facilitate or impede stress cop-
ing capacity, we aimed to consider fundamental personality characteristics that 
could be as potential determinants of cognitive appraisals to acute psychosocial 
stress in women with regard to their personality disorder burden. 
- Since 5-HT is considered an important neurotransmitter regulating the HPA axis 
response to stress and has been implicated in various stress related disorders, 
we sought to examine the effects of the SLC6A4 5-HTTLPR genotype on salivary 
cortisol responses to psychosocial stress in women with personality disorder and 
healthy controls. 
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- Salivary cortisol levels, mean heart rate, SCL and subjective mood were studied 
before, during and after acute psychosocial stress to clarify potential differences in 
stress regulatory systems between distinct clusters of personality disorder (cluster 
C and cluster B) and healthy controls. In addition, considering the high rates of 
early life adversities in the patient samples, we also explored the impact of these 
adversities on the physiological responses to acute psychosocial stress. 
- In developed countries, about 50% of all women of reproductive age rely on 
some method of hormonal contraception. We aimed to investigate the impact of 
these exogenous hormones on the physiological responses to psychosocial stress, 
by studying the functioning of the HPA axis at central and peripheral levels. In 
addition, we examined long-term stress exposure under naturalistic conditions 
using hair cortisol measurements. We studied healthy women in two distinct hor-
monal contraceptive groups (oral monophasic combined preparations containing 
ethinylestradiol and levonorgestrel, and the levonorgestrel-releasing IUD) as well 
as in naturally cycling women. 
- Lastly, we were interested in advancing our understating of how HPA axis activa-
tion might influence HPG axis activity. By administering a low-dose of ACTH to 
healthy women using different contraceptives, we aimed to further dissect the 
hormonal context by which the adrenal cortex activity mediates gonadotropin 
release. Serum steroid and gonadotropin concentrations were measured prior to, 
and after, intravenous ACTH administration.
outline of the thesis
In Chapter 2, the associations between fundamental personality characteristics (at-
tachment styles, temperament) and cognitive appraisals of acute psychosocial stress 
in women with and without personality disorder were explored. In order to under-
stand the individual differences in cognitive appraisal of acute psychosocial stress, 
we constructed a model linking personality characteristics to cognitive appraisals 
while controlling for maladaptive personality traits. In Chapter 3, the impact of the 
genetic factor SLC6A4 5-HTTLPR on the endocrine stress response in women with 
and without personality disorder was investigated. The study described in Chapter 4 
examines psychophysiological responses to acute psychosocial stress in two different 
clusters of personality disorder, cluster B and cluster C, in comparison to healthy 
controls. Chapter 5 investigates the systemic physiological influence of hormonal 
contraception in healthy women, with emphasis on the levonorgestrel-releasing IUD. 
The study in Chapter 6 investigates the effects of low-dose ACTH test on gonadotropin 
release. Finally, the main findings and conclusions of the studies are presented and 
discussed in Chapter 7 in which the research implications and suggestions for future 
research are addressed. 
Chapter 1
20
references
 1. World Health Organisation. Department of Mental Health and Substance Dependence. Gen-
der Disparities in Mental Health World. 2015. 
 2. Marcus SM, Young EA, Kerber KB, Kornstein S, Farabaugh AH, Mitchell J, et al. Gender differ-
ences in depression: Findings from the STAR*D study. J Affect Disord. 2005;87:141-50. 
 3. Lazarus RS. Emotions and interpersonal relationships: Toward a person-centered conceptual-
ization of emotions and coping. Journal of Personality.2006;74:9-46. 
 4. Lazarus RS, Folkman S. The Stress Concept in the Life Sciences. Stress, appraisal, and coping. 
New york; 1984. (p. 1–21). 
 5. Carroll D, Lovallo W, Phillips A. Are Large Physiological Reactions to Acute Psychological 
Stress Always Bad for Health? Soc Personal Compass. 2009;3:725-43. 
 6. Chida Y, Steptoe A. Greater cardiovascular responses to laboratory mental stress are associ-
ated with poor subsequent cardiovascular risk status: A meta-analysis of prospective evidence. 
Hypertension. 2010;55:1026-32. 
 7. Lopez-Duran NL, Hajal NJ, Olson SL, Felt BT, Vazquez DM. Individual differences in cortisol 
responses to fear and frustration during middle childhood. J Exp Child Psychol. 2009;103:285-
95. 
 8. Largo-Wight E, Peterson PM, Chen WW. Perceived problem solving, stress, and health among 
college students. Am J Health Behav. 2005;29:360-70. 
 9. Folkman S, Lazarus RS, Gruen RJ, DeLongis a. Appraisal, coping, health status, and psycho-
logical symptoms. J Pers Soc Psychol. 1986;50:571-579. 
 10. King S, Laplante DP. The effects of prenatal maternal stress on children’s cognitive develop-
ment: Project Ice Storm. Stress. 2005;8:35-45. 
 11. Park CL. Stress-Related Growth and Thriving Through Coping: The Roles of Personality and 
Cognitive Processes. J Soc Issues. 2010;54:267-277. 
 12. Gaab J, Rohleder N, Nater UM, Ehlert U. Psychological determinants of the cortisol 
stress response: the role of anticipatory cognitive appraisal. Psychoneuroendocrinology. 
2005;30:599–610. 
 13. Mangelsdorf SC, Frosch CA. Temperament and Attachment: One Construct or Two? Adv Child 
Dev Behav. 1999;27:181-220. 
 14. Laurent H, Powers S. Emotion regulation in emerging adult couples: temperament, attach-
ment, and HPA response to conflict. Biol Psychol. 2007;76:61-71. 
 15. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 
Fourth Edition, Text Revision; 2000. 
 16. Skodol AE, Stout RL, McGlashan TH, Grilo CM, Gunderson JG, Trade Shea M, et al. Co-
occurrence of mood and personality disorders: A report from the Collaborative Longitudinal 
Personality Disorders Study (CLPS). Depress Anxiety. 1999;10:175-82. 
 17. Skodol AE, Gunderson JG, Pfohl B, Widiger TA, Livesley WJ, Siever LJ. The borderline diagno-
sis I: Psychopathology, comorbidity, and personaltity structure. Biol Psychiatry. 2002;51:936-
950. 
 18. Ward RK. Assessment and Management of Personality Disorders. Am Fam Physician. 
2004;15:1505-1512.
 19. American Psychiatric Association. DSM 5. American Journal of Psychiatry; 2013.
 20. Trull TJ, Widiger TA. Dimensional models of personality: The five-factor model and the DSM-
5. Dialogues Clin Neurosci. 2013;15:135-146. 
General introduction
21
 21. Grilo CM, McGlashan TH, Quinlan DM, Walker ML, Greenfeld D, Edell WS. Frequency of per-
sonality disorders in two age cohorts of psychiatric inpatients. Am J Psychiatry. 1998;155:140-
142. 
 22. Feenstra DJ, Busschbach JJ V, Verheul R, Hutsebaut J. Prevalence and comorbidity of axis I 
and axis II disorders among treatment refractory adolescents admitted for specialized psycho-
therapy. J Pers Disord. 2011;25:842-850. 
 23. Skodol AE, Gunderson JG, SheaMT, McGlashan TH, Morey LC, Sanislow CA, et al. The Col-
laborative Longitudinal Personality Disorder Study (CLPS): overview and implications. J Pers 
Disord. 2005;19:487-504. 
 24. Bateman A, Fonagy P. Mentalization based treatment for borderline personality disorder. 
World Psychiatry. 2010;9:11–5. 
 25. Zimmerman M, Rothschild L, Chelminski I. the Prevalence of DSM-IV Personality Disorders in 
in Psychiatric Outpatients. Am J Psychiatry. 2005;162:1911-1918. 
 26. Marinangeli MG, Butti G, Scinto A, Di Cicco L, Petruzzi C, Daneluzzo E, et al. Patterns of 
comorbidity among DSM-III-R personality disorders. Psychopathology. 2000;33:69-74. 
 27. Grant BF, Chou SP, Goldstein RB, Huang B, Stinson FS, Saha TD, et al. Prevalence, correlates, 
disability, and comorbidity of DSM-IV borderline personality disorder: results from the Wave 
2 National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 
2008;69:533-45. 
 28. Sansone RA, Sansone LA. Borderline Personality and Criminality. Psychiatry. 2009;6:16-20. 
 29. Bateman A, Fonagy P. Mentalization-based treatment of BPD. J Pers Disord. 2004;18:36-51. 
 30. Allen J, Fonagy P, Bateman A. Mentalizing in clinical practice. Americal Psychiatric Publish-
ing; 2008. 
 31. Kröger C, Vonau M, Kliem S, Kosfelder J. Emotion dysregulation as a core feature of borderline 
personality disorder: Comparison of the discriminatory ability of two self-rating measures. 
Psychopathology. 2011;44:253-260. 
 32. Lopes PN, Salovey P, Côté S, Beers M. Emotion Regulation Abilities and the Quality of Social 
Interaction. Emotion. 2005;5:113-118. 
 33. Livesley WJ. Practical Management of Personality Disorder. New York: Guilford Press; 2003. 
 34. Soeteman DI, Verheul R, Busschbach JJ V. The burden of disease in personality disorders: 
diagnosis-specific quality of life. J Pers Disord. 2008;22:259-68. 
 35. van Vreeswijk M, Broersen J, Nadort M, Arntz A. Handbook of Shema Therapy: Theapry, 
Research, and Practice; 2012. (397-414p). 
 36. Nyklicek I, Temoshok L, Vingerhoets A. Emotional expression and health: Advances in theory, 
assessment and clinical applications. Emotional expression and health: Advances in theory, 
assessment and clinical applications. Hove and New York; 2004. 
 37. Bradley SJ. Affect regulation and the development of psychopathology. Affect regulation and 
the development of psychopathology. The Guilford Press, New York; 2000. 
 38. Kleindienst N, Bohus M, Ludäscher P, Limberger MF, Kuenkele K, Ebner-Priemer UW, et al. 
Motives for nonsuicidal self-injury among women with borderline personality disorder. J Nerv 
Ment Dis. 2008;196:230-236. 
 39. Sarkar J, Adshead G. Personality disorders as disorganisation of attachment and affect regula-
tion. Adv Psychiatr Treat. 2006;12:297-305. 
 40. Livesley WJ. Trait and behavioral prototypes of personality disorder. Am J Psychiatry. 
1986;143:728-732. 
Chapter 1
22
 41. Morey LC, Gunderson JG, Quigley BD, Shea MT, Skodol AE, McGlashan TH, et al. The 
representation of borderline, avoidant, obsessive-compulsive, and schizotypal personality 
disorders by the five-factor model. J Pers Disord. 2002;16:215-234. 
 42. Van der Kolk BA, Fisler RE. Childhood abuse and neglect and loss of self-regulation. Bulletin 
of the Menninger Clinic. 1994;58:145-168. 
 43. Rosenthal MZ, Gratz KL, Kosson DS, Cheavens JS, Lejuez CW, Lynch TR. Borderline personal-
ity disorder and emotional responding: a review of the research literature. Clin Psychol Rev. 
2008;2:75-91. 
 44. Deckers JWM, Lobbestael J, van Wingen G A, Kessels RPC, Arntz A, Egger JIM. The influence 
of stress on social cognition in patients with borderline personality disorder. Psychoneuroen-
docrinology 2014;52:119-129. 
 45. Johansen MS, Normann-Eide E, Normann-Eide T, Wilberg T. Emotional dysfunction in avoidant 
compared to borderline personality disorder: A study of affect consciousness. Scand J Psychol. 
2013;54:515-521. 
 46. Bowlby J. Attachment and loss, Volume 1: Attachment. Attachment. 1969. 
 47. Levy KN, Meehan KB, Weber M, Reynoso J, Clarkin JF. Attachment and borderline personality 
disorder: implications for psychotherapy. Psychopathology. 2005;38:64-74. 
 48. Zanarini MC, Ed D, Frankenburg FR, Hennen J, Ph D, Reich DB, et al. Prediction of the 
10-Year Course of Borderline Personality Disorder. Am J Psychiatry. 2006;163:827-832. 
 49. Mikulincer M, Shaver PR. A model of attachment-system functioning and dynamics in adult-
hood. Attachment in adulthood: Structure, dynamics, and change. The Guilford press, New 
York and London; 2007. 
 50. Sapolsky RM. The influence of social hierarchy on primate health. Science. 2005;308:648–52. 
 51. Turnbull AV, Rivier CL. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: 
actions and mechanisms of action. Physiol Rev. 1999;79:1-71. 
 52. Segerstrom SC, Miller GE. Psychological stress and the human immune system: a meta-
analytic study of 30 years of inquiry. Psychol Bull. 2004;130:601-630. 
 53. Handa RJ, Weiser MJ. Gonadal steroid hormones and the hypothalamo-pituitary-adrenal axis. 
Frontiers in Neuroendocrinology. 2014;2:197-220. 
 54. Lovallo W, Thomas T. Stress hormones in psychophysiological research: Emotional, behav-
ioral, and cognitive implications. Handb Psychophysiol. 2000;7:342-367. 
 55. Kirschbaum C, Hellhammer DH. Salivary cortisol in psychobiological research: an overview. 
Neuropsychobiology. 1989;22:150-169. 
 56. Mendel C. The free hormone hypothesis distinction from the free hormone transport hypoth-
esis. J Androl. 1992;13:107-116. 
 57. Bremner JD. Neuroimaging studies in post-traumatic stress disorder. Curr Psychiatry Rep. 
2002;4:254-263. 
 58. Sapolsky RM. Stress and the brain: individual variability and the inverted-U. Nat Neurosci. 
2015;18:1344-1346. 
 59. Juruena MF. Early-life stress and HPA axis trigger recurrent adulthood depression. Epilepsy and 
Behavior. 2014;38:148-159. 
 60. Berntson GG, Cacioppo JT, Quigley KS. Autonomic determinism: The modes of autonomic 
control, the doctrine of autonomic space, and the laws of autonomic constraint. Psychol Rev. 
1991;98:459-487. 
 61. de Kloet ER, Joëls M, Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev 
Neurosci. 2005;6:463-475. 
General introduction
23
 62. Del Giudice M, Ellis BJ, Shirtcliff EA. The Adaptive Calibration Model of stress responsivity. 
Neuroscience and Biobehavioral Reviews. 2011;35:1562-1592. 
 63. Porges SW. The Polyvagal Theory: Neurophysiological Foundations of Emotions Attachment 
Communication Self-Regulation. New York: W.W. Norton & Company; 2011.
 64. Wang J, Harris C. Advances in ExperimentalMedicine and Biology. Glucocorticoid Signaling 
From Molecules to Mice to Man. Springer New York, New York; 2015. 
 65. Handa RJ, Burgess LH, Kerr JE, O’Keefe JA. Gonadal steroid hormone receptors and sex differ-
ences in the hypothalamo-pituitary-adrenal axis. Horm Behav. 1994;28:464-476. 
 66. McCartney CR, Blank SK, Marshall JC. Estradiol and progesterone-induced slowing of gonad-
otropin-releasing hormone pulse frequency is not reversed by subsequent administration of 
mifepristone. Endocrine. 2009;36:239-245. 
 67. Riviera C, Rivest S. Effects of Stress on the Activity of the Hypothalamic-Pituitary-Gonadal 
Axis: Peripheral and Central Mechanisms. Biol Reprod. 1991;45:523-532. 
 68. Toufexis, Rivarola, Lara V. Stress and the Reproductive Cycle. J Neuroendocrinol. 2014;26:573-
586. 
 69. Kirschbaum C, Wust S, Hellhammer D. Consistent Sex Differences in Cortisol Responses to 
Psychological Stress. Psychosom Med. 1992;54:648-657. 
 70. Foley P, Kirschbaum C. Human hypothalamus-pituitary-adrenal axis responses to acute psy-
chosocial stress in laboratory settings. Neurosci Biobehav Rev. 2010;35:91-96. 
 71. Kudielka BM, Kirschbaum C. Sex differences in HPA axis responses to stress : a review. Biol 
Psychol. 2005;69:113-132. 
 72. Kudielka BM, Schmidt-Reinwald AK, Hellhammer DH, Kirschbaum C. Psychological and 
endocrine responses to psychosocial stress and dexamethasone/corticotropin-releasing 
hormone in healthy postmenopausal women and young controls: the impact of age and a 
two-week estradiol treatment. Neuroendocrinology. 1999;70:422-430. 
 73. Rohleder N, Wolf JM, Piel M, Kirschbaum C. Impact of oral contraceptive use on glucocorti-
coid sensitivity of pro-inflammatory cytokine production after psychosocial stress. Psychoneu-
roendocrinology. 2003;28:261-273. 
 74. Nielsen SE, Ertman N, Lakhani YS, Cahill L. Hormonal contraception usage is associated with 
altered memory for an emotional story. Neurobiol Learn Mem 2011;96:378-384. 
 75. Klose M, Lange M, Rasmussen AK, Skakkebaek NE, Hilsted L, Haug E, et al. Factors influenc-
ing the adrenocorticotropin test: role of contemporary cortisol assays, body composition, and 
oral contraceptive agents. J Clin Endocrinol Metab. 2007;92:1326-1333. 
 76. Lee EE, Nieman LK, Martinez PE, Harsh VL, Rubinow DR, Schmidt PJ. ACTH and cortisol 
response to Dex/CRH testing in women with and without premenstrual dysphoria during 
GnRH agonist-induced hypogonadism and ovarian steroid replacement. J Clin Endocrinol 
Metab. 2012;97:1887-96. 
 77. Roca CA, Schmidt PJ, Altemus M, Deuster P, Danaceau MA, Putnam K, et al. Differential men-
strual cycle regulation of hypothalamic-pituitary-adrenal axis in women with premenstrual 
syndrome and controls. J Clin Endocrinol Metab. 2003;88:3057-63. 
 78. F. Chaouloff. Serotonin, stress and corticoids. J Psychopharmacol. 2000;14:139-151. 
 79. Porter RJ, Gallagher P, Watson S, Young AH. Corticosteroid-serotonin interactions in depres-
sion: A review of the human evidence. Psychopharmacology 2004;173:1-17. 
 80. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, et al. Association of anxiety-
related traits with a polymorphism in the serotonin transporter gene regulatory region. Sci-
ence.1996;274:1527-31. 
Chapter 1
24
 81. Karg K, Burmeister M, Shedden K, Sen S. The serotonin transporter promoter variant (5-HT-
TLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch 
Gen Psychiatry 2011;68:444-454. 
 82. Mueller A, Armbruster D, Moser D A, Canli T, Lesch K-P, Brocke B, et al. Interaction of se-
rotonin transporter gene-linked polymorphic region and stressful life events predicts cortisol 
stress response. Neuropsychopharmacology. 2011;36:1332-39. 
 83. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, et al. Influence of life stress 
on depression: moderation by a polymorphism in the 5-HTT gene. 2003;301:386-389. 
 84. Firk C, Markus CR. Review: Serotonin by stress interaction: a susceptibility factor for the 
development of depression? J Psychopharmacol. 2007;21:538-544
 85. Tarullo AR, Gunnar MR. Child maltreatment and the developing HPA axis. Horm Behav. 
2006;50:632-639. 
 86. Kaufman J, Plotsky PM, Nemeroff CB, Charney DS. Effects of early adverse experiences on 
brain structure and function: clinical implications. Biol Psychiatry. 2000;48:778-790. 
 87. Heim C, Newport DJ, Mletzko T, Miller AH, Nemeroff CB. The link between childhood trauma 
and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology. 
2008;33:693-710. 
 88. Teicher MH, Andersen SL, Polcari A, Anderson CM, Navalta CP, Kim DM. The neurobiological 
consequences of early stress and childhood maltreatment. Neuroscience and Biobehavioral 
Reviews. 2003. p. 33–44. 
 89. Margolin G, Gordis EB. The effects of family and community violence on children. Annu Rev 
Psychol 2000;51:445-479. 
 90. Cohen P, Crawford TN, Johnson JG, Kasen S. The children in the community study of develop-
mental course of personality disorder. J Pers Disord. 2005;19:466-486. 
 91. Lustyk MKB, Olson KC, Gerrish WG, Holder A, Widman L. Psychophysiological and neuro-
endocrine responses to laboratory stressors in women: Implications of menstrual cycle phase 
and stressor type. Biol Psychol. 2010;83:84-92. 
 92. Kirschbaum C, Kudielka BM, Gaab J, Schommer NC, Hellhammer DH. Impact of gender, 
menstrual cycle phase, and oral contraceptives on the activity of the hypothalamic-pituitary-
adrenal axis. Psychosom Med.1999;61:154-162. 
 93. Nielsen SE, Segal SK, Worden IV, Yim IS, Cahill L. Hormonal contraception use alters stress 
responses and emotional memory. Biol Psychol. 2013;92:257-266. 
 94. Kavanaugh ML, Jerman J, Hubacher D, Kost K, Finer LB. Characteristics of women in the 
United States who use long-acting reversible contraceptive methods. Obstet Gynecol. 
2011;117:1349-57.
Chapter 2
Maladaptive personality traits 
mediate cognitive appraisal during 
stress
J. Aleknaviciute
J.H.M. Tulen
A.M. Kamperman
S.A. Kushner
C.G. Kooiman
(submitted for publication)
Chapter 2
26
ABstrAct
Attachment and temperamental factors are considered to contribute to how an 
individual negotiates demanding environments. However, the influence of attach-
ment and temperament on the cognitive processing of psychosocial stress in women 
remains incompletely understood. Using structural equation modeling we exam-
ined the direct and indirect impact of attachment insecurity and temperament on 
the cognitive appraisals of acute psychosocial stress in women with high and low 
burdens of psychopathology. Additionally, the mediating role of maladaptive per-
sonality traits was considered. Female outpatients with a personality pathology (N= 
102) and healthy women (N= 96) were recruited. Cognitive appraisal was assessed 
during exposure to acute psychosocial stress in a laboratory setting. Our findings 
revealed that positive affectivity was directly linked to secondary appraisal of acute 
psychosocial stress. Maladaptive personality traits mediated the negative impact 
of both attachment anxiety and negative affectivity on primary appraisal of acute 
psychosocial stress. Notably, this pattern of associations was independently valid in 
both the patient and control samples. These findings confirm that positive affectivity 
buffers acute psychosocial stress. Furthermore, the results suggest that maladaptive 
personality traits are important factors in understanding the relationships between 
attachment, temperament, and mentalization capacity in stressful contexts, not only 
in clinical samples, but also in the general population.
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introduction
Adaptation to our environment involves complex dynamic interaction networks 
comprising emotions, cognitive processes, behavioral experiences and physiological 
responses (1,2). Research examining the utility of cognitive models underlying psy-
chological adjustment to environmental demands has shown that cognitive factors 
can interact significantly with stressors in the prediction of psychological adaptation 
(3-5). In addition, more recent studies have suggested a proximal impact of cognitive 
appraisal processes in mediating physiological responses following a stressor (6-10). 
These findings suggest that cognitive processes can be seen as important elements to 
influence the risk of, and resilience against, maladaptive health outcomes. 
cognitive appraisal during stress
The transactional stress model of Lazarus and Folkman (1984) remains a leading 
model to explain how environmental conditions influence adaptive functioning and 
well-being. This model posits that an individual, when opposed with a threatening or 
challenging situation, undergoes specific cognitive processes: appraisal of threat or 
challenge (how dangerous is the situation) and evaluation of coping resources (what 
are my capabilities to handle a demanding situation adequately). These cognitive ap-
praisal processes are an effortless and automatic interpretation of the perceived situa-
tion and are considered to occur as a result of the interaction between situational and 
personality characteristics (11). Interestingly, few research efforts have been made to 
pinpoint the dispositional personality characteristics contributing to this interaction.
Attachment and temperament: critical factors for psychosocial functioning
According to the stress-diathesis theory, individual differences in reactivity to stressful 
events are dependent on personality characteristics which might buffer, or on the con-
trary exacerbate, emotional upheaval and ultimately the development of psychiatric 
decompensation (12-14). Among the major factors leading to individual differences 
stress reactivity are temperamental biases which appear to be innate and stable over 
time (15-17); DSM-5 section III alternative model for personality disorders). Another 
personality-related aspect of clinical relevance is the concept of attachment style. In 
mammals, the tendency to develop an affective bond with a primary caretaker who 
protects and soothes an infant in distress, is considered to be inborn (18). Depend-
ing on experiences and interferences in (early) development, each infant/individual 
develops so-called working models or basic assumptions of oneself and others which 
establish his/her appraisal process, and psychological and physiological reactions to 
stress (19,20). Secure working models are theorized to be related to more flexible 
appraisal, appropriate emotional arousal and realistic interpretations of experiences, 
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together leading to constructive coping strategies. Conversely, insecure working 
models are associated with more rigid and rapidly established negative appraisals 
and inappropriate emotional arousal (21,22). In the psychotherapeutic literature, 
these working models are considered the building blocks of character and its related 
pathology, with insecure attachment being related with inadequate capacities to 
mentalize that in turn hamper adequate stress regulation. 
Whereas attachment and temperament are considered to be related constructs 
and suggested to contribute to individual differences in organizing and regulating 
thoughts, perceptions and emotions (23-26), very few studies have investigated the 
associations between personality characteristics and cognitive processes when an 
individual is exposed to acute psychosocial stress. Whereas emotional arousal or 
psychosocial stress has been suggested to impair mentalizing ability (27,28), the in-
fluence of basic personality characteristics such as attachment style or temperament 
on cognitive resources remains insufficiently determined.
Some studies of attachment and cognitive appraisal have demonstrated that threat 
appraisal differs between individuals as a function of attachment style during both 
attachment- and non-attachment-related stressors (29-31). Anxiously attached indi-
viduals exhibit hyper-reactivity to stress, tend to exaggerate their helplessness and 
vulnerability, and also are much more likely to ruminate over the stressful event (20). 
In contrast, individuals high in attachment avoidance are associated with emotional 
inhibition or suppression, the dismissal of threatening events, and a tendency to 
trivialize distress (20). Correspondingly, temperament might be considered to shape 
an individual’s appraisal of stress (32-34), and to predict or mediate distress (35-37). 
However, studies on the association between temperament and cognitive appraisal 
of acute stress are also scarce. Nevertheless, there is evidence that temperamental 
traits are related to an individual’s attitude and approach to life. Several reports dem-
onstrate that positive affectivity, as reflected in an optimistic and energetic approach 
to life, is associated with positive stress appraisal and flexible adaptation to changing 
environmental demands (38-42).
impact of maladaptive personality traits
Alternatively, individuals who express high negative affectivity tend to evaluate situ-
ations as threatening, uncontrollable or overall in negative terms (43). In addition, 
negative affectivity has been shown to play an important role in many forms of Axis 
I and Axis II psychopathology (44,45). Negative affectivity has been suggested to be 
related to the affective instability concept, which involves extreme shifts in mood, and 
disturbances in affect intensity and stability (46). Affective instability is an important 
feature in several forms of psychopathology and is widely described in the psychiatric 
literature (47,48). Affective instability might be considered a trait-like dimension or 
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a symptom profile representing a change from premorbid state. Notably, it has been 
suggested that affective instability uniquely predicts individual functioning even after 
controlling for the temperamental factor (49). To that end, dysfunctional personality 
traits such as emotional dysregulation might be more predictive than temperament 
traits in the responding to and approaching of stressful events. Although maladaptive 
personality traits are often found to be prominent in psychopathologies, they are not 
specific for clinical populations. Subclinical levels of dysfunctional traits are found in 
a substantial percentage of the general population (50).
Present study
Taken together, both attachment and temperament are thought to be major organizers 
of early cognitive-emotional development and are important factors in how an indi-
vidual deals with a demanding environment. Thus far, however, little attention has 
been given to the personality aspects involved in stress induced cognitive processes. 
Therefore, the aim of the present study was to explore the role of attachment and 
temperament on cognitive appraisals of acute psychosocial stress by developing an 
integrative model linking attachment insecurities (i.e., attachment related anxiety and 
avoidance) and temperament (positive and negative affectivity) to cognitive apprais-
als of acute psychosocial stress. In addition, we included in our model maladaptive 
personality traits (emotional dysregulation and dissocial behaviour) as a mediating 
variable in order to better understand the impact of dysfunctional personality traits on 
cognitive appraisals of an acute stressful situation. In order to explore the clinical rel-
evance of our model, we included two female samples: healthy females and females 
with a personality psychopathology. There is considerable evidence that cognitive 
appraisal and coping capacity with stress can be influenced by childhood trauma 
(51) as well as by temporary symptoms of anxiety and/or depression (52). Therefore, 
we performed sensitivity analyses to exclude the potential effects of psychological 
distress and childhood trauma on the model.
Psychosocial stress
To induce acute psychosocial stress, we used a well-established paradigm, the Trier 
Social Stress Test (TSST)(53). The TSST employs a combination of two important el-
ements, i.e. social-evaluative threat and uncontrollability (54). The TSST has been 
shown to be a reliable test to induce moderate psychosocial stress in a laboratory 
setting by challenging the participant’s self-esteem in interpersonal situation. Ad-
ditionally, the TSST has been shown to address an important aspect of individual’s 
self-identity including valued traits and abilities (53,54). A number of theories support 
the notion that humans are driven to preserve the social self and are vigilant to threats 
that may endanger their social esteem and status (18,54,55).
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mAteriAls And Procedures
Participants
The study sample comprised 198 female participants aged 18-45 years. Healthy 
female controls (n=96) were recruited through posted flyers and local internet ad-
vertisements. Women with a personality psychopathology (n=102) were recruited 
from the outpatient clinics for mental health in Rotterdam. Diagnoses were made by 
experienced psychotherapists, based on the Axis II DSM-IV criteria (56). Patients were 
considered ineligible to participate if they had a medical or comorbid diagnosis of 
bipolar disorder, schizophrenia or current major depression. Healthy female controls 
had no DSM-IV Axis I or Axis II diagnoses and without any history of psychiatric or 
psychological treatment. All participants were native Dutch speakers, of which the 
majority were Caucasian (n=187, 94.4%). 
Written informed consent was obtained from all participants. The study was con-
ducted according to the declaration of Helsinki and was approved by the Medical 
Ethical Research Committee of the Erasmus MC, University Medical Center Rotter-
dam. Participants were evaluated in two structured visits. During the initial visit, all 
subjects provided sociodemographic data and completed questionnaires regarding 
their general medical health, severity of personality pathology, attachment style, and 
temperament. During the second visit, the Primary Appraisal Secondary Appraisal 
scale (PASA) was administered immediately prior to the TSST.
Questionnaires
Attachment
The revised version of the Experiences in Close Relationships (ECR-r) is a self-report 
questionnaire with 36 items for the assessment of attachment-related anxiety and 
avoidance (57,58). Higher mean scores indicate greater degrees of attachment re-
lated anxiety and/or avoidance, indicating attachment insecurity. Low scores on both 
dimensions are considered to indicate attachment security. Participants were asked 
to think about their romantic partner while rating the appropriateness of each item 
on a 7-point Likert scale. Participants without a current partner were asked to rate 
how they felt generally during intimate relationships. The ECR-r is a frequently used 
self-report questionnaire to assess attachment style and is considered to have good 
psychometric properties (57-60). 
Temperament
The Positive and Negative Affect Scale (PANAS) (43,61) reflects affective processes, 
consistent with most conceptualizations and operational definitions of temperament 
(62). The PANAS comprises 20 items, with 10 items measuring positive affectivity (PA: 
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e.g. energetic, inspired) and 10 items measuring negative affectivity (NA: e.g. angry, 
upset). Each item is rated on a 5-point Likert Scale, ranging from 1 (Not at all) to 5 
(Extremely), measuring the extent to which different affective states have been expe-
rienced at a specific point in time. PA and NA reflect dispositional dimensions, with 
high NA characterized by subjective distress and unpleasant engagement, whereas PA 
refers to the extent to which an individual experiences pleasurable engagement with 
the environment. The PANAS is designed to measure affect in various contexts such 
as at present or in general. Since we were interested in measuring dispositional affect, 
we used the time frame ‘in general’. The PANAS has good reliability and validity (61). 
Dysfunctional Personality traits
The Dimensional Assessment of Personality Pathology - Short Form (DAPP-SF; (63,64) 
is the abbreviated version of the DAPP–BQ (Livesley & Jackson, 2009). The DAPP-
SF has 136 items, scored on a 5-point Likert scale, assessing DSM–IV personality 
pathology. The four scales constitute the domains emotional dysregulation, dissocial 
behavior, inhibition and compulsivity. In this study, the DAPP-SF was not intended 
as an assessment of Axis-II diagnoses of psychopathology according to the DSM-IV 
criteria, but rather to assess maladaptive personality traits, with higher scores indicat-
ing a greater burden of maladaptive personality traits. In the context of our study 
design, i.e. exposure to acute psychosocial stress, we were explicitly interested in 
the mediating effects of emotional dysregulation and dissocial behavior on cognitive 
stress appraisal. Emotional dysregulation is a core feature indicating instability and 
is acknowledged as a more general personality dysfunction (65,66). This domain is 
organized around two core emotional traits, affective lability and anxiety, which are 
associated with cognitive disorganization, especially in times of stress. Dissocial Be-
havior pattern comprises callousness and rejection features which are also related to 
rigid cognitive style. Dissocial Behavior is also seen as an amplifier of the expression 
of other maladaptive traits (66).
Each scale of the DAPP-SF has a theoretical range from 1 to 5, with higher scores 
indicating greater personality pathology. The internal consistency of the DAPP-SF has 
been proven to be satisfactory (0.78–0.89) (63).
Psychological distress and childhood trauma
In order to exclude the potential effects of psychological distress and childhood 
trauma on the model, we administered The Brief Symptom Inventory (BSI) (67) and 
the Childhood Trauma Questionnaire-Short Form (CTQ-SF) (68,69). 
The BSI is a 53-item self-report inventory in which participants rate the extent to 
which they have been bothered (0 =”not at all” to 4=”extremely”) during the past 
two weeks by various symptoms. The BSI has nine subscales (67). For this study, 
Chapter 2
32
we were interested only in the subscales Anxiety and Depression as indicators of 
psychological distress. 
The CTQ-SF is a 28-item self-report questionnaire to assess the severity of multiple 
forms of abuse and neglect during childhood (68,69). The CTQ-SF measures five 
dimensions of childhood trauma: sexual abuse, physical abuse, emotional abuse, 
physical neglect and emotional neglect. Each item is rated on a five-point Likert-type 
scale ranging from (1= Never true to 5=Very often true). The questionnaire provides 
a score for each subscale (from 5 to 25) and a total score. For this study we used the 
total score.
Cognitive appraisal of acute stress
The Primary Appraisal Secondary Appraisal (PASA) scale is a self-report questionnaire 
based on the transactional stress model proposed by Lazarus and Folkman (1984). 
The 16-item PASA scale assesses the anticipatory cognitive appraisal of a stressful 
psychosocial situation using a six-point Likert scale (1=Strongly disagree to 6=Strongly 
agree).The scale has moderate to good internal consistency for both subscales (6). 
The PASA scales are organized into Primary Appraisal and Secondary appraisal 
scales (70). Primary appraisal refers to a person’s judgment about the significance 
of an event as stressful, demanding, or irrelevant. Secondary Appraisal assesses the 
available coping resources and options when faced with a stressor. Whereas high 
scores on the Primary Appraisal scale indicate that the situation is threatening or 
challenging for the individual, high scores on the Secondary Appraisal scale indicate 
that the individual has sufficient resources to handle the situation. Subjects were 
asked to complete the PASA scale during the anticipation period of the psychosocial 
stress task (TSST).
trier social stress test (tsst)
We applied the standard protocol of the TSST as described by Kirshbaum et al. (1993). 
Subjects were informed about the TSST procedure by the researcher and asked to pre-
pare a 5-minute speech intended to convince a panel of judges regarding “why you 
would be a good candidate for your ideal job”. Subjects were introduced to the panel 
of judges (2 persons), and subsequently given 5 minutes to prepare their speech while 
seated (Anticipation Period). Participants completed the self-report PASA scale at the 
end of the Anticipation Period. Next, the panel entered the room and the subjects 
were invited to stand and deliver their speech (Public Speaking Task). The Public 
Speaking Task was followed by a 5-minute Mental Arithmetic Task. During both tasks, 
the panel monitored the participants’ performance without offering any verbal or 
non-verbal feedback, while maintaining affectively neutral facial expressions. After 
the task, the subjects were debriefed about the TSST.
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stAtisticAl AnAlysis
Data were checked for (multivariate) normality, linearity and multicollinearity. We 
did not observe outliers using Mahalanobis distance criterion (71). In 12 cases we 
observed missing values, representing <2% of all data. Cases with missing values 
were dropped list wise. T-tests were used to compare appraisal, attachment, affect 
and personality parameters between patients and healthy control women. Relation-
ships between these variables were calculated using Pearson’s bivariate correlations 
independently for patients and controls. Correlation coefficients for patients and 
healthy controls were compared using Fisher’s z-tests. 
We used structural equation modeling (SEM) analysis to test our model. The major 
advantages of this analysis are: a) the ability to identify direct and indirect effects, 
b) the ability to identify corresponding errors, c) to examine associations among 
multiple independent and dependent variables, and d) to test the invariance of the 
model independently within patient and healthy control groups. For the latter aim 
(d), we used a two-tier approach. The first tier was to analyze an unconstrained and 
a constrained model. In the unconstrained model, magnitude and significance of all 
direct and indirect paths from attachment and temperament to personality and stress 
appraisal were estimated independently in the patient and healthy control groups. 
The effects were free to differ across these two groups. In the constrained model, the 
effects of the independent and dependent variables were constrained to be equal 
across the patient and healthy control groups. If the constrained model significantly 
worsened the fit of the model in comparison to the unconstrained model, this would 
be evidence of differing relationships between the variables between groups (72). 
The second tier was to test whether personality variables contributed significantly 
to the quality of the model fit. For this aim, the magnitude of the direct paths to and 
from the personality variables were constrained to zero (i.e., no effect) in a series of 
models. We started with the most constrained model (all direct paths to and from 
personality parameters constrained to zero), and compared the fit to the model with-
out constraints for the personality parameters. In subsequent steps, less constrained 
models were tested. 
Model fit and path coefficients were estimated using a robust maximum likelihood 
(MLR) method to allow for deviation from multivariate normality and missing data 
(73). Nested models were compared using a chi-squared test with Satorra-Bentler 
correction, in which the degrees of freedom are equal to the difference in the degrees 
of freedom for the test-statistics of two models (74). Goodness of fit of the model was 
evaluated using a chi-squared statistic with non-significant p-value (P>0.05) and a 
c2/df ratio < 1.5, Comparative Fit Index (CFI) ≥ 0.95 (75), Tucker-Lewis Index (TLI) 
≥ 0.95 (76), Root Mean Square Error of Approximation (RMSEA) < 0.06 (77), and a 
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Standardized Root Mean Square Residuals (SRMR) < 0.05 (78). Statistical significance 
of the path coefficients was established through the examination of the z-values (79). 
Sensitivity analyses were conducted by dividing the sample into two subsamples: 
with and without anxiety or depressive symptoms (median split of the scores on the 
BSI subscales Anxiety and Depression). Furthermore, we also tested the invariance 
of the path model both overall and independently across women with and without a 
history of childhood trauma. All analyses were conducted using M-Plus version 7.31.
results
sample description
Participants ranged in age from 18-45 years (M = 29.04 years, SD = 7.35), of which the 
patient and control groups were similarly aged (Table 1). Forty percent of the women 
were unmarried. The majority (83%) of the healthy controls were highly educated, 
whereas 55% of the patients had a high degree of education, 41% of the patients had 
a middle education degree. With regard to ethnicity, 94% of all participants were 
identified as Caucasian. Women with psychopathology reported significantly higher 
rates of childhood trauma and higher scores on depression and anxiety scales (Table 
1). All women lived in the Rotterdam area of the Netherlands.
univariate analyses
Descriptive statistics of the main study variables of both the patient and control 
groups are presented in Table 1. T-tests were used to compare the reported scores of 
cognitive appraisal, attachment styles, affective and dysfunctional personality traits 
(emotional dysregulation and dissocial behavior) between the patient and control 
groups. Significant differences were observed for every parameter examined: patients 
scored significantly higher on primary appraisal, but significantly lower on second-
ary appraisal of acute stress than healthy controls (Table 1). Furthermore, patients 
reported significantly higher scores on attachment related avoidance and anxiety 
dimensions than healthy women. Additionally, patients scored significantly higher 
on negative affect, but lower on positive affect dimensions than healthy women. 
Also, the scores on emotional dysregulation and dissocial behavior were significantly 
higher in patients than in healthy controls. 
Bivariate correlations
Patients and healthy controls were further analyzed by calculating Pearson correla-
tion coefficients independently per group. Moderate to large correlations were found 
among attachment insecurities (anxiety and avoidance), negative affect and maladap-
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tive traits (emotional disturbance and dissocial behavior) in both the healthy and the 
patient groups (Table 2). However, a moderate association between positive affect 
and secondary appraisal was found only in the healthy control group (Table 3). 
measurement model and model fit
The model fit was initially tested for the overall cohort, including both the patients and 
healthy control samples, in which the estimated path coefficients were unconstrained. 
The unconstrained model provided a good model fit: Chi2(2)=2.601; p=0.27;Chi2/
df = 1.30; CFI=0.998; TLI =0.949; RMSEA = 0.055 (95%CI: 0.000 to 0.215); SRMR 
=0.020. Figures 1a and 1b show the final multi-group model for healthy controls and 
patients, respectively. In the final model, all path coefficients were constrained to be 
equal across the patients and healthy controls. The final model also provided a good 
model fit: Chi2 (24) =27.614; p=0.2766; Chi2/df = 1.15; CFI=0.989; TLI =0.974; RM-
SEA=0.039 (95% CI: .000 to .094); SRMR =0.085. Coefficients with 95% confidence 
table 1. Mean (SD) scores of all variables for the patient and control group, separately.
 Patients healthy controls t-test
Mean (SD) Mean (SD)
Age (years) 29.89 (7.69) 28.14 (6.91) t(196)=-1.688; p=0.093
PASA scale
Primary appraisal 9.24 (1.32) 8.26 (1.54) t(193)=-4.788; p<0.001
Secondary appraisal 7.44 (1.19) 8.06 (1.06) t(193)=-3.857; p<0.001
DAPP-SF
Emotional dysregulation 212.36 (48.94) 135.16 (36.46) t(184)=-12.374; p<0.001
Dissocial behavior 76.44 (19.64) 64.55 (16.32) t(184)=-4.448; p<0.001
PANAS
Positive affectivity 27.69 (7.69) 34.92 (5.61) t(196)=7.515; p<0.001
Negative affectivity 31.76 (8.68) 18.63 (6.27) t(196)=-12.144; p<0.001
ECR-r
Anxious attachment 4.12 (1.24) 2.54 (1.15) t(196)=-9.3320; p<0.001
Avoidant attachment 3.24 (1.11) 2.33 (0.84) t(196)=-6.531; p<0.001
CTQTotal 26.42 (8.17) 19.29 (5.57) t(195) =-7.11; p<0.001
bsiANX 1.30 (0.98) 0.16 (0.23) t(192) = -11.01; p<0.001
bsiDEP 1.52 (1.01) 0.21 (0.34) t(192) = -12.04; p<0.001
Abbreviations: Primary Appraisal and Secondary Appraisal scale (PASA); The Dimensional Assessment 
of Personality psychopathology – short form (DAPP-SF); Positive and Negative affect scale (PANAS); 
Experience in Close Relationships- revised (ECR-r). The Childhood trauma questionnaire (total score) 
(CTQTotal); The Brief Symptom Inventory, anxiety scale (bsiANX); The Brief Symptom Inventory, depres-
sion scale (bsiDEP).
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table 2. Correlations between all variables, for the patient (top right corner, grey) and the control group 
(bottom left), separately.
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Emotional dysregulation .36** -.05 1.00 .60** -.18 .57** .46** .11
Dissocial behavior .28** -.06 .71** 1.00 -.06 .32** .31** .09
Positive affectivity -.15 .38** -.27* -.16 1.00 -.06 -.11 -.09
Negative affectivity .25* -.16 .63** .43** .05 1.00 .29** .01
Anxious attachment .29** -.14 .74** .57** -.13 .55** 1.00 .28**
Avoidant attachment .14 -.15 .51** .47** -.19 .39** .55** 1.00
*= p <0.01; **= p < 0.001
table 3. Significance of differences in correlations between patients and healthy controls (Fisher Z-tests).
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intervals (CI) of the paths in the model are reported in Table 4. Thick lines represent 
significant paths (Figure 1). Dotted lines represent paths to and from the personality 
parameters that do not contribute to the model fit. The model demonstrated that 
in patients, attachment avoidance did not have direct or indirect effects on cogni-
tive stress appraisal (β = -0.04, 95%CI = -0.14-0.23). Attachment anxiety was not 
directly associated with primary and secondary appraisal but had an indirect effect 
on primary appraisal outcome (β = 0.12, 95%CI = 0.03-0.21). With respect to the 
temperamental dimensions: positive affect was directly associated with secondary 
appraisal (β = 0.43, 95%CI = 0.31-0.56), whereas negative affectivity had an indirect 
effect on primary appraisal (β = 0.13, 95%CI = 0.03-0.23). 
Notably, the model showed identical pathways in the healthy controls as observed 
among patients. Attachment avoidance exhibited no direct or indirect effects on 
cognitive stress appraisal (β = -0.03, 95%CI = -0.15-0.09). Attachment anxiety was 
not directly associated with primary and secondary appraisal, but it had an indirect 
effect on primary appraisal outcome (β = 0.01, 95%CI = 0.02-0.18). Positive affect 
was directly associated with secondary appraisal (β = 0.38, 95%CI = 0.24-0.51), 
while negative affect had an indirect effect on primary appraisal (β = 0.08, 95%CI = 
0.01-0.14). 
To understand the contribution of the dysfunctional personality trait parameters, 
paths to and from emotional dysregulation and dissocial behavior were fixed at zero 
in a stepwise procedure. Fixing the paths from dissocial behavior to primary and 
secondary appraisal at zero (model 7) did not result in a significant decrease of the 
model fit compared to the unconstrained model (model 0) (Table 5). In contrast, fixing 
paths to and from emotional dysregulation (models 1-3, and models 4-6) resulted in 
a significant worsening of the model fit, confirming the important contribution of 
emotional dysregulation to the quality of the model fit. 
The final model accounted for 4% of the variance of primary appraisal and for 
13% of the variance of secondary appraisal in healthy women. In patients, the model 
accounted for 10% of the variance of primary appraisal and 19% of the variance of 
secondary appraisal. The model also accounted for 60% of the variance of emotional 
dysregulation in healthy women and 46% of the variance of emotional dysregulation 
in patients.
sensitivity analysis
Sensitivity analyses demonstrated an invariant model fit for women with and without 
anxious or depressive symptoms (Chi2(24)=30.589; p=0.167), and for women with 
and without a history of child abuse (Chi2(24) = 22.468; p=0.551). This indicates that 
the outcome of the model varies neither as a function of the presence of depressive or 
anxiety symptoms, nor the presence of a history of childhood trauma.
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figure 1. Path models and standardized path coefficients for the prediction of primary and secondary 
stress appraisal in the patient (A) and the healthy control (B) groups.
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discussion
The aim of this study was to explore the role of general basic personality charac-
teristics, such as adult attachment insecurity and temperament, on cognitive stress 
appraisals in a sample of women with both, high and low burden of personality 
psychopathology. We built a multifaceted model of cognitive stress appraisals that il-
lustrates how adult attachment insecurities and temperament may operate in shaping 
the individuals’ appraisals of psychosocial stress. Given that our sample consisted of 
healthy and females with high burden of personality psychopathology characterized 
with elevated emotional disturbance, we constructed our model with consideration 
of the mediating role of maladaptive personality features. 
Although our model demonstrated no noticeable direct associations between 
attachment insecurities and cognitive stress appraisals, attachment anxiety was 
positively linked to negative affect and maladaptive personality traits. We found that 
emotional dysregulation was significantly associated with primary stress appraisal 
indicating that individuals with higher emotional dysregulation judge situations to be 
more stressful. Accordingly, our final model showed that the influence of attachment 
table 5. Fit of the nested models with constraints for personality parameters. 
Model Description
Log-
Likelihood
∆Chi-
square1
∆df Significance
0 No constrains -4244.11 - - -
emotional dysregulation (ed) and dissocial Behavior (dB)
1
Paths from ED and DB to Primary and Secondary 
Appraisal constrained to ‘0’
-4249.50 10.90 4 P= 0.028
2 Paths to ED and DB constrained to ‘0’ -4364.33 180.90 8 P<0.001
3 All paths to and from ED and DB constrained to ‘0’ -4368.55 202.40 12 P<0.001
emotional dysregulation (ed)
4
Paths from ED to Primary and Secondary Appraisal 
constrained to ‘0’
-4248.74 10.05 2 P<0.007
5 Paths to ED constrained to ‘0’ -4361.56 166.57 4 P<0.001
6 All paths to and from ED constrained to ‘0’ -4365.11 194.09 6 P<0.001
dissocial Behavior (dB)
7
Paths from DB to Primary and Secondary Appraisal 
constrained to ‘0’
-4244.56 0.85 2 P=0.654
8 Paths to DB constrained to ‘0’ -4276.07 60.50 4 P<0.001
9 All paths to and from DB constrained to ‘0’ -4276.56 61.50 6 P<0.001
1 Change in Chi-square value compared to the unconstrained model including Santorra-Bentler cor-
rection
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anxiety and negative affect on primary cognitive appraisal of stress is mediated by 
dysfunctional personality traits. This finding suggests that attachment anxiety and 
negative affectivity do not fully capture the background of cognitive stress appraisal 
during psychosocial stress exposure. However, considering the strong association 
between attachment anxiety, negative affect and emotional disturbance (44,45,80) 
and their indirect link to cognitive appraisal, attachment anxiety and negative af-
fectivity might be considered as predisposing factors for individual differences in 
cognitive stress appraisal.
The inclusion of individual components of dysfunctional personality traits un-
covered the importance of emotional dysregulation in stress appraisal. This finding 
implies that, when exposed to a challenging situation, the significance of cognitive 
appraisal is augmented not only by varying influences of attachment style and/or tem-
perament, but also by emotional dysregulation. Thus, when exposed unexpectedly to 
a socially threatening situation, someone with more affective susceptibility might be 
overwhelmed by intense emotion, leading to exaggerated perceptions of threat of a 
specific situation. In addition, our finding is also in line with studies suggesting that 
affective instability is a better predictor for the adaptive functioning than neuroticism 
(49). As such, this finding might be seen in the context of the multidimensionality 
of the mentalization approach, suggesting that under high arousal situations psy-
chological cognitive understanding is relatively impaired and replaced by emotional 
automatic processing (81). It might be argued that this finding is particularly relevant 
in women with a higher burden of psychopathology who exhibit significantly higher 
levels of maladaptive traits such as emotional dysregulation (82). 
Women with personality disorders reported significantly higher scores of attach-
ment insecurity, higher levels of negative affectivity and lower scores of positive 
affectivity. However, the independent analyses in the healthy and clinical samples 
revealed identical paths underlying the mediating role of dysfunctional traits. From 
a clinical perspective, this finding supports the generally accepted approach that 
people in the general population typically exhibit a combination of adaptive and 
maladaptive personality traits. Recently, it was shown that even in people selected for 
having low levels of maladaptive traits, these traits were still associated with negative 
social integration and health outcomes (83). Although the importance of including 
dimensional scores of maladaptive traits in conceptual and empirical models of 
personality and health outcomes has been recently advocated in clinical studies, the 
majority of studies in healthy populations has failed to consider traits that do not fall 
within the normal range of personality traits. In addition, there is a significant lack 
of agreement and consistency in how maladaptive personality traits are assessed, 
defined and measured. In the present study, we used the DAPP-SF questionnaire to 
assess dysfunctional personality traits. Although the DAPP-SF questionnaire has been 
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introduced as a dimensional alternative to assess DSM-personality pathology, the 
DAPP-SF also shows meaningful relationships with normal personality traits (84). Our 
healthy controls were explicitly screened for a low burden of psychopathology and 
the absence of overt psychiatric illness. However, a substantial variability observed 
in dimensions in our healthy sample supports the argument that maladaptive per-
sonality features are not solely specific to clinical populations (85,86). Accordingly, 
maladaptive personality features should be considered more broadly in the general 
population as an approach to improving the understanding of the factors underlying 
adaptive responses to stress and long-term health outcomes. 
Our model demonstrated that positive affectivity is directly linked to the secondary 
appraisal of psychosocial stress, and negatively associated with emotional dysregula-
tion. In contrast, negative affectivity was not directly related to cognitive stress ap-
praisal, however it was significantly associated with maladaptive personality traits. 
Therefore, individuals characterized with high positive affectivity appear to judge 
themselves as being more capable and having sufficient coping resources to negoti-
ate stressful situations. This finding supports prior research indicating that positive 
affectivity provides a buffer against maladaptive responses to stress and to contribute 
to an individual’s resilience (38,87). Earlier studies have demonstrated that resilient 
individuals who benefit from trait positive affectivity through stressful context reap-
praisal, tend to accomplish this using efficient emotional regulation and through 
more benign interpretations (87). Notably, the direct correlation between positive 
affectivity and secondary stress appraisal that we observed can be at least partly 
attributed to the incorporation of trait aspects of individual beliefs in one’s ability and 
control expectancy within the PASA scales (6). However, positive affectivity was also 
negatively correlated with emotional dysregulation, which is considered to be a more 
state dependent maladaptive trait.
Sensitivity analyses demonstrated that the effects of childhood trauma and gen-
eral distress did not impact the outcome of the model. Although a significant and 
long-lasting impact of childhood trauma on stress regulation has previously been 
postulated (88), correction for childhood trauma had no significant influence on the 
paths of the model. Similarly, the outcome of the model did not change as a function 
of anxiety or depression symptoms, which have been linked to elevated perceptions 
of threat (52). 
Our finding that attachment insecurity and negative affectivity are not directly 
linked to cognitive stress appraisals may be specific to our research design as we 
triggered cognitive appraisal processes following a laboratory-based stress induction. 
Whereas attachment styles and temperament are considered stable patterns with their 
biological implications and lasting manifestation, cognitive appraisal is considered to 
be a dynamic process that might alter the perception of stress. In addition, it has been 
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proposed that individuals do not necessarily appraise acutely stressful situations in 
the same manner as less acute contexts (70). The advantage of the PASA scale is that 
this questionnaire assesses the cognitive appraisals of stress during an anticipation 
period, when the stressor is pending and individual’s social-self is threatened. More-
over, the psychosocial stress task used in this study was not an attachment-related 
stressor which might have contributed to the lack of association between attachment 
style and cognitive appraisal. However, some studies have operationalized the ef-
fects of internal working models as support-seeking, self-esteem and self-worth (89). 
Therefore, the psychosocial stress paradigm which includes elements to intimidate 
an individual’s self-worth (54), might consequently activate the attachment system. 
The most notable limitation of this study is the modest sample size relative to 
typical recommendations for structural equation modeling. However, obtaining large 
samples of patients is difficult with a clinical assessment and detailed structured ex-
perimental protocol. Accordingly, our model will need replication in larger samples 
in order to confirm the validity and reliability of these findings. Furthermore, some 
caution should be used in interpreting the correlations between the constructs. For 
example, a high correlation between emotional dysregulation and negative affectivity 
might have contributed to the overlap between these constructs. However, although 
emotional dysregulation and negative affectivity are related, increasing evidence sup-
ports the conceptualization of emotion dysregulation as a distinct construct (50,90). 
Furthermore, structural equation modeling does not permit assessments of interaction 
effects on the outcome variable. Hence, we were not able to examine the interactive 
contributions of attachment and temperament on the cognitive appraisal, which might 
have better explained the individual susceptibilities to environmental demands.
This study makes several novel contributions to the existing literature. First, our 
model reveals that when exposed to a challenging situation, cognitive perception is 
augmented by the coincident influence of emotional dysregulation, and indirectly by 
varying influences of attachment style and temperament. Second, our model identi-
fies that positive affect contributes to a buffering against maladaptive consequences 
of stress, which might be seen as a key to resilience. Lastly, we found that every 
observed association between attachment styles, temperament and cognitive stress 
appraisals, including the mediating role of maladaptive traits, applied equivalently to 
women with low or high burdens of psychopathology. Accordingly, this observation 
provides additional evidence that maladaptive personality traits are critical factors 
in understanding the contribution of individual characteristics on the cognitive ap-
praisal of acute psychosocial stress.
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ABstrAct
The serotonin transporter gene-linked polymorphic region (5-HTTLPR) has previ-
ously been associated with hypothalamus-pituitary-adrenal (HPA) axis function. 
Moreover, it has been suggested that this association is moderated by an interaction 
with stressful life experiences. We investigated the moderation of cortisol response to 
psychosocial stress by 5-HTTLPR genotype, either directly or through an interaction 
with early life stress. One hundred and fifty one women performed the Trier Social 
Stress Test (TSST), during which salivary cortisol response patterns were assessed. Our 
results demonstrate a main effect of genotype on cortisol reactivity, in which women 
carrying two copies of the long version of the 5-HTTLPR exhibited stronger cortisol 
responses to psychosocial stress than women with at least one copy of the short 
allele. However, the proportion of the variance in cortisol response explained by 
5-HTTLPR genotype as a single factor was not further strengthened when an interac-
tion of 5-HTTLPR genotype with early life adversity was considered. Future studies 
are needed to further explore the psychophysiological and molecular factors affecting 
the relationship between 5-HTTLPR and HPA axis reactivity to psychosocial stress.
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introduction
Gene by environment interactions have been a widely touted, but often difficult 
to replicate, concept in psychiatric genetics (1). In particular, a considerable focus 
has been devoted to potential interactions between the serotonin transporter gene 
polymorphic region (5-HTTLR) and adverse life experience. A common 44 base pair 
insertion/deletion polymorphism in the 5-HTTLPR is known to be involved in the 
reuptake of serotonin by the serotonin transporter in the brain through transcriptional 
efficiency of the long (L) and short (S) alleles (2). The seminal report of a prospec-
tive longitudinal study of Caspi et al. (3), showing the S allele carriers to be more 
vulnerable to depression upon exposure to environmental adversities, was followed 
by many studies which varied in their success to replicate this finding (4-10). Fur-
thermore, several meta-analyses, focused on the 5-HTTLPR by environmental stress 
interaction in depression as the outcome variable, demonstrated inconclusive results 
(11,12). Nevertheless, the diversity of studies and ongoing controversy have led to an 
increasing interest in stress-related biological pathways mediated by the serotonergic 
system in the development of psychopathology. 
The hypothalamus-pituitary-adrenal (HPA) axis is one of most well studied mecha-
nisms through which the 5-HTTLPR might interact with stressors (13). The serotoner-
gic system has been suggested to be ideally positioned to regulate glucocorticoid 
secretion via its ability to influence neural activity at the hypothalamic, pituitary, 
and adrenal levels (12). Based on the observations of altered HPA axis activity in a 
broad range of stress-related psychiatric disorders (14,15), a number of studies have 
focused on the associations between the 5-HTTLPR genotype and HPA axis reactivity 
to acute stress (16-23). Thus far, contradictory results have been found. Several stud-
ies demonstrated that 5-HTTLPR homozygous S allele carriership is associated with 
elevated cortisol responsivity to psychosocial stress (16-18). However, other studies 
failed to support these initial findings (19-22), or reported opposite results (23). Re-
cently, a meta-analysis has been published in which the authors reported statistically 
significant association of small effect between the 5-HTTLPR genotype and HPA 
axis reactivity to acute psychosocial stress with the SS variant demonstrating higher 
cortisol responses than the SL or LL variant of the 5-HTTLPR (24). In addition, there is 
increasing evidence that the association between 5-HTTLPR and HPA axis reactivity 
is stronger when stressful environmental factors are taken into account (18,22). Two 
previous studies have suggested that the effects of the 5-HTTLPR on cortisol reactivity 
are stronger in individuals with a history of stressful life events (19,23).
Taken together, the nature of the relationship between the 5-HTTLPR and cortisol 
reactivity remains unresolved. Our primary goal was to assess whether cortisol reac-
tivity to psychosocial stress varies as a function of 5-HTTLPR genotype in a cohort 
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of women. In addition, we aimed to examine whether the magnitude of cortisol 
reactivity is modulated by an interaction between 5-HTTLPR genotype and childhood 
adversity. While a certain degree of challenge during childhood may enhance lifelong 
coping skills (25), overwhelming early life stress has been strongly associated with 
an increased lifetime risk of psychopathology (26). Therefore, in order to have the 
potential to evaluate a wider range of childhood maltreatment severity, we included 
both medication-free women who were recently diagnosed with personality disorder 
and at the beginning of outpatient therapy, as well as matched healthy controls. 
methods
Participants
The study sample comprised 151 female participants of reproductive age (18-45 
years). Women were self-referred in response to advertisements (n=66), or recruited 
from mental health outpatient clinics (n=85). Personality disorders were diagnosed 
using Axis II DSM-IV criteria (27). Patients were considered ineligible to participate 
if they had a medical or comorbid diagnosis of bipolar disorder, schizophrenia or 
current major depression. Women screened for the control group were excluded 
on the basis of any DSM-IV Axis I or Axis diagnosis, or any history of psychiatric 
or psychological treatment. In addition, global exclusion criteria for both groups 
included current medication (with the exception of oral monophasic contraceptives 
containing a combination of ethinylesatradiol and androgenic progestin), pregnancy, 
lactation, irregular menstrual cycle, and body mass index (BMI) < 18 or >30. In 
addition, women were excluded on the basis of any prior diagnosis of endometriosis, 
polycystic ovary disease, or gynaecologic infection. Naturally-cycling women were 
studied in the luteal phase of their menstrual cycle. Women using oral contraceptives 
were tested during the active pill weeks. The majority of the sample were Caucasian 
(n=139) and native Dutch speakers. Twelve Dutch-speaking women were of Nether-
lands Antilles heritage and mixed ethnicity.
Written informed consent was obtained from all the participants. The study was 
conducted according to the declaration of Helsinki and approved by the Medical 
Ethical Research Committee of the Erasmus MC, University Medical Center Rotter-
dam.
Procedure
After a structured interview by telephone to confirm the inclusion and exclusion 
criteria, participants were invited to the first session, which comprised the diagnostic 
interview for Axis I disorders using the Structured Clinical Interview for DSM-IV-TR 
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(SCID) (27). In addition, participants completed the Brief Symptom Inventory (BSI) 
(28-30) to evaluate psychological distress and psychiatric disorders, and the short 
form of the Childhood Trauma Questionnaire (CTQ) (31,32) to assess the severity of 
multiple forms of abuse and neglect.
The experimental session was scheduled during a second visit to the lab. The par-
ticipants were asked to abstain from alcohol, nicotine, caffeine and intense physical 
activity for at least 24 hours prior to the experimental session. All measurements were 
performed between 14.00 and 16.00 hours to minimize potential circadian influences 
on cortisol responses. After an acclimatization period of 15 minutes, the experiment 
began with a baseline period of 5 minutes, after which a saliva sample was obtained. 
Subsequently, the participants underwent the TSST procedure. Immediately following 
the TSST, additional saliva samples were obtained at +1, +15, +35, and +55 minutes. 
The subjects were debriefed after the last saliva sample was collected.
Questionnaires
The Brief Symptom Inventory (BSI) (28-30) is a self-report questionnaire with 53 items 
on a four-point Likert scale assessing general psychological difficulties (total score) 
including somatisation, anxiety, depression, hostility (nine subscales). The BSI has 
adequate psychometric properties and good sensitivity to therapeutic changes. 
The 28-item Childhood Trauma Questionnaire – Short Form (CTQ) was used to as-
sess the severity of multiple forms of abuse and neglect during childhood (31,32) The 
CTQ has five domains: physical abuse, sexual abuse, emotional abuse, physical ne-
glect, and emotional neglect. The total CTQ score was used as an index of childhood 
trauma. 
the trier social stress test (tsst)
All participants performed the TSST. The TSST was administered according to the 
protocol of Kirshbaum et al. (33). First, the subjects were informed about the TSST 
procedure and asked to prepare a 5-minute speech intended to convince a panel 
of judges regarding why they would be a good candidate for their ideal job. Sub-
jects were given 5 minutes to prepare their speech while being seated (Anticipation 
period). Next, the panel entered the room and subjects were invited to stand and 
deliver their speech (Public Speaking Task, PST). The PST was followed by a 5-minute 
Mental Arithmetic Task (MAT). During the PST and the MAT, the panel monitored the 
participants’ performance without offering any verbal or non-verbal feedback, and 
while maintaining an affectively neutral facial expression. Furthermore, the subjects 
consented to audio-video recording of the session, for which the camera and tripod 
were positioned prominently within the room, in direct view of the subject. 
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cortisol assay
Saliva samples were collected using Sarstedt Cortisol Salivette® cotton swab collec-
tion tubes. Participants were asked to chew on the swabs for 2 minutes to stimulate 
saliva flow. Samples were stored at -20 °C until analysis. The free salivary cortisol was 
measured using a commercially available ELISA kit (Demeditec Diagnostics, Kiel, 
Germany, DES6611). The inter- and intra-assay coefficients of variation were below 
10% and 7%, respectively.
5-httlPr genotyping
DNA was isolated from the saliva collected with the Salivette® device from Sarstedt 
using an adapted version of the Qiagen Buccal Brush DNA purification kit. Purified 
DNA was PCR amplified using the following primers [Fw 5’-TGCGGGGGAATACT-
GGTAGG-3’; Rev 3’-GAACGTGGGAGGCAGCAGAC-5’]. Amplified DNA was 
separated with electrophoresis using a 2% agarose gel containing ethidium bromide. 
Electrophoresis was performed at 120V and 100mA for 2 hours. %-HTTLPR genotype 
was visually determined based on the height and number of DNA bands under ultra-
violet light.
statistical analysis
Statistical analyses were performed using the SPSS statistical software package (IBM 
SPSS Statistics, Version 21). Results are expressed as means ± SEM, unless otherwise 
specified. Data per parameter was tested for normality of the distribution using visual 
inspection of q-q plots and Levene’s tests for homogeneity of variance. To meet the 
normality assumption, cortisol data was logarithmically transformed. For descriptive 
purposes, the mean data shown in the figures is presented in original units. Hardy–
Weinberg equilibrium was determined based on the total 5-HTTLPR sample (N =151) 
using chi-square tests. Initial group comparisons between women with personality 
disorders and healthy controls were conducted using chi-square tests and analyses of 
variance (ANOVA). In subsequent analyses, main effects of, and interactions between, 
the 5-HTTLPR genotype (bi-allelic genotype classification) and CTQ total scores on 
the cortisol stress response were assessed. The cortisol response to the TSST was 
computed by subtracting the baseline measurement of cortisol from the peak value, 
15 minutes after the stress test. In accordance with previous studies, we identified 
oral contraceptive status (non-users vs users) and psychopathology (healthy controls 
vs Cluster-C PD vs BPD) as variables associated with altered cortisol reactivity; these 
variables were entered as fixed factors in the analyses. Although equally distributed 
between genotypes (Table 1), additional analyses were calculated controlling for age, 
BMI and ethnicity to ensure robustness of the results. However, due to their insig-
nificance, these variables were omitted from the final analyses. Greenhouse-Geisser 
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corrections were applied where appropriate, and adjusted results are reported. Effect 
sizes were calculated by partial eta squared (Ƞ2). P values less than 0.05 were consid-
ered to be statistically significant.
results
Sample characteristics of the participants classified by 5-HTTLPR genotype are 
shown in Table 1. Participants were divided on the basis of the bi-allelic (SS, SL and 
LL) classification. Genotype frequencies were consistent with the Hardy–Weinberg 
Equilibrium [c2 (1) = 0.43; P = 0.51]. Participants classified by 5-HTTLPR genotype 
did not differ regarding age, BMI, ethnicity, oral contraceptive use, distribution of 
psychopathology, childhood trauma score, or psychological distress score (all P-
values ≥ 0.10). 
We found a significant effect of the 5-HTTLPR genotype on cortisol responsivity 
to the TSST [F(2,142) = 3.46, P = 0.03, Ƞ2 = 0.05]. Specifically, the LL allele carriers 
demonstrated the strongest cortisol responses to psychosocial stress (Figure 1). Analy-
sis of covariance revealed no significant influence of the CTQ score [F(1,44) = 0.07, P 
= 0.80], nor was there a significant interaction of 5-HTTLPR x CTQ score on cortisol 
responsivity to the TSST [F(2,142) = 0.66, P = 0.52]. The main effect of 5-HTTLPR 
genotype remained significant when controlling for psychopathology and oral con-
traceptive use, as well as when age, BMI, and psychological distress were included 
as covariates. In addition, no effect of ethnicity was found on cortisol responsivity 
to the TSST. A significant main effect of psychopathology was observed [F(2,141) = 
table 1. Sample characteristics (mean, SD) categorized by 5-HTTLPR genotype.
5-HTTLPR genotype P
Total (n = 151) LL (n = 46) SL (n = 71) SS (n = 34)
Age (SD) 28.29 ± 6.97 28.00 ± 6.03 28.51 ± 7.41 28.24 ± 7.38 0.93
BMI (SD) 23.13 ± 6.97 22.80 ± 3.20 22.98 ± 3.24 23.87 ± 5.12 0.41
Smokers No. (% yes) 23.2% 19.6% 18.3% 38.2% 0.10
Ethnicity No. (% Caucasian) 92.1% 89.1% 94.4% 91.2% 0.69
Oral contraceptives (% yes) 47.0% 41.0% 50.7% 47.1% 0.55
Psychopathology (% yes) 55.8% 56.5% 50.7% 67.6% 0.40
CTQ total score (SD) 43.54 ± 12.62 45.59 ± 13.41 41.52 ± 11.05 44.97 ± 14.25 0.18
BSI total score (SD) 0.77 ± 0.81 0.69 ± 0.59 0.70 ± 0.79 1.03 ± 0.81 0.10
Abbreviations: CTQ, Childhood Trauma Questionnaire; BSI, Brief Symptom Inventory; BMI, Body Mass 
Index.
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3.28, P = 0.04, Ƞ2= 0.05], in which women with BPD exhibited signifi cantly lower 
cortisol responses to the TSST. Moreover, we observed a signifi cant main effect of oral 
contraceptives [F(1, 141) = 12.82, P < 0.0001, Ƞ2= 0.08] in which women using oral 
contraceptives had signifi cantly lower cortisol responsivity to the TSST.
To ensure that the signifi cance of the 5-HTTLPR effects on cortisol response were 
not infl uenced by sample stratifi cation regarding psychopathology or contraceptive 
use, the relationship between the 5-HTTLPR genotype and cortisol responsivity 
to the TSST was examined separately for each psychopathology group as well as 
the healthy control group. Although comparisons within these subsamples lacked 
suffi cient statistical power to established defi nitive conclusions, the qualitative 
genotype-dependent pattern of cortisol responsivity was similar in each group, with 
LL allele carriers showing the highest cortisol responses (Table 2). Likewise, a similar 
genotype-dependent pattern of cortisol response was observed as a function of oral 
contraceptive use, with LL allele carriers exhibiting higher cortisol responses to the 
TSST than SL or SS allele carriers (Table 2). 
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figure 1. Mean (± SEM) salivary cortisol response to the Trier social stress test (computed by subtracting 
the baseline measurement time point from the peak value 15 min. post-stress) as a function of 5-HT-
TLPR genotype in female participants; (* P < 0.05).
table 2. Mean salivary cortisol response (SEM) to the TSST in each psychopathology and oral contracep-
tive group by 5-HTTLPR genotype
Cortisol response (nmol/L) Psychopathology Oral contraceptives
HC Cluster-C BPD Non-users Users
LL 9.40 (2.12) 8.45 (2.76) 5.40 (1.56) 9.80 (1.85) 5.45 (1.53)
SL 5.72 (1.20) 5.37 (1.74) 1.47 (1.09) 6.17 (1.27) 2.66 (0.88)
SS 4.22 (2.29) 8.01 (2.37) 2.44 (1.26) 6.76 (1.89) 2.74 (1.24)
Abbreviations: HC, Healthy Controls; BPD, Borderline Personality Disorder.
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discussion
The results of our study demonstrated that 5-HTTLPR genotype is signifi cantly as-
sociated with cortisol responsivity to psychosocial stress in women. In particular, 
women with the LL genotype demonstrated signifi cantly higher free salivary cortisol 
responses to the TSST, compared to women carrying at least one S allele. Furthermore, 
the association of 5-HTTLPR genotype with cortisol responsivity to the TSST was not 
moderated by the burden of early life adversity as quantifi ed by the CTQ. 
While our results are in line with those of Mueller et al.(23), these fi ndings are 
more diffi cult to reconcile with other studies (16-22). Sex-based infl uences might be 
one of the important sources of this distinction. Based on the existing literature, it is 
diffi cult to draw fi rm conclusions about the infl uence of sex with regard to associa-
tions between 5-HTTLPR and cortisol responses to stress. Most studies have failed to 
specifi cally address sex-based differences, mostly due to study design, inadequate 
power problems, and by modeling sex as a covariate. Two earlier studies observed 
that cortisol responsivity to stress was particularly enhanced in female homozygous S 
allele carriers (16,34). In contrast, we now report a signifi cant, but opposite, associa-
tion. Several reasons might be responsible for the differences between earlier stud-
ies and our study. First, there are notable differences in age. The majority of earlier 
studies investigated particularly young cohorts, including newborns and adolescents 
(16,18-21), whereas our study included adult females with a mean age of 28 years, 
in a period of reproductive hormonal cycling that is highly distinct from children and 
young adolescents. A broad range of different behaviors and effects on physiological 
systems are highly infl uenced by ovarian steroid functioning (35). In addition to the 
well-known effects of the menstrual cycle on HPA axis activity, several studies have 
suggested that ovarian steroids exert a strong infl uence on the serotonergic system 
(36-39). Therefore, the modulating effect of the 5-HTTLPR on the cortisol response 
to stress might be different across qualitatively distinct reproductive age cohorts. Ac-
cordingly, age accounts for a substantial proportion of the variance across 5-HTTLPR 
genetic association studies of depression (40,41).
The infl uence of hormonal contraceptives containing ethinylestradiol should also 
be noted. Considering that the majority of women during their reproductive age rely 
upon hormonal contraceptives, we ensured that we were adequately powered to 
examine the infl uence of oral contraceptives. Our inclusion criteria required that oral 
contraceptives contained the most commonly used preparation of ethinylestradiol 
in combination with androgenic progestins. We observed a main effect of oral con-
traceptive use on the cortisol response to psychosocial stress. Cortisol responsivity 
was signifi cantly attenuated in women using oral contraceptives. This fi nding is con-
sistent with the well-established estradiol-induced increase in CBG levels, thereby 
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enhancing the buffering capacity of serum cortisol with a reduction of free cortisol 
availability (42). Yet, this observed effect of oral contraceptive use did not alter the 
association between 5-HTTLPR genotype and cortisol responsivity to the TSST. For 
future studies, an even greater emphasis on endogenous and exogenous hormones 
is needed in order to identify the underlying mechanisms by which hormonal status 
influences HPA axis functioning in women and the relationship to the serotonergic 
system.
More than half of the women included in our study were diagnosed with a per-
sonality disorder and were seeking outpatient psychological treatment. Although our 
sample has notable distinctions from the majority of previously investigated samples, 
some of the clinical features such as stress-vulnerability are comparable to previ-
ous samples at high-risk for depression (16,34). Indeed, in this study we observed 
that altered HPA axis reactivity to stress was associated with psychopathology. We 
acknowledge that including women with psychopathology complicates the interpre-
tation of the relationship between 5-HTTLPR genotype and cortisol reactivity. It has 
previously been suggested that psychopathological state affects both the HPA axis 
and the serotoninergic system (3,12,43,44). Nevertheless, when controlling for psy-
chopathology status, the main effect of 5-HTTLPR genotype on the cortisol response 
to the TSST remained significant and in the same direction. Although we phenotyped 
151 females, our sample was unfortunately underpowered to evaluate subsamples of 
psychopathological subgroups. However, inspection of these subsamples revealed 
a similar pattern of elevated cortisol reactivity in LL genotype carriers, compared to 
women with at least one S allele. 
Regarding childhood trauma, our study conflicts with two earlier studies demon-
strating that 5-HTTLPR genotype interacts with stressful life events in the cortisol 
response to psychosocial stress (19,23). However, it is important to note that adverse 
life events were assessed differentially between our study and these two earlier 
studies. Alexander et al., (19) demonstrated that homozygous S allele carriers had 
significantly higher cortisol responsivity, but this was only observed in people with a 
high burden of stressful life events. Mueller et al., (23) demonstrated that individuals 
carrying the LL allele showed a higher cortisol response to stress than S allele carri-
ers, but this pattern was reversed when individuals were exposed to three or more 
stressful life events during the first five years of life. Our findings highlight the lack of 
a significant interaction between 5-HTTLPR genotype and burden of early life events 
on the cortisol response to psychosocial stress.
We employed the CTQ scale for the assessment of early adversity (31,32). The 
CTQ is a retrospective self-report inventory, intended to measure childhood abuse or 
neglect during the first 15 years of life. It is plausible that imprecise characterization 
of early adversities, type of incidence, and the time when this incidence has hap-
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pened, might be a source of inconsistent findings. Unfortunately, we were not able to 
divide the CTQ score in more specific age periods of life, nor to define whether abuse 
was incidental or chronic. In addition, retrospective methods of assessment might 
result in impaired accuracy of answers due to recall bias. Nevertheless, good cor-
relations have been reported between CTQ scores and clinician ratings obtained by 
semi-structured interviews (45). Furthermore, it has been suggested that sexual abuse 
and the 5-HTTLPR genotype have stronger effects on depressive symptoms than other 
forms of maltreatment (46). Therefore, subtypes of maltreatment may interact more 
specifically with genetic factors on HPA axis functioning and the etiology of stress-
related disorders. Unfortunately, we did not have sufficient power in our sample to 
investigate different subtypes of childhood trauma, but a more detailed examination 
is needed and should be considered in future larger samples. However, stressful 
events occurring in childhood have been shown to be more consistently associated 
with neurobiological changes than those limited to adulthood (47,48). In addition, 
adversities in early childhood, compared to those limited to adulthood, have been 
demonstrated to interact with the 5-HTTLPR as a predictor of clinical depression (1).
The TSST has repeatedly been shown to be a reliable tool to elicit robust endocrine 
and cardiovascular responses in the vast majority of subjects (49). Notably, some 
studies which have utilized modified TSST protocols (e.g. by leaving out the presence 
of an evaluative audience) failed to observed an association between the 5-HTTLPR 
genotype and cortisol reactivity, suggesting the importance of the nature of the psy-
chosocial stressor (19,20). However, several studies have demonstrated a significant 
impact of the 5-HTTLPR on cortisol response to a mild stressor in psychologically 
vulnerable subjects, which might suggest different relationships between genetic 
determinants and specific physiological and psychological processes (16,34).
Several limitations should be taken into account when evaluating our findings. We 
did not consider modulatory polymorphisms of the L allele, designated as LA and 
LG, which have been reported to provide different levels of transporter expression 
(50-52). The LG and S allele were demonstrated to have a similar serotonin transporter 
expression, both with lower expression than the LA allele (50). However, other studies 
found no significant differences between classifications based on inferred levels of 
transporter expression (16,22). Our sample was also characterized by a minor ethnic 
heterogeneity, although women were primarily Caucasian (92.1%) and no significant 
differences were observed in the distribution of genotypes among ethnic groups. 
Although we enrolled a considerable sample of women (n=151 in total), it should 
be noted that the statistical power of our analyses was still relatively limited and, 
therefore, our study should be regarded as an exploratory study.
In conclusion, our findings support the notion that functional genetic variation is 
associated with cortisol responsivity to psychosocial stress. We observed that women 
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carrying the LL allele exhibit higher cortisol responses to psychosocial stress than 
women with at least one copy of the S allele. Our results reflect the need to clarify 
the sex-specific biological interaction between the serotonergic system and ovarian 
hormones, because these important factors are frequently overlooked. Furthermore, 
our results show that childhood maltreatment, specifically during the first 15 years 
of life, is unlikely to exert a modulating influence of 5-HTTLPR genotype on cortisol 
responsivity to psychosocial stress in women. Future studies are needed to clarify 
potentially contribution of biological and environmental factors, regarding the influ-
ence of 5-HTTLPR allelic variation on HPA axis reactivity to stress.
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ABstrAct
Background. Maladaptive emotional control is a defining feature of personality dis-
orders. Yet little is known about the underlying physiological dynamics of emotional 
reactivity to psychosocial stress across distinct personality disorders. The current 
study compared subjective emotional responses with autonomic nervous system and 
HPA axis physiological responses to psychosocial stress in women with cluster C 
personality disorder (CPD) and borderline personality disorder (BPD). 
Methods. Subjective mood ratings, salivary cortisol, heart rate (HR), and skin conduc-
tance level (SCL) were assessed before, during, and after exposure to a standardized 
psychosocial stress paradigm (Trier Social Stress Test, TSST) in 26 women with BPD, 
20 women with CPD, and 35 healthy female controls. Subjects were free of any 
medication including hormonal contraceptives, had a regular menstrual cycle, and 
were tested during the luteal phase of their menstrual cycle. 
Results. Both CPD and BPD patients reported a similar burden of subjective mood 
disturbance. However, only BPD patients demonstrated reduced baseline cortisol 
levels with a blunted cortisol and HR reactivity to the TSST. In addition, BPD patients 
exhibited a generalized increase of SCL. No significant differences in baseline or 
TSST reactivity of cortisol, HR, or SCL were observed between CPD patients and 
healthy controls.
Conclusion. These findings indicate that patients with BPD have significant alterations 
in their physiological stress reactivity, which is notably distinct from patients with 
CPD and those of healthy controls.
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introduction
Individuals with personality disorders have significant difficulties in their interpersonal 
relationships, which has been widely attributed to dysfunction in affect regulation 
(1,2). Among the personality disorders, borderline personality disorder (BPD) is con-
sidered the prototype severe personality disorder (1,3). However, although clinically 
less disruptive, patients with Cluster C personality disorder (CPD) suffer from very 
comparable psychosocial impairment and subjective distress to that of BPD patients 
(4). Emotional dysregulation has been suggested to underlie many of the maladaptive 
behaviors, difficulties in the interpersonal domain, and dysfunctional coping strate-
gies employed by patients with BPD (1,3,5,6). This maladaptive functioning across a 
broad range of personal and social situations is associated with a significant quality 
of life burden for individuals with BPD, resulting in an increased reliance on social 
support and health care services (7). A typical maladaptive interpersonal pattern is 
also identifiable in individual with CPD, who often experience dysfunctional rela-
tionships, hypersensitivity to negative evaluation (8,9), overregulation of emotions 
and impaired metacognition (10). Although CPD is presumed to be a less emotionally 
expressive disorder, adults diagnosed with CPD often exhibit heightened emotional 
reactivity (11).
Although BPD and CPD are equivalently common in clinical practice, BPD is by 
far the most intensively studied of the all personality disorder categories. This distinc-
tion is probably because of the relatively higher incidence of social rule-breaking 
behavior, suicide attempts, and self-injurious behavior in BPD patients which leads 
them to be more likely to have contact with mental health care providers. The wide 
range of behavioral problems in BPD requires a comprehensive treatment, whereas 
patients with cluster C personality disorder usually have a less problematic course 
in therapy (12). However, CPD patients also often remain in a passive patient role, 
demanding treatment without making the essential steps that are needed to recover. 
Therefore, cluster C personality disorders are also associated with high societal costs 
and low quality of life (13). Furthermore, although cluster C disorders (dependent and 
avoidant) are widely regarded as a disorder of medium severity, these assumptions 
have not been thoroughly studied in empirical studies.
The maladaptive emotional control of individuals with personality disorders has 
been hypothesized to result from childhood adversity and the quality of early-life at-
tachment, most notably with neglecting or abusive primary caregivers (14–17). Such 
adverse events during early-life development may result in an insecure attachment 
style which in turn prevents the development of a proper affect regulatory capacity, 
impaired cognition, and coping in emotional relationships (15,18,19). 
Chapter 4
70
Despite an extensive literature on personality pathology and emotion regulation, 
the influence of personality features on the psychophysiological responses to psycho-
social stress has not been sufficiently explored. In comparison with the most widely 
held models postulating HPA axis hyper-reactivity and reduced feedback sensitivity 
in BPD patients after neuroendocrine challenge testing (20,21), the few studies using 
psychosocial stress challenges have reported conflicting results (16,22–24).
Only four published studies to date have investigated HPA axis responsivity to 
psychosocial stress in patients with BPD. Simeon et al. (2007) found that a subgroup 
of patients with BPD and severe dissociation demonstrated a significantly higher peak 
cortisol reactivity to the Trier Social Stress Test (TSST) when compared to a less disso-
ciative subgroup (24), suggesting that hyper-reactivity of the HPA axis is possibly the 
result of a symptomatic state rather than the trait of BPD. Nater et al. (2010) observed 
lower baseline cortisol levels and a blunted cortisol response to psychosocial stress in 
women with BPD compared to healthy controls (23). In line with these findings, Scott 
et al. (2013) demonstrated an attenuation of cortisol reactivity to the TSST in female 
BPD patients, although this may have resulted from elevated baseline cortisol levels 
or medication use (16). More recently, Deckers et al. (2015) reported significantly 
attenuated cortisol responses to psychosocial stress in BPD patients, however their 
use of a modified version of the TSST is difficult to compare with other studies (22).
Notably, the findings of previous studies of autonomic reactivity in BPD patients 
during psychosocial stress have not been entirely consistent. Depending upon the 
experimental conditions, BPD patients have been shown to exhibit autonomic hy-
perarousal (25) or the absence of autonomic modulation (24). However, more recent 
studies have presented a more consistent pattern of autonomic hypoarousal in patients 
with BPD (16,22,23). The divergence in the findings regarding autonomic nervous 
system responses in BPD is likely to be related to the multifactorial complexity of the 
stress response system, as well as the diversity of outcome measures employed.
Even less is known about this relationship in patients with CPD, although this cluster 
of personality disorders has been found to be among the most prevalent personality 
disorder in outpatient clinical populations and in the general community (26,27). 
Only one previous study has reported assessments of psychophysiological responses 
to stress in CPD patients (22), which found elevated subjective emotional reactivity 
similar to that of BPD patients, but without any discernible physiological differences 
compared to BPD patients and healthy controls. Thus, more empirical knowledge is 
needed to understand the relationship between emotional and physiological reactiv-
ity among the most highly prevalent personality disorders. 
The current study was designed to compare emotional and physiological responses 
to psychosocial stress across three groups: outpatients with CPD, outpatients with 
BPD, and healthy controls. Importantly, our study design was chosen in an effort to 
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resolve some of the difficulties inherent in previous reports by integrating measure-
ments of cortisol, HR, and SCL responses using the standardized version of the TSST. 
Moreover, all participants were enrolled and examined under strictly standardized 
conditions, including matching for age, body-mass index (BMI), medication, hor-
monal contraceptives, as well as the time of day and menstrual cycle phase during 
testing. Based on previous results, we hypothesized that BPD patients would exhibit 
elevated emotional distress with attenuated cortisol, HR, and SCL responses to the 
TSST, compared to healthy controls. We expected CPD patients to also report greater 
distress but with increased autonomic and HPA axis responses to the TSST, compared 
to healthy controls. In addition, considering high rates of insecure attachment style 
and childhood trauma in the patient samples, we also explored the impact of these 
early life adversities on psychophysiological responses to stress.
methods
Participants
The study was carried out at the department of Psychotherapy of the Riagg Rijnmond 
(Schiedam, The Netherlands) in collaboration with the department of Psychiatry of 
the Erasmus University Medical Center (Rotterdam, The Netherlands). Twenty-seven 
women diagnosed with BPD, 20 women with CPD, and 35 female healthy controls 
participated in the study. One of the 27 patients with BPD was unable to complete 
the testing procedure due to severe emotional reactions during the TSST. In total, data 
from 26 women with BPD, 20 women with CPD, and 35 healthy female controls were 
included in our analyses.
Patients were recruited from the outpatient mental health psychotherapy depart-
ment of the Riagg Rijnmond. Diagnoses were made by experienced psychotherapists 
(psychiatrists, clinical psychologists and psychotherapists), based on DSM-IV Axis II 
criteria (28). In the BPD group, 16 women had co-morbid Axis II disorders, includ-
ing avoidant (n = 7), dependent (n = 4), narcissistic (n = 3), and histrionic (n = 2) 
personality disorder. From a clinical perspective, the borderline presentation makes a 
critical difference in symptom expression between the comorbid clusters. Therefore, 
women with a diagnosis of BPD comorbid with avoidant, dependent, narcissistic, 
or histrionic personality disorder were classified in the BPD group and defined as 
having complex personality disorder (i.e., the patient meets the actual criteria for 
one or more personality disorders within more than one cluster). Participants with 
CPD, defined as having dependent and/or avoidant personality disorder without BPD, 
had no other Axis II co-morbidities and were therefore defined as having simple 
personality disorder (i.e., the patient meets actual criteria for one or more personality 
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disorders within the same cluster). No participants were identified with obsessive-
compulsive personality disorder. Co-morbid Axis I diagnoses were assessed using 
the Structured Clinical Interview for DSM-IV axis I disorders (SCID-I) (Table 1) (28). 
Patients were considered ineligible to participate if they had a comorbid diagnosis 
of bipolar disorder, schizophrenia, current major depression, or used psychotropic 
medication within the previous 9 months. Healthy female controls were recruited 
from the community through local advertisements. Eligibility requirements included 
the absence of any DSM-IV Axis I or Axis II diagnoses, and no history of psychiatric 
or psychological treatment.
All subjects underwent a general medical examination prior to study enrollment. 
Exclusion criteria included: a) a history of any neurological or endocrine disorders, 
b) substance or alcohol abuse within the previous 4 months, c) BMI < 18, d) current 
pregnancy or lactation, and e) hormonal contraceptive use or irregular menstrual 
cycles within the previous 9 months.
materials
Diagnostic assessments
Considering that dysfunctional personality traits are strongly associated with adver-
sity and neglect during childhood, attachment quality and childhood maltreatment 
(1) were measured with self-report questionnaires.
The revised version of the Experiences in Close Relationships (ECR-r) is a self-
report questionnaire with 36 items using a 7-point Likert scale for the assessment 
of attachment-related anxiety and avoidance (29,30). Participants were asked to 
think about their romantic partner while rating the appropriateness of each item on 
a 7-point Likert scale. For participants without a current partner, they were asked to 
rate how they feel generally during intimate relationships. Attachment-related anxiety 
and avoidance were dichotomized into high versus low using median split analysis 
[Anxiety: High (n = 36), Low (n = 38); Avoidance: High (n = 38), Low (n = 36)].
The 28-item Childhood Trauma Questionnaire – Short Form (CTQ) was used to 
assess the severity of multiple forms of abuse and neglect during childhood (31,32). 
The total CTQ score was dichotomized into high (n = 36) versus low trauma (n = 38) 
using median split analysis.
The Trier Social Stress Test (TSST)
The TSST was performed according to the protocol of Kirshbaum et al., 1993 (33). 
After an acclimatization period of 15 minutes, the experiment began with a baseline 
period of 5 minutes. Subsequently, the subjects were informed about the TSST proce-
dure and asked to prepare a 5-minute speech intended to convince a panel of judges 
regarding “why you would be a good candidate for your ideal job”. The subjects 
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were given 5 minutes to prepare their speech while seated (Anticipation Period). 
Next, the panel entered the room and the subjects were invited to stand and deliver 
their speech (Public Speaking Task, PST). The PST was followed by a 5-minute Mental 
Arithmetic Task (MAT). During the PST and MAT, the panel monitored the participants’ 
performance without offering any verbal or non-verbal feedback, and maintaining an 
affectively neutral facial expression. Subjects provided written informed consent to 
allow audio-video recording of the session, for which a camera and tripod were 
positioned prominently within the room and in direct sight of the subject.
Subjective mood
To assess the subjective emotional state, we used the visual analogue scales (VAS) 
of the shortened 32-adjective Dutch version of the Profile of Mood States (POMS) 
(34,35). For each pair of adjectives, scores range from 0 to 100, defined by a mark 
placed by the subject on a standardized linear scale. The POMS measures 5 dimen-
sions: depression, anger, fatigue, tension, and vigor. To compute the Total Mood Dis-
turbance (TMD) score, the sum of the dimensional mean scores for depression, anger, 
fatigue and tension were subtracted from the dimensional mean score for vigor.
Procedure
The study was approved by the Medical Ethical Committee of the Erasmus University 
Medical Center. All participants provided written informed consent after the study 
procedures were fully explained both orally and in writing.
Participants were invited for two visits. During the initial visit, subjects completed 
questionnaires regarding their general medical health, severity of personality pathol-
ogy, attachment style, childhood trauma, and subjective mood. Axis I co-morbidity 
was assessed by means of the SCID-I. During the second visit, the TSST was performed 
with continuous recordings of HR and SCL. Salivary samples for the assessment of 
cortisol were obtained 20 and 5 minutes prior to the TSST (baseline) and at +1, +15, 
+35, and +55 minutes after completion of the TSST. Changes in subjective mood 
were assessed by the POMS before, immediately following, and 45 minutes after the 
TSST. All measurements were performed between 14.00 and 16.00 hours to minimize 
circadian influences on the salivary and physiological assessments. Participants were 
asked to abstain from alcohol, nicotine, caffeine, and intense physical activity for 
at least 24 hours prior to the session, and to have been awake for at least 5 hours 
prior. Testing was performed during the luteal phase (day 20-28) of the menstrual 
cycle. Compliance with the instructions was assessed by means of a general checklist. 
Menstrual cycle phase was reconfirmed on the day of testing.
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Hormonal and physiological measures
Saliva samples were collected using Sarstedt Cortisol Salivette® collection tubes 
and stored at -20 °C until they were analyzed. Free salivary cortisol was measured 
using a commercially available ELISA kit (Demeditec Diagnostics, Kiel, Germany, 
DES6611). The inter- and intra-assay coefficients of variation were below 10% and 
7%, respectively. 
Electrocardiographic (ECG) recordings were obtained using a precordial elec-
trode, sampled at 512 Hz. SCL was assessed using 2 Ag/AgCl electrodes attached 
to the medial phalanx of the index and ring finger of the non-dominant hand and 
recorded at a sampling rate of 16 Hz. All data were stored on a flashcard by means 
of a portable digital recorder (Vitaport System®; TEMEC Instruments B.V., Kerkrade, 
The Netherlands). HR was determined from consecutive R-R intervals of the ECG. 
Recordings were visually inspected for detection and removal of artifacts. HR and 
SCL measurements were averaged across the baseline period and binned for each 
successive period of the TSST and recovery phase. Physiological responsivity to the 
TSST was determined as the difference between mean values during the baseline and 
TSST periods. 
statistical analysis
Statistical analyses were conducted using the SPSS statistical software package (IBM 
SPSS Statistics, Version 21). Results are expressed as mean ± SEM values unless 
otherwise indicated. A priori power analyses were performed with regard to cortisol 
level and HR. A total sample of n=78 participants for HR and n=69 for cortisol level 
would be required for detection of an interaction between time and condition of η2 
≥ 0.15 with a power of 0.80 at a significance level of α = 0.05 (Cohen, 1988). The 
expected effect size of 0.15 is derived from the findings in previous studies examining 
cortisol (Deckers, 2015) and HR (Deckers, 2015; Weinberg, 2009). Effect size (η2) 
was calculated from F values and degrees of freedom associated with the F-test (Nater 
et al., 2010). 
Data was tested for normality of distribution using the Kolmogorov-Smirnov test, 
and for homogeneity of variance by visual inspection of the q-q plots and Levene’s 
tests. To examine group differences in demographic and clinical characteristics, 
chi-squared tests (for categorical variables) and one-way ANOVAs (for continuous 
variables) with post-hoc testing (Scheffé) were conducted. In case of non-normality, 
the data was log transformed. Cortisol, HR, SCL, and subjective mood levels in re-
sponse to the TSST were compared using a repeated measures analysis of variance 
(ANOVA), with Group (BPD, CPD, healthy controls) as a between-subject factor, and 
Time (baseline, TSST, recovery) as a within-subject factor. Confounding variables such 
as age, BMI, education, and smoking behaviour did not yield any significant main 
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or interaction effects on cortisol levels, HR, or SCL. For repeated measures ANOVA, 
the corresponding F values, degrees of freedom, and p values were corrected by the 
Greenhouse-Geisser procedure whenever the assumption of sphericity was violated. 
Effect sizes were calculated by partial eta squared (η2). The value of eta squared 
ranges from 0 and 1. An eta squared <0.1 was interpreted as a weak effect, 0.1 to 0.3 
as modest, 0.3 to 0.5 as moderate, and >0.5 as a strong effect. P values less than 0.05 
were considered statistically significant. To reduce the possibility of a Type I error 
when analyzing stress reactivity, statistical significance for these tests was defined at 
the more stringent threshold of P < 0.01. Post-hoc analyses were carried out using 
Bonferroni adjustments. To control for the effects of the presence of post-traumatic 
stress disorder and eating disorders on cortisol responses, the primary analyses were 
re-run to serially exclude each of these diagnostic groups individually. Since the pres-
ence of Axis II psychopathology is strongly related with insecure attachment style, 
and childhood trauma, we performed sensitivity analyses in which we repeated the 
repeated measures ANOVA while including attachment style and childhood trauma 
as between-subject variables.
results
subject characteristics
BPD, CPD, and healthy control (HC) groups were similar in age, BMI, smoking 
behavior, and educational attainment (Table 1). Patients with BPD reported higher 
childhood trauma CTQ scores than the other two groups (P < 0.001), for which no 
significant differences were found between CPD and HC. The ECR-r attachment 
anxiety score was highest for patients with BPD, intermediate for CPD, and lowest 
for HC (post-hoc analyses: BPD > CPD > HC, p values < 0.01) (Table 1). Similarly, 
patients with BPD showed higher ECR-r attachment avoidance score. No differences 
were found between patients with CPD and healthy controls.
subjective mood
BPD and CPD groups had significantly greater mood disturbance (higher TMD scores) 
than the HC group at all time-points measured: baseline, TSST, and recovery period 
[Group: F(2,77) = 18.52; p < 0.001, η2 = 0.33]. The TSST induced a time-dependent 
increase in TMD score [Time: F(2,154) = 91.79, p < 0.001, η2 = 0.54] (Figure 1). A 
nominally significant Time x Group interaction was observed [F(4,154) = 2.71, p = 
0.04]. Post-hoc analyses demonstrated that the increase in TMD elicited by the TSST 
was significantly elevated in BPD and CPD, compared to the HC [F(2,79 = 3.52, p = 
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0.04]. The BPD and CPD groups exhibited a similar heightened increase of the TMD 
score in response to the TSST.
salivary cortisol
The TSST induced a time-dependent increase in salivary cortisol levels [Time: 
F(4,308) = 52.66, p < 0.001, η2 = 0.41], which differed significantly between the 3 
groups [Group: F(2,77) = 13.63, p < 0.001, η2 = 0.26] (Figure 2). Peak concentrations 
of post-TSST salivary cortisol levels were observed 15 minutes after completing the 
TSST. Patients with BPD demonstrated significantly lower baseline cortisol levels than 
either comparison group, with no differences observed between CPD and HC in 
baseline cortisol levels [F(2,80) = 8.12, p < 0.001, η2 = 0.17; post-hoc analyses: HC 
(9.06 nmol/l) = CPD (11.63 nmol/l) > BPD (5.48 nmol/l)]. When baseline cortisol 
level was included as a covariate in the repeated measures ANOVA, a nominally 
table 1. Subject characteristics, frequencies of Axis I diagnoses and clinical characteristics of the diag-
nostic groups
BPD 
(n = 26)
CPD
(n=20)
HC 
(n=35)
Statistics
demographic data
Age, mean (SD), years 29.23 (6.4) 31.35 (6.7) 28.60 (7.1) F(2,80) = 1.08, p = 0.35
BMI, mean (SD), kg/m2 24.50 (4.2) 23.49 (3.7) 22.41 (3.3) F(2,80) = 2.36, p = 0.10
Smokers/ non-smokers (n) 9/17 6/14 8/27 X2(2,80) = 1.25, p = 0.54
Educational level (n) X2(2,80) = 4.98, p = 0.29
Low 2 0 1
Middle 13 7 11
High 11 13 23
Axis-i diagnosis comorbidity
Panic Disorder (n) 2 1 -
Anxiety Disorder (n) 7 7 -
Obsessive Compulsive Disorder (n) 4 3 -
Eating Disorder (n) 12 6 -
Post-Traumatic Stress Disorder (n) 7 1 -
Psychometric data
CTQ-SF, mean (SD) 56.2 (16.3) 42.5 (10.8) 39.5 (7.3) F(2,79) = 43.20, p < 0.001
ECR-r, Attachment Anxiety, mean (SD) 4.7 (0.9) 3.7 (1.3) 2.6 (1.2) F(2,79) = 24.41, p < 0.001
ECR-r, Attachment Avoidance, mean (SD) 3.6 (1.1) 2.9 (1.1) 2.4 (0.9) F(2,79) = 9.87, p < 0.001
BPD: Borderline Personality Disorder; CPD: Cluster C Personality Disorder; HC: Healthy Controls
CTQ-SF: the Childhood Trauma Questionnaire – Short Form; ECR-r: the Experiences in Close Relation-
ships-revised
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signifi cant Time x Group interaction was observed [F(6,228) = 2.53, p = 0.04]. Post-
hoc analyses revealed that the BPD group had a blunted cortisol response to the TSST, 
in comparison to both CPD and HC. Although CPD patients had higher cortisol levels 
across all time points (Figure 2), no statistical differences were observed in the TSST-
induced cortisol responses between patients with CPD and the HC group. Moreover, 
we evaluated whether BPD patients differed in their cortisol responses depending 
on the presence or absence of co-morbid CPD. BPD patients with co-morbid CPD 
(N=11) versus exhibited a highly similar cortisol response to the TSST compared to 
those without co-morbid CPD (N=14) [Group: F(1,23) = 0.03, p = 0.86].
heart rate
HR was signifi cantly increased during the TSST, as demonstrated by a signifi cant main 
effect of Time [F(3,228)= 277,07, p < 0.001, η2 = 0.79], which varied in magnitude 
between the groups [Time x Group, F(6,228) = 3.70; p < 0.01, η2 = 0.09]. The BPD 
group demonstrated a signifi cantly blunted HR response to the TSST, compared to 
the CPD and HC groups [F(2,78) = 4.49, p < 0.01, η2 = 0.10, post-hoc analyses: HC 
(increase 26.78 beats/min) = CPD (27.01 beat/min) > BPD (18.14 beats/min)] (Figure 
3). Patients with CPD exhibited a similar HR response to the TSST as the HC group. 
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figure 1. subjective response to the tsst. The To-
tal Mood Disturbance (TMD) score is presented 
as mean (±SEM) values in women with borderline 
personality disorder (BPD), cluster C personality 
disorder (CPD) and healthy controls (HC). The 
ANOVA for repeated measures demonstrated 
signifi cant overall levels of mood disturbance be-
tween the groups (p < 0.001). The differences in 
response magnitude did not reach the statistical 
signifi cance when the stringent criterion (p<0.01) 
was used (Group x Time, p = 0.04).
0
5
10
15
20
25
-5 0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75
 S
a
liv
a
ry
 c
o
rt
io
sl
 (
n
m
o
l/
L)
 
Time after exposure to the TSST in minutes 
BPD
CPD
HC
 Baseline 
TSST 
figure 2. salivary cortisol response to the tsst. 
Mean (±SEM) untransformed salivary cortisol val-
ues in women with borderline personality disor-
der (BPD), cluster C personality disorder (CPD) 
and healthy controls (HC). The ANOVA for repeat-
ed measures demonstrated signifi cant differences 
in cortisol levels between groups in response to 
the TSST (p < 0.001).
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skin conductance level
A signifi cant main effect of Group was observed for the SCL measurements [F(2,78) 
= 4.12, p < 0.01, η2 = 0.10), of which BPD patients exhibited an overall increase 
of SCL compared to both CPD and HC. The TSST induced a signifi cant increase in 
SCL [Time: F(3,231)= 1076.70, p < 0.001, η2 = 0.93], already evident during the 
anticipation period (Figure 4). When normalized for their respective baseline SCL, 
no signifi cant difference in the SCL response to the TSST was observed between the 
groups [F(2,79) = 2.74, p = 0.07). 
sensitivity analyses
ANOVA analyses were repeated, excluding 1) patients with post-traumatic stress dis-
order, and 2) patients with an eating disorder. These analyses supported the direction 
and magnitude of the effects observed reported for the total sample, suggesting that 
the results cannot be explained by either comorbid post-traumatic stress disorder or 
eating disorders within our sample.
Additional sensitivity analyses revealed that participants reporting a higher level 
of childhood trauma has a signifi cantly lower overall cortisol level [Group: F(1,72) = 
9.93, p < 0.01, η2 = 0.12]. Additionally, participants with the highest level of child-
hood trauma demonstrated signifi cantly reduced HR responses to the TSST relative to 
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figure 3. heart rate responsivity to the tsst. 
Mean Heart Rate is depicted as mean (±SEM) 
values in women with borderline personality dis-
order (BPD), cluster C personality disorder (CPD) 
and healthy controls (HC). The ANOVA for repeat-
ed measures demonstrated signifi cant differences 
in response magnitude (group x time, p< 0.05) be-
tween the groups. 
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figure 4. skin conductance responsivity to the 
tsst. Log transformed skin conductance levels 
(SCL) are shown as mean (±SEM) values in wom-
en with borderline personality disorder (BPD), 
cluster C personality disorder (CPD) and healthy 
controls (HC). The ANOVA for repeated measures 
demonstrated signifi cant differences in baseline 
SCL (p< 0.01). A signifi cant main effect of group 
was found (p< 0.01) with BPD patients demon-
strating higher overall SCL.
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low-trauma participants [Time x Group: F(3,71)= 3.55, p = 0.05]. No signifi cant main 
effects or interactions with childhood trauma were found regarding SCL. 
Participants with higher levels of attachment anxiety exhibited blunted cortisol 
[Group: F(1,72) = 4.39, p = 0.04] and HR responses [Time x Group: F(3,213) = 4.40, 
p = 0.02] to the TSST. No signifi cant main effects or interactions with attachment 
anxiety were found regarding SCL. No signifi cant differences in cortisol levels, HR 
reactivity, or SCL responses were found between participants with high versus low 
levels of attachment-related avoidance. Taken together, these results confi rm the 
relationship between Axis II psychopathology, insecure attachment, and childhood 
trauma.
discussion
This study was designed to investigate differences in affect regulation between female 
BPD and CPD outpatients in comparison to healthy controls by investigating HPA 
axis and autonomic responsivity to a well-established acute psychosocial stressor, the 
Trier Social Stress Test. 
In response to the TSST, patients with CPD and BPD reported signifi cantly higher 
subjective mood disturbance compared to healthy controls. Despite their similar 
subjective experience, BPD patients showed a highly distinct pattern of cortisol 
regulation: signifi cantly reduced cortisol levels at baseline and a blunted response 
to the TSST. In contrast, CPD patients tended to have heightened cortisol levels and 
stress induced responses although this did not reach statistical signifi cance, prob-
ably due to insuffi cient power. Furthermore, BPD patients demonstrated a blunted 
HR response to the TSST, whereas CPD patients and healthy controls had nearly 
identical HR responses. In contrast to the attenuated pattern of HR reactivity, the BPD 
group exhibited a signifi cantly higher overall SCL, while SCL was similar between 
CPD patients and healthy controls. Additional analyses suggested that these results 
could not be explained by comorbid psychopathology such as post-traumatic stress 
disorder or eating disorders. Furthermore, in line with our expectations, we found 
that participants with higher levels of childhood trauma and/or increased attachment 
related anxiety exhibited attenuated cortisol and HR responses to the TSST, analogous 
to patient with BPD.
These fi ndings underline the presence of a disturbed mood state and psychological 
hyper-reactivity among women with BPD and CPD, providing further support to the 
existing evidence of intense subjective negative affect in patients with severe person-
ality pathology (20,36–38). High levels of negative affect may predispose individuals 
with Cluster B or C personality disorder to intense maladaptive emotional responses 
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and dysfunctional cognitive processes such as selective attention to negative or 
threatening cues (22,39,40) and hypervigilance to threat (41,42) Such maladaptive 
cognitive processes can result in emotional dysregulation and impaired social func-
tioning (39). Moreover, an increased perception of threat accompanied by elevated 
emotional states might exacerbate negative responses to ongoing stressors or serve 
itself a source of chronic stress, with the resulting stress-related co-morbidities (43).
Our data demonstrate a contrasting pattern of cortisol responses to the TSST be-
tween CPD and BPD. Specifically, patients with BPD exhibited significantly lower 
baseline cortisol levels and a blunted cortisol response to the TSST, compared to 
either patients with CPD or healthy controls. This finding implies that independent of 
the presence of heightened mood disturbance in patients with personality disorder, 
the dysregulation of affect in patients with BPD is associated with a physiological 
hypo-reactivity, which appears specific for BPD compared to CPD. However, this 
finding should be considered with caution given the nominal statistical significance of 
the difference. Nevertheless, the finding of HPA axis hypo-reactivity in BPD patients 
replicates the earlier studies that reported blunted cortisol response to psychosocial 
stress in patients with BPD (16,22,23). It has been postulated that hypo-reactivity in 
BPD may result from the influence of early-life trauma due to chronic activation of the 
stress response system, including the HPA axis and autonomic nervous system (44). 
Although patients with CPD also report similar persistent psychosocial impairments 
and subjective distress (4), BPD and CPD patients differ significantly in their rates of 
exposure to harsh adversities in childhood and insecure attachment style.
Recent studies support the notion that attachment is biologically rooted (45,46). 
Early childhood attachment has a significant impact on the neurobiology of emotion 
regulation and psychosocial functioning in adulthood (45). However, an insecure 
attachment pattern in adulthood might be a predisposing factor that does not neces-
sarily explain the psychophysiological features of personality disorders. Nevertheless, 
childhood trauma and deprivation of expected parental care have been previously as-
sociated blunted cortisol reactivity and the development of BPD (47–49). Moreover, 
there is growing evidence that adverse childhood experiences result in a lifelong 
blunting of HPA axis reactivity (47,50). Long-term modification of HPA axis func-
tion after childhood trauma exposure might be a homeostatic mechanism to protect 
against the detrimental effects of chronically elevated cortisol levels during sustained 
periods of stress in adulthood. Our results show similar effects of problematic attach-
ment and childhood trauma on autonomic and HPA axis functioning in patients with 
BPD, but not in patients with CPD. However, given that our data is cross-sectional, 
we acknowledge the limitation of being unable to exclude reverse causality.
Our findings of a more pronounced overall SCL elevation in patients with BPD 
versus CPD or healthy controls in the presence of a blunted HR response to psycho-
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social stress might be interpreted as an indication of a sympathetic / parasympathetic 
disbalance regarding stress reactivity in patients with BPD. Skin conductance level 
is an established index of sympathetic nervous system activity (51). Previous stud-
ies examining catecholaminergic responses to psychosocial stress failed to observe 
significant alterations of plasma epinephrine or norepinephrine responses in patients 
with BPD (23,24). Although we found an overall increase of SCL in patients with 
BPD patients, the observed responses to the TSST were notably similar across all 
three groups. Hence, the blunted HR response might be explained by an impairment 
of vagal withdrawal. Furthermore, our data are in agreement with studies reporting 
that early-life stress mediates diminished HR responses to stress in adulthood (50,52).
Although we controlled our study for relevant factors known to influence endocrine 
outcomes, the present findings should be considered in the light of some limitations. 
High rates of comorbid psychiatric diagnoses among patients with BPD, in particular 
post-traumatic stress disorder and eating disorders, might have confounded the ob-
served outcomes. It has been previously reported that post-traumatic stress disorder 
and eating disorders are associated with alterations in HPA axis functioning (53–55). 
Importantly however, when patients with post-traumatic stress disorder and eating 
disorders were excluded from the analysis, our findings were not significantly altered. 
Moreover, it should be noted that a complex interaction of causal factors and comor-
bidities is highly consistent with personality disorders. Patients with BPD and CPD 
are often burdened with co-morbid psychiatric illnesses, such as eating disorders 
and/or post-traumatic stress disorder (55–59). Furthermore, when presuming child-
hood trauma as a causal factor of emotional dysregulation, BPD may be considered 
as a risk factor for post-traumatic stress disorder. Given the severity of emotional 
dysregulation, patients with BPD may have a higher likelihood of engaging in risky 
behaviors which could result in a consequently higher rate of exposure to potentially 
traumatic experiences. Unfortunately, our sub-samples were homogeneous in this 
respect and insufficient in size to explore whether the physiological responses are 
specific for BPD or might extend specifically to those patients with BPD who have 
a higher burden of childhood trauma or attachment insecurity. Future studies will 
be required in larger cohorts to identify additional risk and resilience factors that 
regulate the autonomic and HPA axis dysfunction in BPD versus CPD.
Taken together, our current findings demonstrate under highly controlled experi-
mental conditions that unmedicated women suffering from either BPD or CPD exhibit 
analogous robust mood disturbances to psychosocial stress. However, patients with 
BPD demonstrated significant attenuations of cortisol and HR reactivity compared to 
patients with CPD or healthy controls. Moreover, this pattern of blunted cortisol and 
HR reactivity to psychosocial stress appears specific to patients with BPD, rather than 
simply a consequence of emotional vulnerability. In addition, our findings suggest 
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that the underlying physiological responses to stress among patients with BPD are 
not fully captured by subjective reporting of their emotional response, and thereby 
highlight the complexity of emotional dysregulation to psychosocial demands in 
patients with BPD versus CPD. A substantial proportion of CPD patients are known 
to function psychosocially at a qualitatively higher level than BPD patients (3). In 
our study, we found that CPD patients, in contrast with BPD patients, have a distinct 
psychophysiological responsivity to psychosocial stress, indicating a potentially 
distinct underlying biology. Furthermore, research on the relationship between child-
hood adversities, attachment insecurity, and HPA axis activity in personality disorders 
other than BPD remains sparse. Considering the high prevalence and burden of CPD, 
continued studies of Cluster C personality disorder is clearly warranted. Improved 
understanding of the psychophysiological responses across distinct personality disor-
ders may help guide the development of novel psychotherapeutic or pharmacologic 
interventions to improve adaptive affective responses to psychosocial stressors and 
enhance quality of life.
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ABstrAct
Background. The levonorgestrel-releasing intrauterine device (LNG-IUD) is currently 
recommended as a first-line contraceptive with an exclusively local intrauterine influ-
ence. However, recent clinical trials have identified side effects of LNG-IUD that ap-
pear to be systemically mediated, including depressed mood and emotional lability.
Methods. We performed two experimental studies and a cross-sectional study. For 
each study, women were included from three groups: LNG-IUD (0.02mg / 24 hours), 
oral ethinylestradiol/levonorgestrel (0.03mg/0.15mg; EE30/LNG) and natural cycling 
(NC). Study 1 – Salivary cortisol was measured at baseline and at defined intervals 
following the Trier Social Stress Test (TSST). Heart rate was monitored continuously 
throughout the TSST. Study 2 – Salivary cortisol and serum total cortisol were evalu-
ated relative to low-dose (1µg) adrenocorticotropic hormone (ACTH) administration. 
Study 3 – Hair cortisol was measured as a naturalistic measure of long-term cortisol 
exposure. 
Results. Women using LNG-IUD had an exaggerated salivary cortisol response to the 
TSST (24.95 ± 13.45 nmol/L, 95% CI 17.49-32.40), compared to EE30/LNG (3.27 ± 
2.83 nmol/L, 95% CI 1.71-4.84) and NC (10.85 ± 11.03 nmol/L, 95% CI 6.30-15.40) 
(P < 0.0001). Heart rate was significantly potentiated during the TSST in women using 
LNG-IUD (P = 0.047). In response to ACTH challenge, women using LNG-IUD and 
EE30/LNG had a blunted salivary cortisol response, compared to NC (P < 0.0001). 
Women using LNG-IUD had significantly elevated levels of hair cortisol compared to 
EE30/LNG or NC (P < 0.0001).
Conclusions: Our findings suggest that LNG-IUD contraception induces a centrally-
mediated sensitization of both autonomic and hypothalamic-pituitary-adrenal (HPA) 
axis responsivity. LNG-IUD sensitization of HPA axis responsivity was observed 
acutely under standardized laboratory conditions, as well as chronically under natu-
ralistic conditions. 
LNG-IUD potentiates stress reactivity
89
introduction
Since the launch of the first hormonal contraceptive in 1960, providing women 
with convenient and effective protection from pregnancy, continuous progress has 
been made in order to both minimize side effects and improve compliance without 
compromising efficacy (1). Long-acting reversible forms of contraceptives, such as 
the levonorgestrel-releasing intrauterine device (LNG-IUD), are currently among the 
most popular forms of birth control in North America and Europe (2-5). The National 
Institute for Health and Care Excellence and the American College of Obstetricians 
and Gynecologists both endorsed the use of the LNG-IUD as a first-line contracep-
tive option (6-8). This recommendation has also been advocated by the American 
Academy of Pediatrics, encouraging pediatricians to recommend the LNG-IUD to 
sexually active adolescents for prevention of unintended pregnancies (9).
In addition to providing long–acting protection (5 years per device), the LNG-IUD 
is a highly effective but rapidly reversible contraceptive method (10). Furthermore, 
the LNG-IUD can be used by women of any age or parity, requires minimal to no 
maintenance, has extensive evidence supporting its safety, and has an added value for 
a range of gynecological conditions (6,11-12). Moreover, and central to its popularity, 
the LNG-IUD is widely claimed to have no systemic physiological effects (13-15). 
The most widely held model for the hormonal mechanism of action of LNG-IUD 
is by local intrauterine progestin release that results in extensive decidualization of 
the endometrium, an environment unsuitable for fertilization and implantation (10). 
The LNG-IUD has been shown to have little influence on ovarian activity, leading 
to widespread consensus that the release of LNG into the systemic circulation is 
below the physiologically-active level with a consequently negligible risk of adverse 
systemic effects (12,14-17). However, several studies have recently cast doubt upon 
the claim that LNG-IUD functions with an exclusively local intrauterine influence 
(18-20), due to side effects including depressed mood and emotional lability (20,21). 
A recent Danish population-based epidemiologic study established an association 
between progestin-containing hormonal contraceptives, including the LNG-IUD and 
other progestin-only contraception, with both a significantly elevated risk of diagnosis 
for depression and a higher rate of antidepressant use (22). 
Although these findings might suggest a systemic influence of progestin release, di-
rect physiological evidence has never been established. Extensive studies of baseline 
endocrine measurements have been performed without any significant alterations 
identified (23,24). However, baseline serum measurements might be insufficient to 
evaluate alterations in stress reactivity. Therefore, the aim of the current studies was 
to directly investigate whether the LNG-IUD influences the physiological responses 
to stress by examining autonomic and hypothalamic-pituitary-adrenal (HPA) axis 
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responsivity in women using the LNG-IUD, oral combination estrogen-progestin 
contraception, or naturally cycling. Moreover, to evaluate the possible influence of 
the IUD itself – independent of levonorgestrel – on cortisol responsivity during the 
TSST, we also recruited 10 women using a copper IUD. 
In Study 1, we applied the Trier Social Stress Test (TSST) to induce moderate psy-
chosocial stress in a laboratory setting. In Study 2, we performed the low-dose (1 µg) 
Synacthen test to distinguish between central and peripheral mechanisms of HPA axis 
functioning. In Study 3, we examined long-term cortisol exposure under naturalistic 
conditions using hair cortisol measurements. 
mAteriAls And methods
study design and participants
The studies were approved by the Medical Ethical Committee of the Erasmus MC 
University Medical Center Rotterdam. The subjects were recruited from April 2011 to 
December 2013. All participants provided written informed consent after the study 
procedures were fully explained both orally and in writing. Subjects were recruited 
through posted flyers and local internet advertisements, and financially compensated 
for their participation. Inclusion criteria were female gender, age 18 to 45 years old, 
body mass index (BMI) between 19 and 30, and Dutch language fluency. All partici-
pants were assessed with a clinician-administered Structured Clinical Interview for 
DSM-IV Axis I Disorders (SCID-I). Exclusion criteria were any Axis I psychiatric dis-
order (acute or in remission), current pregnancy or lactation, thyroid disorder, recent 
(within 4 months) medical illness, or use of any prescription medication other than 
hormonal contraceptives. Women having a prior diagnosis of endometriosis, polycys-
tic ovary disease, or gynaecologic infection were excluded. In addition, women using 
hormonal contraceptives for treatment or prophylaxis of gynaecological (e.g. heavy 
menstrual bleeding) or dermatological (e.g. acne) conditions were excluded. 
In each of the three studies, women were enrolled in the following groups: 
levonorgestrel-releasing intrauterine device (0.02mg/24hours; LNG-IUD, Mirena®), 
oral monophasic ethinylestradiol/ levonorgestrel (0.03mg/0.15mg; EE30/LNG) and 
natural cycling (NC). Women in the LNG-IUD and EE30/LNG groups were using 
these respective hormonal contraceptives for at least four months. Women in the 
LNG-IUD group with a regular menstrual cycle (25-33 days) were tested during the 
luteal phase (days 21-27). Women with amenorrhea secondary to the LNG-IUD were 
tested on a matched schedule with the other participants regarding the day of the 
week and time of day. Women in the EE30/LNG group were tested during the active 
pill weeks. The NC group consisted of women with a regular menstrual cycle, who 
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reported no use of hormonal contraceptives for at least four months. Women in the 
NC group were tested during the luteal phase of their menstrual cycle to minimize 
hormonal variation across the menstrual cycle. The luteal phase was determined by 
menstrual cycle tracking based on the length of each woman’s menstrual cycle over 
the prior three months.
In addition to these three primary study groups, we also recruited 10 demograph-
ically-matched women using a non-hormonal copper-IUD, in order to evaluate the 
influence of the intrauterine device – independent of LNG – on stress responsivity 
during the TSST. Women using a copper-IUD were also tested during the luteal phase 
of their menstrual cycle.
The Positive and Negative Affect Scale (PANAS) was used to evaluate affective 
symptomatology (Table 1) (25). This scale consists of 20 adjectives describing a range 
of feelings and emotions, and measures general, positive and negative affective dimen-
sions. Each item was rated on a 5-point Likert scale ranging from 1 (very slightly or not 
at all) to 5 (extremely) using the time frame ‘in general’. The PANAS demonstrated high 
reliability (Positive affect: Cornbach’s α = 0.89, Negative affect: α = 0.85) (25,26).
exPerimentAl Procedures
study 1: trier social stress test (tsst)
In total, 55 healthy women participated in Study 1 (LNG-IUD, n=15; EE30/LNG, 
n=15; and NC group, n=25). The TSST was conducted according to the original 
protocol reported by Kirshbaum et al. (1993), including a preparation period, free 
speech task and verbal mental arithmetic task, each five minutes in duration (27). 
Subjects underwent the TSST in the presence of a two-member panel who maintained 
affectively neutral facial expressions throughout the procedure and provided the 
participant with no verbal or non-verbal feedback. Saliva samples were collected 
immediately prior (baseline) and at defined intervals following the TSST (+15, +30, 
+50, +70 minutes). 
Heart rate (HR) was monitored continuously throughout the TSST procedure. Elec-
trodes for electrocardiographic (ECG) signal recordings were applied using standard 
laboratory procedures, as previously described (28). Heart rate (HR) was determined 
using consecutive R-R intervals of the ECG and sampled at 512 Hz by means of a 
portable digital recorder (Vitaport System; TEMEC Instruments B.V., Kerkrade, The 
Netherlands). Interbeat intervals were calculated using R-top detection and visually 
inspected for detection and removal of artifacts. Physiological responsivity was evalu-
ated by computing mean baseline-to-peak HR responses for each distinct phase of 
the TSST. 
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Testing was conducted using a highly standardized procedure. The TSST began 30 
to 40 minutes after the arrival to the laboratory. Upon arrival to the lab, participants 
were administered a short interview of 10 to 15 minutes to allow them to feel at ease 
and to confirm their compliance with the instructions provided during the earlier 
pre-assessment. Thereafter, the physiological measurement procedure was explained 
and the electrodes were applied. Next, the participants were given a 10 minute 
period of quiet rest, seated in a room together with the experimenter, and permitted 
to read magazines and newspapers provided by the study staff. After the completion 
of the TSST, the participants remained seated in the same room as the experimenter 
for 55 minutes while again being permitted to read quietly. During this period, the 
experimenter interacted with the participants only for collection of the post-TSST 
saliva samples. At no time during the study procedure were participants permitted 
to use their cell phones, computers, or engage in any other activity. After collection 
of the final saliva sample, participants were fully debriefed about the study protocol.
study 2: low-dose (1µg) Acth stimulation test
An entirely independent group of 60 healthy female participants were enrolled in 
Study 2 (LNG-IUD, n=20; EE30/LNG, n=20; and NC group, n=20). None of these 
women participated in Study 1. Adrenal cortex sensitivity was investigated using the 
low-dose (1µg) intravenous ACTH stimulation test (Synacthen®). Blood samples were 
obtained at baseline, +30, and +90 minutes following ACTH administration. Saliva 
samples were collected at baseline, +15, +30, +60, and +90 minutes. Baseline blood 
samples (2 x 9 mL) were obtained for assessment of corticosteroid binding globulin 
(CBG). Subjects rested quietly in a semi-recumbent position throughout the entire 
procedure.
In Studies 1 and 2, all measurements were performed between 14.00 and 16.00 
hours in an effort to minimize any potential confounding of circadian influences. 
Participants abstained from alcohol, nicotine, caffeine, and intense physical activity 
for at least 24 hours prior to the experimental session.
study 3: naturalistic cortisol exposure
In total, 95 healthy women were enrolled in Study 3 (LNG-IUD, n=33; EE30/LNG, 
n=33; and NC group, n=29), of which 60 women (n=20 per group) also participated 
in Study 2. Approximately 150 hairs were removed with scissors at the posterior 
vertex position, as close to the scalp as possible. Hair samples were stored at room 
temperature in a paper envelope until analysis, secured and marked to indicate their 
proximal end. Cortisol measurements were performed using the most proximal 3 cm 
of the hair samples, corresponding to the cumulative systemic cortisol level during 
the prior three-month period (29).
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Biochemical parameters
All samples were blinded upon collection to participant identity and group assign-
ment using anonymized coding. Biochemical analyses were conducted by laboratory 
personnel who had no involvement or knowledge of the details of the sample col-
lection. Saliva samples were collected using Sarstedt Cortisol Salivette® collection 
tubes and stored at -20°C until analysis. Salivary cortisol was measured using a 
commercially available ELISA kit (Demeditec Diagnostics, Kiel, Germany, DES6611). 
Inter- and intra-assay coefficients of variation were below 10% and 7%, respectively. 
Blood samples were immediately placed on ice upon collection and centrifuged for 
serum extraction. Serum was stored in aliquots at -80°C. Serum CBG was determined 
by radioimmunoassay (DRG Instruments GmbH, Marburg, Germany). Serum cortisol 
was measured using a two-site, solid-phase chemiluminescent immunometric assay 
(Immulite XPi, Siemens, Los Angeles, CA, USA).
Preparation and analysis of hair samples was performed as previously described 
(29). Fifteen milligrams of the most proximal 3 cm of hair was obtained for determina-
tion of the cortisol concentration. Extraction was performed in 1 mL of methanol at 
52°C for 16 hours, evaporated under a constant nitrogen stream, and eluted into 
250 µL of phosphate buffered saline (PBS, pH 8.0). Samples were measured using a 
commercially available enzyme-linked immunosorbent assay (ELISA) kit for salivary 
cortisol (DRG Instruments GmbH, Marburg, Germany). 
statistical analysis
Results are expressed as mean ± SEM unless otherwise indicated. Data were tested 
for normality using the Kolmogorov-Smirnov Test and visual inspection of Q-Q plots. 
Homogeneity of variance was confirmed using Levene’s test. To meet the normal-
ity assumption, all data were log transformed. To examine group differences in 
demographic characteristics and hair cortisol levels, chi-squared tests and one-way 
ANOVAs were conducted. Hormone profiles and HR responsivity during the TSST 
and ACTH stimulation test were compared using a repeated measures analysis of 
covariance (ANCOVA), with time as a within-subject factor and experimental group 
as a between-subject factor. For all general linear models, the corresponding F values, 
degrees of freedom and P values were corrected by the Greenhouse-Geisser proce-
dure whenever the assumption of sphericity was violated. Effect sizes were calculated 
by partial eta squared (η2). P values less than 0.05 were considered statistically sig-
nificant. Post-hoc analyses were evaluated using a Bonferroni adjustment. Factors 
considered to be potentially confounding the main or interaction effects on cortisol 
and HR included: age, BMI, ethnicity, parity, PANAS scores, smoking, educational 
level, employment status, and duration of contraceptive use. These potential con-
founders were assessed in a set of ANOVAs with repeated measures. None of these 
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table 1. Demographics and baseline characteristics
lnG-iud ee30/lnG nc P value
study 1: tsst (n=15) (n=15) (n=25)
Age, mean (SD), y 28.87 (7.43) 25.07 (5.98) 29.40 (5.75) 0.10
BMI, mean (SD), kg/m2 21.11 (2.05) 21.82 (3.03) 22.82 (2.99) 0.17
Smokers/ non-smokers 0/15 2/13 4/21 0.29
Ethnicity: Caucasian/ non-Caucasian 10/5 14/1 22/3 0.11
Partner: yes/ no 6/9 4/11 12/13 0.41
Education: middle/high 4/11 3/12 9/16 0.54
Employment: labor/student 8/7 7/8 8/17 0.38
PANAS Positive Affect, mean (SD) 36.27 (6.8) 33.53 (6.37) 34.40 (6.11) 0.49
PANAS Negative Affect, mean (SD) 17.20 (6.41) 19.07 (8.08) 19.20 (7.26) 0.68
Heart Rate baseline, mean (SD), beats/min 67.42 (9.99) 73.19 (9.74) 70.41 (10.29) 0.33
Parous/ nulliparous 2/13 1/14 1/24 0.54
Duration of current contraception,
median (IQR), months
15.0 (14.0) 47.0 (53.0) - -
study 2: Acth stimulation test (n=20) (n=20) (n=20)
Age, mean (SD), y 24.21 (4.28) 22.2 (1.47) 22.11 (2.85) 0.10
BMI, mean (SD), kg/m2 22.6 (1.87) 22.53 (2.89) 21.66 (1.74) 0.22
Smokers/ non-smokers 2/18 1/19 2/18 0.80
Ethnicity: Caucasian/ non-Caucasian 16/4 18/2 17/3 0.68
Partner: yes/ no 11/9 8/12 11/9 0.62
Education: middle/high 5/15 4/16 7/13 0.55
Employment: labor/student 6/14 7/13 4/16 0.56
Parous/ nulliparous 0/20 0/20 0/20 -
Duration of current contraception, 
median (IQR), months
16.0 (12.0) 22.5 (42.0) - -
study 3: naturalistic cortisol exposure (n=33) (n=33) (n=29)
Age, mean (SD), y 24.94 (4.45) 23.15 (3.33) 23.59 (3.83) 0.16
BMI, mean (SD), kg/m2 22.45 (1.90) 22.93 (2.55) 21.67 (2.20) 0.90
Smokers/ non-smokers 2/31 1/32 2/27 0.77
Ethnicity: Caucasian/ non-Caucasian 28/5 31/2 24/5 0.38
Partner: yes/ no 14//19 18/15 15/14 0.59
Education: middle/high 10/23 12/21 7/22 0.58
Employment: labor/student 9/24 7/26 10/19 0.51
Parous/ nulliparous 1/32 1/32 0/29 0.64
Duration of current contraception,
median (IQR), months
 18.0 (10.0)  25.0 (39.0) - -
Abbreviations: TSST (Trier Social Stress Test), BMI (Body Mass Index), PANAS (Positive Affect and Nega-
tive Affect Scale), ACTH (Adrenocorticotropic Hormone).
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factors yielded significant main or interaction effects, on either cortisol levels or heart 
rate responses. Age and BMI were included as covariates in all relevant analyses. 
Additionally, considering that ethinylestradiol is known to influence CBG levels, for 
which a substantial proportion of CBG is bound to circulating cortisol, CBG concen-
trations were included as a covariate in the analyses of serum cortisol concentrations 
in Study 2. For all studies, a priori power analyses were performed to determine the 
required sample size at 80% power with a significance threshold of 0.05.
results
The flowcharts of study inclusion are shown in Figure 1. For each of the three studies, 
LNG-IUD, EE30/LNG, and NC groups had similar baseline characteristics, including 
age, BMI, smoking, and ethnicity (Table 1).
study 1: trier social stress test (tsst)
The TSST induced a time-dependent increase in salivary cortisol (F[1.87, 97.03] = 
87.37, P < 0.0001), which differed between the three groups (F[2, 50] = 15.03, P 
< 0.0001, η2= 0.38). A TSST x group interaction was observed (F[(3.78, 94.42] = 
11.84, P < 0.0001, η2 = 0.32; post-hoc analysis of peak cortisol response: LNG-IUD 
[24.95 ± 13.45 nmol/L, 95% CI 17.49–32.40] > NC [10.85 ± 11.03 nmol/L, 95% CI 
6.30–15.40] > EE30/LNG [3.27 ± 2.83 nmol/L, 95% CI 1.71-4.84]) (Figure 2a). 
Heart rate was increased during the TSST (F[1.8, 93.44] = 201.77, P < 0.0001), 
and varied in magnitude between the three groups (group, F[2, 52] = 3.79, P = 0.03; 
group x time, F[3.59, 93.44] = 2.60, P = 0.047; post-hoc analysis: LNG-IUD > EE30/
LNG = NC). In particular, women using LNG-IUD demonstrated a strong potentiation 
of HR response, compared to women using EE30/LNG or NC (peak HR response: 
LNG-IUD [38.56 ± 18.14 beats/min, CI 95% 28.51–48.61] > EE30/LNG [28.24 ± 
15.07 beats/min, CI 95% 19.89–36.58] = NC [27.57 ± 12.41 beats/min, CI 95% 
22.45–32.69]) (Figure 2b).
Importantly, women using a copper-IUD had similar cortisol responses (peak cor-
tisol response = 6.49 ± 5.70 nmol/L, CI 95% 2.41–10.57) to the NC group (F[1, 31] 
= 3.41, P = 0.08). Furthermore, no difference in heart rate response was observed 
between women using a copper-IUD (peak HR response = 28.35 ± 5.70 beats/min, 
CI 95% 24.27–32.43) versus the NC group (F[1, 31] = 0.05, P = 0.80).
study 2: low-dose (1µg) Acth stimulation test
Administration of low-dose (1µg) ACTH induced a time-dependent increase in sali-
vary cortisol (F[2.31,131.75] = 356.66, P < 0.0001), which differed by group (F[2, 
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55] = 7.18, P = 0.002, η2= 0.21) during the post-administration period (group x time, 
F[4.67,128.55] = 8.22, P< 0.0001, η2 = 0.23; post-hoc analysis: NC > LNG-IUD = 
EE30/LNG, P = 0.001) (Figure 3).
ACTH induced an increase in total serum cortisol (F[2, 114] = 373.08, P < 0.0001). 
The groups differed significantly with the EE30/LNG group displaying a significantly 
higher total serum cortisol response in comparison with NC or LNG-IUD groups 
(F[2, 57] = 65.59, P < 0.0001). A significant Group x Time interaction was observed 
(F[4,114] = 9.76, P < 0.0001, η2= 0.69). Corticosteroid-binding globulin (CBG) levels 
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figure 1. flowchart of participants.
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differed signifi cantly between the groups (F(2,59) = 143,34; P < 0.001, η2= 0.83) 
and were positively correlated with serum cortisol at baseline (r = 0.82, P < 0.001) 
and at the +30 min post-ACTH peak (r = 0.93, P < 0.001) (Figure 5). Notably, after 
controlling for CBG levels, no signifi cant group or interaction effect on total serum 
cortisol remained. In addition, both the serum and salivary cortisol fi ndings remained 
signifi cant despite correction for all known glucocorticoid receptor (N3RC1) poly-
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figure 2. salivary cortisol and heart rate response to the tsst 
A. Untransformed raw cortisol mean (±SEM) values in women using LNG-IUD, EE30/LNG or Copper-
IUD, and naturally cycling women. ANCOVA demonstrated signifi cant differences in cortisol between 
groups in response to the TSST (group, P < 0.0001; group x time, P < 0.0001). B. Heart rate responses 
are reported as mean (±SEM). ANCOVA demonstrated signifi cant differences in response magnitude 
(group, P = 0.03; group x time, P = 0.047). 
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figure 3. salivary cortisol response to a low dose (1µg) Acth stimulation
Untransformed raw cortisol mean (±SEM) values in women using LNG-IUD or EE30/LNG, and naturally 
cycling (NC) women. ANCOVA demonstrated signifi cant differences in cortisol between groups follow-
ing low-dose ACTH (group, P = 0.002; group x time, P < 0.0001).
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morphisms that have been previously shown to modulate cortisol levels: rs6189/
rs6190, rs6195, rs6198, rs10052957, rs41423247 (P < 0.001) (30).
study 3: naturalistic cortisol exposure
Hair cortisol differed signifi cantly between groups (F[2,90] = 13.35, P < 0.0001). 
Analogous to the fi ndings of the TSST, women using LNG-IUD had elevated hair 
cortisol and EE30/LNG users had reduced hair cortisol, compared to NC women 
(post-hoc analyses: LNG-IUD > NC > EE30/LNG, P = 0.047) (Figure 5).
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figure 5. hair cortisol concentrations. Untransformed hair cortisol mean (±SEM) values in women us-
ing LNG-IUD or EE30/LNG and naturally cycling (NC) women. ANCOVA demonstrated signifi cant dif-
ferences in hair cortisol between groups (P < 0.001). * P < 0.05, ** P < 0.001 calculated using ANOVA.
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discussion
These studies are the fi rst to demonstrate that the LNG-IUD alters the systemic 
physiological responses to stress. In particular, we fi nd that women using LNG-IUD 
have substantially potentiated free cortisol and heart rate responses during moderate 
psychosocial stress compared to oral estrogen-progestin contraception or natural 
cycling.
Our data demonstrate a contrasting pattern of hormonal contraceptive modula-
tion of endocrine responses to the TSST. Relative to natural cycling, women using 
LNG-IUD exhibited a robust potentiation of the salivary cortisol response during the 
TSST, whereas women using combination estrogen-progestin contraception showed 
a relatively blunted cortisol response. Ethinyl estradiol has been previously shown to 
increase CBG levels by approximately two-fold, thereby signifi cantly enhancing the 
buffering capacity of serum cortisol with a concomitant reduction of the unbound 
fraction (31-33). In addition to a potentiation of cortisol responsivity, women using 
LNG-IUD had a >10 beats/min increase of psychosocial stress-induced heart rate. 
In contrast, copper-IUD users had cortisol and HR responses that were similar to 
naturally cycling women, confi rming that secreted progestin was responsible for the 
potentiated stress responsivity in women using the LNG-IUD.
Mechanistically, we examined whether the observed changes in cortisol responsiv-
ity during the TSST were due to central (hypothalamic/pituitary) versus peripheral 
(adrenal cortex/CBG) alterations. In women using combination estrogen-progestin 
contraception, direct stimulation of the adrenal cortex using low-dose ACTH stimu-
lation resulted in a blunted salivary cortisol response, analogous to the outcome 
following the TSST. In contrast, the blunted salivary cortisol response to ACTH in 
women using LNG-IUD, which led to a potentiated cortisol response during the TSST, 
occurred despite a normal CBG level. Taken together, these fi ndings suggest a ho-
meostatic downregulation of adrenal cortex function in LNG-IUD users secondary to 
the chronic potentiation of acute cortisol responsivity. Therefore, LNG-IUD appears 
to induce both a centrally-mediated potentiation of HPA reactivity and a peripheral 
downregulation of adrenal cortex reactivity. 
We also investigated whether the alterations identifi ed using the laboratory-based 
assessments of acute HPA axis responsivity were evident in measurements of longi-
tudinal cortisol levels. Previous studies have established the reliability, sensitivity, 
and validity of hair cortisol measures for longitudinal assessments (34). Therefore, 
we sought to determine the real-world relevance of the observed laboratory-based 
fi ndings by sampling hair cortisol in women under naturalistic conditions. Indeed, 
similar to the fi ndings of the TSST, women using LNG-IUD showed signifi cantly 
higher concentrations of hair cortisol than naturally cycling women. Conversely, 
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women using combination estrogen-progestin contraception had decreased hair 
cortisol levels, again reflecting the changes observed during the TSST. Together, these 
data confirm the naturalistic relevance of the influence of LNG-IUD on chronic HPA 
axis functioning. 
The present study was not possible to implement using randomized group allo-
cation due to ethical considerations in designing studies to investigate medication 
side effects (35). However, non-randomized designs are well suited for the study 
of unintended pharmacological effects (36). Moreover, we made extensive efforts 
to control for potential sources of bias. First, we established strict definitions for 
each contraceptive group. Second, we considered multiple potentially confounding 
variables including age, BMI, ethnicity, affective symptoms, duration of contracep-
tive use, parity, education, employment status, and smoking. Third, we attempted to 
replicate the main effect of LNG-IUD in both an experimental study using controlled 
laboratory conditions and an observational study under naturalistic conditions. 
We observed potentiated cortisol responsivity (Studies 1 and 3) in the setting of 
a downregulation of adrenal cortex function (Study 2) in healthy women using the 
LNG-IUD. Elevated basal cortisol levels and HPA negative feedback dysregulation 
have been consistently linked to affective symptomatology. Alterations in HPA axis 
responses are present in a significant proportion of people with affective disorders 
(37). Moreover, previous studies have shown that women of childbearing age exhibit 
demonstrable HPA axis and mood alterations in response to sex steroids (38-40). 
Unfortunately, the design of our study did not permit the determination of sex steroid 
levels that might have helped to further elucidate the underlying mechanism by 
which the LNG-IUD modulates stress responsivity. We further acknowledge that our 
study does not permit an assessment of whether the observed systemic physiological 
influences of LNG-IUD are associated with mood disturbances or emotional lability. 
However, our results are in line with previous studies reporting an excess burden 
of affective symptoms in LNG-IUD users (18-20,40,41), and the recent findings of 
a large-scale longitudinal study suggesting a 34 percent higher risk of depression in 
women using the LNG-IUD (22). 
In conclusion, our findings suggest that LNG-IUD robustly potentiates the systemic 
responses to psychosocial stress. Given the ACTH results demonstrating a centrally-
mediated mechanism, it is likely that the levonorgestrel - IUD (Mirena®) is leaking a 
sufficient amount of progestin into the systemic circulation to sensitize hypothalamic/
pituitary function which might influence mood and emotion.
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ABstrAct
study question: Does adrenocorticotropic hormone (ACTH) induce gonadotropin 
release in premenopausal women?
summary answer: Administration of ACTH stimulates gonadotropin release, most 
likely by stimulation of the production of cortisol, in premenopausal women.
What is known already: In animal models, acute activation of the hypothalamic-
pituitary-adrenal (HPA) axis has been shown to induce gonadotropin release in the 
presence of sufficiently high estrogen levels. However, it is unknown whether the 
HPA axis has a similar influence on gonadotropin release in humans.
study design, size, duration: A mixed factorial design. A total of 60 healthy female 
participants participated in an experimental study.
Participants/materials, setting, methods: The study sample comprised three distinct 
hormonal-based populations: 1) lowPROG-lowE2, 2) lowPROG-highE2 and 3) 
highPROG-highE2 women. A low-dose (1 µg) of ACTH (Synacthen®) was adminis-
tered to all study participants. Serum steroid and gonadotropin concentrations were 
measured prior to, and at 30 and 90 minutes after, intravenous ACTH administration.
main results and the role of chance: Mean serum cortisol levels increased signifi-
cantly following ACTH administration in all groups (P<0.001). Similarly, the serum 
levels of 17-OH-progesterone, androstenedione, dehydroepiandrosterone and testos-
terone increased significantly in all groups (P < 0.01). The lowPROG-highE2 and 
highPROG-highE2 groups exhibited a significant increase in LH and FSH levels (P 
< 0.001), whereas the lowPROG-lowE2 group demonstrated blunted LH and FSH 
responses to ACTH administration (P < 0.05).
limitations, reasons for caution: Testing during the follicular phase of the natural 
menstrual cycle might have elicited premature, or more pronounced, LH surges in 
response to ACTH administration. 
Wider implications of the findings: Our findings suggest a novel mechanism by which 
the adrenal cortex functions as a mediator of gonadotropin release. These findings 
contribute to a greater understanding of the influence of acute stress on reproductive 
endocrinology.
study funding/competing interest(s): Erasmus University Medical Center
trial registration number: EudraCT Number 2012-005640-14
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introduction
Psychosocial stress is a highly significant factor predicting health outcomes and 
quality of life (1). The best-studied physiological response to stress is mediated 
by the hypothalamic-pituitary-adrenal (HPA) axis, which can be affected by the 
hypothalamic-pituitary-gonadal (HPG) axis, regulating metabolism and reproductive 
function, respectively (2,3). Previous studies have also demonstrated that chronic 
persistent stress interferes with the release of hypothalamic gonadotropin releasing 
hormone (GnRH), resulting in a suppression of gonadotropin levels (4,5). Studies in 
animal models have elucidated candidate physiological mechanisms underlying the 
well-replicated finding of stress-induced reproductive suppression in humans (6–8). 
The female reproductive system is powerfully modulated by stress, often leading to 
chronic anovulation and amenorrhea during periods of persistent stress (9). In adoles-
cents, chronic stress has been shown to significantly delay the onset of puberty (10).
Contrary to the effects of persistent stress, acute stress has been repeatedly shown to 
facilitate reproductive functioning by stimulating gonadotropin secretion (5,11,12). 
Animal studies have yielded a candidate hormonal mechanism through which acute 
stressors facilitate the release of luteinizing hormone (LH) and follicle stimulating hor-
mone (FSH) (13). Notably, the effect of acute stress on gonadotropin release is highly 
dependent upon the circulating level of estradiol (13–15). Moreover, adrenalectomy, 
but not ovariectomy, abolishes the facilitation of gonadotropin release by acute stress 
in rodents (15,16). Lastly, adrenal progesterone has been implicated as an important 
mediator of the stimulatory effect of stress on gonadotropins in the presence of an 
estrogen-primed environment (12,17). Taken together, widely convergent evidence in 
animal studies has given considerable support to the hypothesis that the facilitation of 
gonadotropin release by acute stress is mediated through adrenal steroids. 
To date, studies regarding the effects of HPA-axis stimulation on LH release in 
humans have concluded that in postmenopausal women the LH response to adre-
nal stimulation is highly estrogen-dependent (15), and significantly potentiated by 
progesterone (18). However, it remains unknown whether gonadotropin release is 
facilitated by adrenal stimulation in premenopausal women, and the extent to which 
this may be governed by ovarian function.
Therefore, the aim of this study was to determine the influence of acute adrenocor-
tical stimulation by administration of a low dose of ACTH on the release of LH and 
FSH in women with a normal menstrual cycle. In addition, we sought to explore the 
modulatory effect of estrogen and progestin on adrenal facilitation of gonadotropin 
release by administering a low dose of ACTH in three distinct healthy populations: 1) 
women having a natural menstrual cycle, 2) women taking oral contraceptive pills (a 
combination of estrogen/progestin), and 3) women using a progestin-releasing intra-
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uterine device (IUD). Combination estrogen/progestin contraceptives have previously 
been shown to inhibit ovarian function (19,20). In comparison, the progestin-releasing 
IUD has been suggested to only partly and only during the first year inhibit ovarian 
function, leaving circulating estradiol within the normal range for women of repro-
ductive age (21,22). Considering that LNG-IUD does not generally excrete sufficient 
amounts of progesterone to suppress the hypothalamic-ovarian axis (23), and given 
the possibility of a difference in gonadotropin release between young premenopausal 
women in the pre-ovulatory versus post-ovulatory phase, we reclassified the groups 
based on progesterone level and ovulatory phase. This study design provided us with 
the opportunity to compare the effects of acute stimulation of the adrenal cortex on 
gonadotropin release under conditions of intact ovarian function at different cycle 
phases, as well as in a setting of complete ovarian suppression. In addition, given 
previous studies reporting an association of hormonal contraceptives with emotional 
lability, anxiety, and depression (24), we performed structured assessments of the 
psychological affective state of our study participants in order to evaluate potential 
confounding effects. 
suBjects And methods
subjects
An a priori power analysis was performed at 80% power with a significance threshold 
of 0.05 in order to determine the cohort sample size. The power analysis indicated 
that a total sample size of 60 would provide confidence to detect differences of at least 
medium effect size between conditions. A total of 60 healthy women of reproductive 
age participated in this study (mean 22.83, SD 3.12, range 18-30 years). Subjects 
were recruited through local advertisements, and provided with monetary compensa-
tion (€50) for their participation. Hormonal contraceptive use was determined based 
on a structured questionnaire during the initial telephone screening, and reconfirmed 
on the day of testing. Women were considered eligible for the study only if they met 
one of the following inclusion criteria for continuous hormonal contraceptive use for 
at least the previous 4 months: 1) oral monophasic combined preparation containing 
ethinylestradiol (EE) 0.03mg and 0.15mg levonorgestrel (Ethinylestradiol/levonorg-
estrel, Microgynon® 30) [EE30/LNG group; N=20], 2) progestin-only LNG releasing 
IUD 0.02mg/24 hours (Mirena®; Bayer [LNG-IUD group; N=20], or 3) absence of any 
hormonal contraceptives and having a regular menstrual cycle length between 23 and 
35 days (naturally cycling) [NC group; N=20]. The duration of LNG-IUD use ranged 
from 16 to 28 months. All participants had a normal menstrual cycle length between 
26 and 29 days. Exclusion criteria were a history of clinically-significant psychiatric, 
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neurologic, endocrine or medical illness (including alcohol or drug dependence, 
asthma, allergies, cardiovascular disease, endometriosis, polycystic ovary disease, 
or gynaecologic infection), body-mass-index (BMI) <19 or >26 kg/m2, atypical sleep 
pattern, the use of any prescription medication other than hormonal contraceptives 
within the previous 4 months, and pregnancy or lactation within the previous 12 
months. Women in the EE30/LNG group were tested during the active pill weeks. NC 
women were tested in the luteal phase of the menstrual cycle, between days 20 and 
27 of their cycle.
The study was conducted according to the declaration of Helsinki and was ap-
proved by the Medical Ethical Research Committee of the Erasmus MC, University 
Medical Center Rotterdam. All subjects provided written informed consent for their 
participation.
Psychological assessment
To examine the possibility that responses to ACTH administration could be con-
founded by differences in affect regulation between the contraceptive groups, all par-
ticipants completed the Positive and Negative Affect Scale (PANAS), a well-validated 
questionnaire for measuring general, positive and negative affective states (Watson 
et al., 1988). Each of the 20 items is rated on a 5-point Likert scale ranging from 1 
(very slightly or not at all) to 5 (extremely). The PANAS has been established to have 
high reliability (Positive affect scale: Cornbach’s α = 0.89, Negative affect scale: α = 
0.85) (25).
Acth administration
Participants abstained from smoking, alcohol, caffeinated beverages, and physical 
exercise on the day of testing. There were no other dietary restrictions. Testing was 
conducted between 13.00 and 16.00h. The testing procedure began with a general 
medical examination to reconfirm the subject’s physical and mental health status. 
An intravenous catheter was inserted either into the antecubital or the medial cubital 
vein to obtain serial blood samples. The intravenous catheter was flushed with normal 
saline immediately after each blood sampling time point. Following an initial 30 
minute rest period, baseline venous blood samples were obtained for steroid and pro-
tein hormone assessments (cortisol, 17-hydroxyprogesterone [17-OH-progesterone], 
progesterone, testosterone, dehydroepiandrosterone [DHEA], androstenedione, 
dehydroepiandrosterone sulfate [DHEAS], and estradiol [E2]), globulin levels (corti-
costeroid binding globulin [CBG], sex hormone binding globulin [SHBG]), LH and 
FSH). Immediately following withdrawal of the baseline venous blood samples, a 1 
µg IV bolus of 1-24 ACTH (Synacthen®; Novartis, Basel, Switzerland) was admin-
istered. Additional blood samples were obtained at 30 and 90 minutes following 
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ACTH administration. Subjects were asked to sit quietly in a semi-recumbent position 
throughout the entire procedure. No adverse events were reported.
sample collection
Blood samples were collected using Vacutainer® tubes, immediately placed on ice 
upon collection and centrifuged at 4°C for 10 minutes at 3000 x g within 1 hour of 
collection. The resulting serum was aliquoted prior to storage at -80°C.
hormone determinations
With the exception of estradiol, steroid hormones were measured using the LC-MS/MS 
method with the CHS™ MSMS Steroids Kit (Perkin Elmer, Turku, Finland). The Steroids 
Kit uses a combined solvent extraction and protein precipitation method with aceto-
nitrile containing the deuterated internal standards 2H5-androstenedione, 
2H3-cortisol 
, 2H8-17-OH-progesterone, 
2H6-DHEA, 
2H9-progesterone, and 
2H5-testosterone. The 
internal standards undergo processing identical to the analytes. Chromatographic 
separation was performed on a Waters® (Milford, MA, USA) Acquity™ UPLC HSS 
T3 1.8 µm column (diameter 1 mm, length 10 cm) with acetonitrile/MeOH gradient, 
and in-line filters with 0.2 µm frits. A Waters® XEVO-TQ-S system equipped with an 
electrospray ionization (ESI) source operating in the electrospray positive mode was 
used except for DHEAS (negative ESI). Multiple reaction monitoring was applied for 
the detection of the analytes using both quantifiers and qualifiers.
The lower limits of quantification for androstenedione, cortisol, DHEA, DHEAS, 
progesterone, 17-OH-progesterone and testosterone were 0.20, 2.57, 2.2, 24.7, 
0.13, 0.10, and 0.07 nmol/L, respectively. During the LC-step of the steroid assay, 
progesterone and 17-OHP were completely separated, thereby removing the pos-
sibility of cross-reactivity in this assay. Estradiol was measured by the Coat-A-Count 
radioimmunoassay of Siemens Healthcare Diagnostics Products (Los Angeles, CA, 
USA). Intra- and inter-assay coefficients of variation for the steroid assays were <7.0 
and <8.0% for androstenedione, <6 and <6% for cortisol, <7 and <8% for DHEA, 
<8 and <13% for DHEAS, <6 and <7% for progesterone, <6 and <6% for 17-OH-
progesterone, <6 and <9% for testosterone and <5 and <7% for estradiol. LH, FSH, 
and SHBG concentrations were measured using the Siemens Immulite XPi system. 
Serum CBG concentrations were determined by radioimmunoassay (DRG Instru-
ments GmbH, Marburg, Germany). Intra- and inter-assay coefficients of variation 
were <4 and <7% for LH, <3 and 6% for FSH, <4 and <5% for SHBG and <9 and 
<11% for CBG. 
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data analysis
Given the influence of menstrual phase (pre-ovulatory vs. post-ovulatory) on go-
nadotropin release, participants from the natural cycling and LNG-IUD groups were 
classified based on progesterone level. Women with progesterone concentrations 
above 5 nmol/l were classified in the highPROG/highE2 group (n=12) and women 
with a lower progesterone concentration in the lowPROG/highE2 group (n=28). 
Estradiol levels in these two groups were not different. Women using EE30/LNG were 
designated as lowPROG/lowE2 (n=20). 
Statistical analyses were conducted using the SPSS statistical software package (IBM 
SPSS Statistics, Version 21). Results are expressed as means ± SEM, unless otherwise 
specified. Data per parameter were tested for normality of distribution and homo-
geneity of variance using Kolmogorov—Smirnov and Levene’s tests. In six patients, 
one of the hormone measurements was not possible to quantify due to interfering 
peaks in the chromatogram (progesterone, n=1; E2, n=1; androstenedione, n=4). To 
meet the normality assumption, where necessary, hormonal data were logarithmi-
cally transformed. After log-transformation, the data were normally distributed. In 
order to examine group differences in demographic characteristics and affect, chi-
squared tests and one-way ANOVAs were conducted. To analyse hormone profiles in 
response to ACTH administration, ANOVAs were performed with a repeated-measure 
factor Time (baseline, +30 minutes, +90 minutes), between-subject factor Group 
(lowPROG-lowE2, lowPROG-highE2, highPROG-highE2), and the interaction effect 
of Time x Group. Post hoc analyses, where necessary, were performed using Bonfer-
roni multiple means comparisons. To reduce the possibility of a Type I error when 
analyzing steroids reactivity, statistical significance for these tests was defined at the 
more stringent threshold of P < 0.01. In order to check for potentially confounding 
effects of age, BMI, and PANAS scores on the steroid and gonadotropin responses, 
these parameters were first evaluated separately in a set of ANOVAs for repeated 
measures. Age, BMI, and PANAS scores did not yield significant main or interaction 
effects in relation to the steroid or gonadotropin responses. Therefore, these variables 
were not included as covariates in subsequent analyses.
Since ethinylestradiol influences levels of CBG, which binds cortisol with high 
affinity, CBG concentrations were included as covariates in analyses of cortisol 
concentrations. For general linear models (GLMs), F-values, degrees of freedom, and 
P values were corrected by the Greenhouse-Geisser procedure whenever the assump-
tion of sphericity was violated. Effect sizes were calculated by partial eta squared (Ƞ2). 
P values less than 0.01 were considered to be statistically significant.
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results
subject characteristics, and baseline Acth and binding globulin levels
The groups did not differ significantly in age or BMI (Table 1). No significant dif-
ferences were found in positive or negative affect scores on the PANAS, indicating 
comparable baseline affective states between the study groups (Table 1). The study 
groups were also similar in their baseline ACTH levels (Table 1). Importantly however, 
the lowPROG-lowE2 group exhibited significantly higher baseline CBG (P < 0.001) 
and SHBG levels (P < 0.001), due to the stimulating effect of the synthetic estrogen in 
the oral contraceptive (Table 1). 
effect of Acth administration on gonadotropin release
ACTH administration resulted in significant time-dependent changes of LH and FSH 
levels in all groups (lowPROG-highE2 and highPROG-highE2, P < 0.001; lowPROG-
lowE2, P < 0.05). The groups differed significantly regarding LH levels, with the 
lowPROG-lowE2 group displaying overall lower LH concentrations (P < 0.001; post 
hoc: lowPROG-highE2 = highPROG-highE2 > lowPROG-lowE2; Figure 1a). No 
significant Group x Time interaction effect was observed. The FSH levels differed 
significantly between the study groups (P < 0.001). A significant Group x Time inter-
action was observed (P < 0.05; post hoc: lowPROG-highE2 > highPROG-highE2 > 
lowPROG-lowE2; Figure 1b): the EE30/LNG group displayed a blunted FSH response 
to ACTH administration (P < 0.01).
table 1. Subject characteristics, affect state, and baseline globulin and ACTH levels of the experimental 
groups
lowProG/ highe2 highProG/ highe2 lowProG/ lowe2
(n=28) (n=12) (n=20)
Age, mean (SD), years 23.04 (3.26) 23.42 (4.64) 22.2 (1.47)
BMI, mean (SD), kg/m2 22.16 (2.11) 21.87 (1.30) 22.53 (2.89)
PANAS
 Positive Affect scale, score 28.14 (5.82) 28.58 (3.87) 29.45 (6.89)
 Negative Affect scale, score 13.75 (3.23) 13.17 (2.73) 12.00 (2.15)
SHBG, mean (SD), µg/ml 25.76 (8.53) 26.41 (8.94) 50.94 (14.69)*
ACTH, mean (SD), µg/ml 3.40 (1.37) 2.03 (1.07) 3.07 (3.35)
CBG, mean (SD), µg/ml 52.91 (8.60) 57.08 (6.11) 120.99 (22.11)*
Abbreviations: Positive affect and Negative affect scale (PANAS), cortisosteroid binding globulin (CBG), 
sex hormone binding globulin (SHBG), adrenocorticotropic hormone (ACTH).
*One-way ANOVA between three experimental groups, P < 0.001.
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figure 2. Untransformed raw Cortisol (a), Progester-
one (b) and Estradiol (c) mean ±SEM values at base-
line, 30 and 90 minutes after administration of low 
dose (1µg) ACTH.
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figure 1. Untransformed raw LH (a) and FSH (b) mean ± SEM values at baseline, +30, and +90 minutes 
after administration of low dose (1µg) ACTH. 
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effects of Acth administration on the steroid profile
ACTH administration resulted in significant time-dependent changes in the levels 
of cortisol, 17-OH-progesterone, progesterone, testosterone, DHEA, DHEAS, and 
androstenedione (P< 0.001 for each group x steroid combination), all displaying sig-
nificant increases at 30 minutes after ACTH administration (P < 0.01 for each group 
x steroid combination). With regard to E2, a significant increase was observed 90 
minutes after ACTH administration in the lowPROG-highE2 and highPROG-highE2 
groups (P< 0.001 for each group), but no change was found in the lowPROG-lowE2 
group.
cortisol. The study groups differed significantly with regard to total serum cor-
tisol levels. Women using oral contraceptives (lowPROG-lowE2 group) exhibited 
significantly higher mean total cortisol levels, compared to the lowPROG-highE2 and 
highPROG-highE2 groups (P< 0.001; Figure 2a). However, after controlling for CBG 
levels, no significant group or interaction effect remained, confirming the influence 
of CBG on cortisol levels.
Progesterone. The study groups differed significantly regarding progesterone lev-
els, with the highPROG-highE2 group showing higher overall progesterone than the 
lowPROG-highE2 and lowPROG-lowE2 groups (P < 0.001). ACTH administration in-
duced a significant increase in progesterone in the lowPROG-highE2 and lowPROG-
lowE2 groups, but not in the highPROG-highE2 group (P < 0.001; Figure 2b).
17-oh-progesterone. 17-OH-progesterone levels differed significantly between 
the study groups at baseline, +30 and +90 minutes post-ACTH administration (P < 
0.001; post hoc: highPROG-highE2 > lowPROG-highE2 > lowPROG-lowE2). Further-
more, a significant Group x Time interaction effect was observed (P < 0.001), with the 
lowPROG-lowE2 group displaying relatively higher 17-OH-progesterone increases 
at 30 minutes post-ACTH administration compared to the highPROG-highE2 and 
lowPROG-highE2groups (Table 2).
Androstenedione. Androstenedione levels differed significantly between the groups 
(P < 0.001; post hoc: highPROG-highE2 = lowPROG-highE2 > lowPROG-lowE2), 
with the lowPROG-lowE2 group displaying overall lower androstenedione levels, 
compared to the highPROG-highE2 and lowPROG-highE2 groups (Table 2). No 
significant Group x Time interaction effect was observed. 
dehydroepiandrosterone. The study groups differed significantly in DHEA concen-
trations at baseline, and +30 and +90 minutes post-ACTH administration (P < 0.001; 
post hoc: highPROG-highE2 = lowPROG-highE2 > lowPROG-lowE2; Table 2). No 
significant Group x Time interaction effect was observed.
dehydroepiandrosterone sulfate. DHEAS levels differed significantly between the 
study groups (P < 0.01; post hoc: highPROG-highE2 = lowPROG-highE2 > lowPROG-
lowE2), with the highPROG-highE2 and lowPROG-highE2 groups displaying higher 
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table 2. Adrenal steroid levels in response to ACTH stimulation in the experimental groups
lowProG/ 
highe2
highProG/ 
highe2
lowProG/ 
lowe2
P-value
within 
group
P-value
Between 
group
Cortisol (nmol/L) (n=28) (n=12) (n=20)
Baseline 182.58 (89.16) 158.82 (41.55) 386.60 (116.99)
P < 0.001 P < 0.00130 min 435.73 (61.28) 456.86 (77.89) 791.81 (183.24)
90 min 261.26 (56.25) 295.48 (65.88) 612.08 (176.64)
Progesterone (nmol/L) (n=28) (n=11) (n=20)
Baseline 0.63 (0.50) 25.71 (16.88) 0.19 (0.06)
P < 0.001 P < 0.00130 min 0.93 (0.68) 20.53 (12.77) 0.55 (0.25)
90 min 0.81 (0.78) 24.06 (14.45) 0.28 (0.09)
17-OH Progesterone (nmol/L) (n=28) (n=12) (n=20)
Baseline 1.25 (0.76) 4.35 (1.89) 0.19 (0.13)
P < 0.001 P < 0.00130 min 2.39 (0.98) 5.79 (2.69) 1.49 (0.71)
90 min 1.41 (0.69) 4.38 (1.90) 0.39 (0.21)
Androstenedione (nmol/L) (n=27) (n=12) (n=17)
Baseline 4.01 (1.70) 3.90 (1.48) 1.73 (.71)
P < 0.001 P < 0.00130 min 5.48 (2.27) 5.51 1.33) 2.61 (0.84)
90 min 4.16 (1.61) 4.01 (1.20) 1.92 (0.63)
DHEA (nmol/L) (n=28) (n=12) (n=20)
Baseline 21.50 (10.43) 16.84 (5.48) 11.18 (4.91)
P < 0.001 P < 0.00130 min 43.73 (15.95) 45.31 (12.90) 24.52 (10.73)
90 min 21.25 (8.57) 20.52 (7.48) 11.85 (3.87)
DHEAS (µmol/L) (n=28) (n=12) (n=20)
Baseline 5.15 (2.43) 6.06 (2.73) 4.10 (1.69)
P < 0.01 P = 0.0230 min 5.34 (2.53) 5.87 (2.16) 4.21 (1.68)
90 min 5.15 (2.29) 5.97 (2.31) 4.06 (1.66)
Testosterone (nmol/L) (n=28) (n=12) (n=20)
Baseline 0.97 (0.36) 1.04 (0.45) 0.55 (0.18)
P < 0.001 P < 0.00130 min 1.11 (0.36) 1.13 (0.36) 0.70 (0.23)
90 min 1.08 (0.40) 1.10 (0.41) 0.58 (0.17)
E2 (pmol/L) (n=27) (n=12) (n=20)
Baseline 253.96 (197.80) 304.27 (106.38) 39.44 (15.97)
P < 0.001 P < 0.00130 min 243.00 (181.95) 292.58 (103.17) 34.71 (17.47)
90 min 324.45 (244.79) 348.72 (136.16) 37.80 (18.49)
Data are presented as mean ± SD.
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overall levels when compared to the lowPROG-lowE2 group (Table 2). No significant 
Group x Time interaction effect was observed.
testosterone. The lowPROG-lowE2 group exhibited overall lower testosterone 
levels, compared to the highPROG-highE2 and lowPROG-highE2 groups (P < 0.001; 
Table 2). A significant Group x Time interaction effect demonstrated a larger increase 
of testosterone levels following ACTH administration in the lowPROG-lowE2 group, 
compared to the highPROG-highE2 and lowPROG-highE2 groups (P < 0.01).
estradiol. E2 levels were significantly different between the study groups: the 
lowPROG-lowE2 group had lower E2 levels than the highPROG-highE2 and low-
PROG-highE2 groups (P < 0.001). No differences were observed in E2 levels between 
the highPROG-highE2 and lowPROG-highE2 groups. ACTH administration induced 
a significant increase of E2 in the highPROG-highE2 and lowPROG-highE2 groups, 
but not in lowPROG-lowE2 users (P < 0.001; post hoc: NC = LNG-IUD > EE30/LNG; 
Figure 2c).
discussion
The aim of our study was to examine the influence of acute adrenal cortex stimulation 
on gonadotropin release in 3 groups of premenopausal women distinguished by the 
different levels of progesterone and estradiol: highPROG-highE2, lowPROG-highE2 
and lowPROG-lowE2. Basal hormone levels differed between groups on the basis of 
cycle phase (progesterone and 17-OH progesterone in the highPROG-highE2 and 
lowPROG-highE2 groups), and on the basis of suppression of LH and FSH in the 
female group using oral contraceptives, lowPROG-lowE2 leading to suppression of 
the ovarian component of the production of androgens and estradiol.
Steroid-dependent regulation of gonadotropin release has been shown to involve 
a complex interaction with estrogen, as observed in studies of estrogen-replacement 
therapy in postmenopausal women, in which activation of the HPA axis resulted in 
gonadotropin release only in the presence of sufficient levels of circulating estrogen 
(15). In our study, estrogens were present in all study groups: endogenous estradiol 
in the highPROG-highE2 and lowPROG-highE2 groups, and ethinylestradiol in the 
lowPROG-lowE2 group. Further evidence that adrenal steroid secretion is associated 
with gonadotropin release comes from animal studies in which both adrenalectomy 
and pre-treatment with RU486, which has antiglucocorticoid and antiprogesterone 
activities, each abolished stress-induced gonadotropin release (12,17,26). Similar to 
the results of human studies, the stimulatory effect of ACTH was observed only in 
estrogen-primed rats, consistent with the essential requirement of adequate estradiol 
(12,16). 
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In our data, a significant increase of ACTH-induced gonadotropin levels was 
observed in all groups. Among women with low levels of progesterone, ACTH 
administration led to increased progesterone in the presence of normal estradiol 
levels. This permissive hormonal context is comparable to that in the beginning of the 
midcycle peak of LH and FSH (27). Earlier research has established that estradiol and 
progesterone influence the induction of the midcycle gonadotropin surge (28,29). In 
our study, adrenal stimulation by ACTH caused a near doubling of the relatively low 
progesterone levels in the lowPROG-highE2and lowPROG-lowE2groups. However, 
in the highPROG-highE2 group, in which estradiol levels were comparable to those 
in lowPROG-highE2 group, a similar increase in gonadotropin levels was observed 
in the absence of increased progesterone levels. Therefore, the analogous ACTH ef-
fects on gonadotropin release in the highPROG-highE2 and lowPROG-highE2 groups 
suggests that progesterone is unlikely to be mediating the increase in LH and FSH. 
Alternative mechanisms to explain the ACTH-induced release of LH and FSH might 
involve the influence of 17-OH-progesterone, androgens, estradiol or cortisol. In our 
study, the relative effect of ACTH on circulating levels of 17-OH-progesterone was 
even larger than observed for progesterone, in accordance with previous studies (30). 
Elevated levels of 17-OH-progesterone are in line with earlier reports showing that 
peripheral levels of 17-OH-progesterone during the luteal phase of the cycle are 
higher than those during the follicular phase (31). It has recently been described that 
17-OH-progesterone may have glucocorticoid activity due to its binding to the gluco-
corticoid receptor (GR) and its ability to transactivate the GR in vitro (32). However, 
considering that 17-OH-progesterone binds weakly to the GR and is a less potent 
agonist of GR than cortisol, it is unlikely that the observed gonadotropin increase 
in our study is mediated by 17-OH-progesterone (32). Furthermore, although earlier 
research in rhesus monkeys has suggested that 17-OH-progesterone may facilitate the 
onset of LH surges (33), the stimulating effect of 17-OH-progesterone on LH release 
was not found in humans (34). This makes it unlikely that the increase of 17-OH-
progesterone caused the surge of gonadotropins. 
Regarding the influence of increased levels of androgens and estradiol in the 
ACTH-induced release of gonadotropins, it is very unlikely that these steroids func-
tion prominently, since only suppressive effects of androgens have been described 
in patients with androgen producing tumours (35,36), or in rats (37). Moreover, the 
increase of estradiol levels was detectable only 90 minutes after the administration of 
ACTH, whereas the surge of LH and FSH was already evident after 30 minutes. 
Taken together, we believe that cortisol is the most parsimonious mediator of the 
increased levels of LH and FSH after ACTH injection. This is in accordance with the 
results of experiments in rats, in which glucocorticoids have been shown to affect 
gonadotropin release via receptor mediated mechanisms (38), and for which GR 
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activity has been shown to modulate LH through both pituitary and neuroendocrine 
mechanisms following exposure to stress (39–41).
The present study has several limitations. Because this is a secondary data analysis, 
examining the impact of acute adrenal stimulation on gonadotropin release was not 
the primary goal when designing the original study. Therefore, women having a natu-
ral menstrual cycle were tested during their luteal phase. Testing during the follicular 
phase of the menstrual cycle might have elicited premature, or more pronounced, 
LH surges in response to ACTH administration. However, reclassification of our data 
based on different progesterone levels though similar estradiol concentrations did not 
change the findings. Additionally, women were not randomly assigned to the study, 
but were recruited based on their use of contraceptives. However, the groups were 
very similar for all known confounding variables, including general medical health, 
age, BMI, affective state. 
While it is likely that the increase of gonadotropins observed in this study are 
due to a mediating effect of cortisol, it is also possible that administration of the 
ACTH might have resulted in downstream adaptations to CRH through a secondary 
feedback loop. However, the low-dose (1µg) ACTH stimulation test has been well 
documented to be more physiological and sensitive than for example the higher-dose 
(250µg or 100µg) ACTH stimulation tests. The 1µg low-dose administration results 
in a maximal serum ACTH concentration of 200 ng/l, which is of a similar order of 
magnitude as observed in venous blood samples from the sinus petrosus inferior 
(W.W. de Herder, unpublished data). Therefore, it seems unlikely that a 1µg dose 
of ACTH directly affects pituitary function, in addition since the extensive literature 
of investigations using the same low-dose ACTH formulation has never previously 
reported direct alteration of pituitary function. Furthermore, we acknowledge the 
lack of prolactin measurements which might have provided better insight into the 
stress induced gonadotropin release. However, considering that prolactin is released 
from the anterior pituitary and our focus was on the effects of adrenal stimulation, we 
considered the effect of prolactin to be negligible. 
In conclusion, our data are the first to demonstrate that acute stimulation of adrenal 
steroid production, most likely cortisol, mediates enhanced gonadotropin release in 
healthy premenopausal women. More generally, these findings contribute to an im-
proved understanding of the influence of acute stress on reproductive endocrinology. 
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mAin findinGs
Psychosocial stress is an inevitable component of our daily lives, which can affect both 
our mental and physical health. Therefore, detailed knowledge of the psychobiologi-
cal pathways linking stress and psychopathology is of major importance. The studies 
presented in this thesis report data on stress regulation in women with and without 
personality disorders. The aims of the studies were: a) to explore the fundamental 
personality characteristics that contribute to cognitive appraisals of psychosocial 
stress, b) to expand our knowledge of the underlying biological mechanisms of stress 
responses in women with and without personality disorder, and c) to shed light on the 
factors that modulate physiological reactivity to acute psychosocial stress. For these 
purposes, healthy women and women diagnosed with a personality disorder (Bor-
derline personality disorder and Cluster C personality disorder) were administered 
the Trier Social Stress Test (TSST). Cognitive appraisals, as well as psychological and 
physiological responses, were assessed before, during and after the TSST. In addition, 
to improve our understanding of the effects of sex hormones on stress induced physi-
ological responses, we administered low-dose (1µg) intravenous adrenocorticotropic 
hormone (ACTH) in an additional sample of healthy women.
The main findings of our studies demonstrated that (see Figure 2 for schematic 
representation):
- when exposed to a challenging situation, cognitive perception of stress was 
augmented directly by emotional dysregulation, and indirectly by attachment 
style and temperament. Positive affectivity contributes to preservation against 
stress, which might be seen as a key to resilience. Notably, all of the observed 
associations between attachment styles, temperament and cognitive stress ap-
praisals, including the mediating role of maladaptive personality traits, applied 
independently to women with low and high burden of psychopathology. These 
findings underline the importance of dysfunctional traits in understanding the role 
of individual characteristics on cognitive appraisals of acute psychosocial stress. 
- the 5-HTTLPR genotype was found to be associated with cortisol responsivity 
to psychosocial stress. Women with the LL genotype demonstrated significantly 
higher salivary cortisol responses to psychosocial stress than women with at least 
one copy of the S allele. Additionally, our results showed that early life adversi-
ties did not modulate the effects of the SLC6A4 5-HTTLPR genotype on salivary 
cortisol responses to psychosocial stress in women.
- women suffering from either BPD or CPD exhibited similarly robust mood dis-
turbances in response to acute psychosocial stress. However, patients with BPD 
demonstrated significant attenuations of salivary cortisol levels and heart rate 
reactivity as compared to patients with CPD or healthy controls. Thus, this pattern 
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of blunted cortisol and heart rate reactivity to psychosocial stress appeared to be 
specific for patients with BPD. 
- distinct hormonal contraceptive methods have contrasting effects on endocrine 
reactivity to psychosocial stress. Compared to naturally cycling women, women 
using an LNG-IUD exhibited a robust potentiation of their salivary cortisol re-
sponse during the TSST. However, women using combination estrogen-progestin 
contraception showed a relatively blunted cortisol response versus naturally cy-
cling women. Moreover, women using an LNG-IUD had a greater potentiation of 
heart rate responsivity to the TSST than women using oral combination estrogen-
progestin contraception. In line with these findings, women using an LNG-IUD 
exhibited significantly higher concentrations of hair cortisol than naturally cycling 
women.
- acute stimulation of adrenal steroid production, by means of a low-dose ACTH 
challenge test, mediated enhanced LH and FSH release in healthy premenopausal 
women. In addition, our findings confirmed a permissive function of estradiol, i.e. 
activation of the HPA axis, resulting in gonadotropin release only in the presence 
of sufficient levels of circulating estrogen. 
coGnitive APPrAisAls
Given the central role of cognitive appraisal in the process of stress regulation and 
its potential to mediate endocrine responses to environmental demands, we explored 
how fundamental personality characteristics, attachment and temperament modu-
lated cognitive appraisals of acute stress. Furthermore, we examined whether the 
potential relationships between personality characteristics and cognitive appraisals 
were mediated by emotional dysregulation. Cognitive appraisals were assessed dur-
ing the anticipation period of a pending acute psychosocial stressor. 
The findings of this thesis imply that, when exposed to a challenging situation, in-
dividuals with high positive affectivity judged themselves as being more capable and 
having sufficient coping resources to confront stressful situations. We did not observe 
direct associations between attachment insecurities and cognitive stress appraisals. 
However, our model showed that the significance of cognitive perception can be 
augmented by emotional dysregulation. This finding provides additional evidence 
that maladaptive personality traits are important factors in understanding the con-
tribution of individual characteristics to cognitive appraisals of acute psychosocial 
stress. Remarkably, the analyses revealed that the same pathway, with a mediating 
role of dysfunctional traits, applied to both healthy controls and women with per-
sonality disorders. From a clinical perspective, this finding supports the generally 
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accepted approach that all people have a mix of personality traits that are adaptive 
and functional, and traits that are less optimal and might lead to increased stress 
susceptibility (1,2). Consequently, this might influence how individuals dynamically 
adapt to environmental demands, resulting in the subjective experience and objec-
tive physiological state of well-being. 
Genetic fActors
In order to further assess the factors that enhance stress vulnerability, we aimed to 
shed light on the role of specific genetic factors on the variability of the cortisol 
response to acute psychosocial stress. Gene variants of the serotonin transporter 
have been associated with vulnerability to stress-related disorders and HPA-axis 
reactivity to stress (3–5). The findings reported in Chapter 3 support the theory that 
functional genetic variation is associated with cortisol responsivity to psychosocial 
stress. However, whereas earlier studies have found that particularly homozygous S 
allele carriers are associated with an augmented cortisol response to a stress test (6,7), 
we found the opposite association, i.e. women with the LL genotype demonstrated 
significantly higher salivary cortisol responses to psychosocial stress than women 
with at least one copy of the S allele. These opposing findings could be partly due 
to differences in age and hormonal status. The majority of earlier studies on 5-HT-
TLPR and salivary cortisol reactivity were performed using young subjects, including 
newborns and adolescents (6,8,9), whereas our study included older women, most 
likely with a different hormonal status than adolescent girls. Apart from the well-
known effects of the menstrual cycle on the HPA axis, several studies suggest that 
ovarian steroids (estradiol and progesterone) have a strong influence on serotonin 
synthesis, and expression of serotonergic receptors and 5-HTT (10–12), indicating 
that the effects of 5-HTTLPR on brain activity in women may change with alterations 
in hormonal status. Our findings indicate the need to further clarify the sex-specific 
biological interaction between the serotonergic system and ovarian hormones. These 
important factors are unfortunately often overlooked in studies combining data from 
male and female subjects.
We were not able to confirm a moderating effect of early life adversities on the 
5-HTTLPR effects on cortisol response to stress. Our results show that childhood (the 
first 15 years of life) maltreatment is unlikely to account for the modulating role of 
the 5-HTTLPR genotype in women. However, different measures of adversity or less 
accurate classification and timing of these adversities might have been the reason of 
the divergent findings. Future studies are needed to further explore the interaction 
of 5-HTTLPR and environmental adversity on cortisol responses to stress, through 
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increasingly precise definitions of adverse life events and more detailed biomarker 
analyses including genome-wide DNA methylation profiling, which has recently 
been shown to be informative (13).
PsychoPAtholoGy
There is ample evidence that patients with personality psychopathology experience 
an elevated perception of threat and have difficulties regulating their affect. However, 
the evidence for biological sensitivity is more ambiguous (14). In order to improve our 
understanding of the underlying biological mechanisms of emotional dysregulation 
in women with personality disorders, we conducted a study comparing emotional 
and physiological responses to psychosocial stress across three groups: outpatients 
with cluster C personality disorder (CPD), outpatients with borderline personality 
disorder (BPD), and healthy controls.
In response to the TSST, patients with CPD and BPD reported significantly higher 
subjective mood disturbance compared to healthy controls. Despite their similar 
subjective experience, BPD patients showed a distinct pattern of cortisol levels: 
significantly reduced cortisol levels at baseline and a blunted response to the TSST. 
In contrast, CPD patients tended to have heightened cortisol levels, both at baseline 
and in stress induced responses. Furthermore, BPD patients demonstrated a blunted 
heart rate response to the TSST, whereas CPD patients and healthy controls had 
nearly identical heart rate responses. In contrast to the attenuated pattern of heart 
rate reactivity, the BPD group exhibited a significantly higher overall SCL. SCL was 
similar between CPD patients and healthy controls. Additional analyses suggested 
that these results could not be explained by the presence of comorbid psychopathol-
ogy such as post-traumatic stress disorder or eating disorders. Furthermore, in line 
with our expectations, we found that participants with higher levels of childhood 
trauma and/or increased attachment related anxiety exhibited attenuated cortisol and 
heart rate responses to the TSST, analogous to the patient group with BPD. This is not 
surprising, as it is well know that individuals who experience childhood trauma and 
related factors leading to insecure attachment, are heavily overrepresented among 
BPD patients. Moreover, it should be noted that a complex interaction of causal 
factors and comorbidities is present in patients with personality disorders. Patients 
with BPD and CPD are often burdened with co-morbid psychiatric illnesses, such 
as eating disorders and/or post-traumatic stress disorder (15–17). Nevertheless, we 
found that patients with BPD, in contrast to patients with CPD, manifest a distinct 
psychophysiological responsivity to psychosocial stress, indicating a potentially 
distinct underlying biology. 
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It should be mentioned that this study was based on a cross-sectional design, which 
precluded firm conclusions regarding the causality of the observed results. Further-
more, we acknowledge that we were not able to perform a semi-structured interview 
for Axis II diagnoses in order to make a comprehensive assessment of the patients 
included in this study. Hence, we might have missed some comorbid diagnoses, 
which therefore cannot be completely ruled out as a potential confounder of our 
findings. However, patients were clinically referred and the diagnoses were made by 
qualified and experienced psychotherapists, based on the DSM-IV criteria for person-
ality disorders. Furthermore, we relied on self-report data of early childhood trauma, 
which is sensitive to uncertainty regarding the extent to which retrospective reports 
of early life adversities reflect the actual behavior of caregivers versus the subjective 
experience of them. However, current studies show that retrospective reports are well 
correlated with prospectively collected data (18). Above all, depending on the cohort 
and evaluation method, up to 81% of people with BPD report a history of childhood 
trauma (19), which is consistent with the widely held view that a lack of secure 
attachment is essential to the development of borderline psychopathology. Therefore, 
it is unlikely that retrospective accounts have significantly influenced the findings. 
However, future studies are required in larger cohorts to better identify risk and resil-
ience factors that regulate autonomic and HPA axis dysfunction in BPD versus CPD.
exoGenous hormonAl fActors
In western countries, nearly half of all women of reproductive age rely on some 
method of hormonal contraception. Yet we know surprisingly little about how these 
exogenous hormones influence stress reactivity. Part of our study examined the ef-
fects of hormonal contraception on female stress induced physiology (Chapter 5). 
We focused on combination oral contraceptive pills and the levonorgestrel-releasing 
intrauterine device (LNG-IUD). During the last few years, women have been in-
creasingly opting for the LNG-IUD given its widespread clinical endorsement as a 
safe, reliable method with negligible systemic effects (20). However, the findings 
reported in Chapter 5 do not support these claims. Relative to naturally cycling 
women, women using an LNG-IUD exhibited a robust potentiation of the salivary 
cortisol response to the TSST, whereas women using combination estrogen-progestin 
contraception exhibited a blunted cortisol response. Moreover, women using an 
LNG-IUD experienced a greater than 10 beats/min potentiation of their heart rate 
responsivity to the TSST. To confirm the hypothesis of the systemic effects of the 
LNG-IUD on stress induced physiology, we directly stimulated the adrenal cortex 
by administering a low-dose ACTH. In women using combination estrogen-progestin 
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contraception, this stimulation resulted in a blunted salivary cortisol response, analo-
gous to the outcome following the TSST. Notably, this finding is consistent with the 
well-established estradiol-induced increase in cortisol binding globulin (CBG) levels, 
thereby enhancing the buffering capacity of serum cortisol with a reduction of the 
unbound fraction (21,22). In contrast, the blunted salivary cortisol response to ACTH 
in women using an LNG-IUD, which led to a potentiated cortisol response during the 
TSST, occurred despite the presence of a normal CBG level. Together, these findings 
suggest a homeostatic downregulation of adrenal cortex function in LNG-IUD users 
secondary to the chronic potentiation of acute cortisol responsivity. The LNG-IUD 
appears to induce both a centrally-mediated potentiation of HPA reactivity and a 
peripheral downregulation of adrenal cortex reactivity. Investigation of hair cortisol 
concentrations, reflective of chronic naturalistic cortisol secretion, demonstrated that, 
similar to the findings of the TSST, women using an LNG-IUD had significantly higher 
concentrations of hair cortisol than naturally cycling women. Conversely, women 
using combination estrogen-progestin contraception had significantly decreased hair 
cortisol levels. Therefore, our findings confirm the systemic influence of LNG-IUD 
on HPA axis functioning under both acute stress, as well as through daily life stress. 
stress And the reProduction system
Systems activated by stress can influence reproduction at the hypothalamic, pituitary 
and gonadal levels (23). It has been well recognized that reproductive function is 
suppressed under stressful conditions (24). However, stress has been demonstrated to 
exert both inhibitory and stimulatory effects on reproductive function, dependent on 
the length of stress exposure and the background of estrogen priming (24). Previous 
studies using animal models have suggested that acute stress leads to facilitation of 
gonadotropin release through stimulation of the HPA axis. However, despite increas-
ing scientific attention to the deleterious impact of stress on reproductive health, no 
previous studies have ever examined whether gonadotropin release is influenced by 
acute HPA axis stimulation in premenopausal women.
In Chapter 6, we reported that acute administration of ACTH significantly enhances 
gonadotropin release in healthy premenopausal women. We examined this effect in 
3 independent groups defined by their differential use of hormonal contraceptives: 
1) women having a natural menstrual cycle, 2) women using oral contraceptives 
(combination estrogen/progestin), and 3) women using a levonorgestrel-releasing 
intrauterine device (IUD). With this study design, we have been able to further dis-
sect the hormonal context by which adrenal cortex activity mediates gonadotropin 
release. Notably, our results confirm a permissive function of estradiol and sug-
General Discussion
131
gest a novel mechanism by which cortisol functions as an important mediator of 
gonadotropin release. Our data suggested that acute stimulation of adrenal steroid 
production, most likely cortisol, mediates enhanced gonadotropin release in healthy 
premenopausal women. 
The interpretation of these findings might be limited by the cycle phase during 
testing. While women having a natural menstrual cycle were tested during their luteal 
phase, testing during the follicular phase of the menstrual cycle might have elicited 
premature, or more pronounced, LH surges in response to ACTH administration. Ad-
ditionally, women were not randomly assigned to the study, but were recruited based 
on their use of contraceptives. However, the groups were very similar across many 
potentially confounding variables, including general medical health, age, body-mass 
index (BMI), and affective state. Although it is likely that the increase of gonadotro-
pins observed in this study are due to a mediating effect of cortisol, it is also possible 
that administration of ACTH might have resulted in downstream adaptations to CRH 
through a secondary feedback loop. However, the low-dose (1µg) ACTH stimulation 
test has been well documented to be more physiological and sensitive than higher-
dose (250µg) ACTH stimulation. Therefore, it seems unlikely that a 1µg dose of ACTH 
directly affects pituitary function. Future studies with different pharmacological chal-
lenge tests, such as Dex/CRH administrations, are needed to expand our knowledge 
of HPA axis physiology and in particular, female reproductive functioning. 
strengths and limitations
The strengths of the presented studies include the use of a realistic and standardized 
social stress procedure, the inclusion of clinically referred patient samples, the use 
of well-defined contraceptive use groups and the measurement of multiple response 
systems (i.e., HPA axis, ANS, and subjective emotional experiences) through the full 
trajectory of the stress response, from baseline to recovery. In addition, we made 
thorough efforts to control for potential sources of bias. Moreover, in order to hold 
the known influential factors constant across subjects, all participants were enrolled 
and examined under strictly standardized conditions, including matching for age, 
BMI, medication, hormonal contraceptives, and time of day and menstrual cycle 
phase during testing. All measurements were performed in the afternoon, between 
14.00 and 16.00 hours to minimize circadian influences on salivary and physiologi-
cal assessments. Participants were asked to abstain from caffeine and intense physical 
activity for at least 24 hours prior to the session, and to have been awake for at least 
5 hours prior. Women having a natural cycle were tested during the luteal phase of 
the menstrual cycle. 
In addition, all participants were carefully evaluated using a general health assess-
ment, comprehensive self-report questionnaires and a structured clinical interview 
Chapter 7
132
for Axis I disorders. All of the included patients were diagnosed with personality 
disorder and were receiving psychotherapy at a mental health clinic. Healthy controls 
were a representative sample of women of reproductive age, and recruited from the 
general community. Assessment of attachment and childhood trauma allowed for the 
examination of these factors as potential influences on emotional reactivity in women 
with and without personality disorder. 
The original version of the TSST, i.e. mock job interview plus mental arithmetic 
tasks in front of a real panel of judges, was highly effective in eliciting a stress re-
sponse in every participant. Social evaluative threat and uncontrollability have been 
shown to be the major characteristics of the TSST explaining its effectiveness (25). 
Subjective reporting of disturbed mood in response to the TSST procedure suggested 
that all participants became personally involved in the task and found it to be highly 
stressful and disturbing. Notably, the majority of patients experienced the TSST as an 
overwhelming procedure which quite often resulted in outbreaks of emotional reac-
tions such as anger, crying, sorrow or aggressive behavior. However, patients were 
able to complete the testing despite severe emotional reactions. One might argue 
whether a laboratory stressor consisting of these two essential elements, social evalu-
ation and uncontrollability, is a proper reflection of the actual distress that patients 
face in their daily lives. Most of the time, they can use more avoidant stress regulation 
strategies to control the situation they face. On the other hand, in many naturalistic 
situations social evaluative threat and uncontrollability are strongly interconnected. 
For example, the behavior of the interaction partner in many situations cannot always 
be predicted. Also, in order to study HPA axis reactivity properly, a robust stressor is 
needed to evoke reliably significant elevations of free unbound cortisol.
Finally, the use of noninvasive sampling methods has both advantages and dis-
advantages. A noninvasive procedure improves patient recruitment. For example, 
saliva sample collection compared with blood sample collection increases patient 
acceptability and compliance (26). In addition, saliva sampling comes at a lower 
cost and allows an accurate determination of free unbound cortisol, which is, in 
contrast to protein-bound cortisol, responsible for cortisol’s hormonal physiological 
function. However, saliva testing restricted us from further investigation of other im-
portant stress related hormones and globulins, for which blood samples are essential. 
Given that the TSST requires central processing, the assessments of cortisol releasing 
hormone and adrenocorticotropin hormone, together with cortisol, might have al-
lowed the determination of more characteristic stress response patterns between the 
groups at different HPA axis levels. A similar need for blood sampling applies for the 
examination of genetic factors. However, saliva samples were viable alternatives for 
DNA extraction to perform genotyping of the serotonin transporter polymorphism. 
When studying the impact of contraceptives on the cortisol response following psy-
General Discussion
133
chosocial stress, the assessment of globulins that could have been studied in blood 
samples, which might function as important regulators of HPA axis responses, would 
have been useful. However, in the setting where we performed our TSST study, blood 
sampling was not a feasible option. Nevertheless, we were able to address some of 
these issues in our additional study, in which we administered a low-dose of ACTH 
to stimulate the adrenal cortex in healthy women. Future studies assessing a broader 
profile of steroid responses are needed in patients with personality disorders as well, 
to achieve a better understanding of the underlying biology of the disorders. 
future PersPectives
The findings of this thesis underline the need to improve our understanding of the 
factors that increase vulnerability to stress. When considering normal homeostatic 
responses to environmental stressors, future research should aim to study both sexes, 
and take into account the hormonal status of the participants, especially in women. 
Fortunately, the inclusion of women in research trials and experimental designs is 
becoming increasingly more common. Although there is a general acceptance that 
inclusion of women in research studies is necessary for valid inferences about health 
and disease in women, stress research focused on women is growing less rapidly 
compared to men. Plausible reasons for this is the importance of considering women’s 
reproductive status when assessing variations in HPA axis functioning and physiologi-
cal stress levels. Due to hormonal fluctuations across the menstrual cycle, research 
in women is considered more costly and time consuming, and therefore quite often 
accompanied with high drop-out rates due to inaccurate self-reports of menstrual 
cycle phase (27). In addition, the recruitment of women who do not use hormonal 
contraceptives is challenging as well, often leading to small study samples. Hence, 
most of the studies investigate one particular menstrual cycle phase instead of doing 
research during both follicular and luteal phases. Although that is not necessarily a 
problem, it hinders our understanding of the potential impact of fluctuating hormones 
in women’s health. 
In Chapter 4 we reported that women with BPD and CPD had distinct physiologi-
cal responses to psychosocial stress, when tested during luteal phase. Although we 
have carefully defined the menstrual cycle phase during which we performed our 
studies, it is currently unclear whether the findings would be applicable during the 
follicular phase. In contrast to the luteal phase, the follicular phase is marked with 
more fluctuations. The early follicular phase is characterized by both low estradiol 
and progesterone levels, whereas the mid to late follicular phase is associated with 
markedly elevated estradiol concentrations (28). Ovarian hormone fluctuations 
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across the menstrual cycle have been shown to co-vary with stress resilience and 
changes in mood (29,30). Several studies have documented that when progesterone 
and estradiol levels decline after a relatively stable period of elevated concentra-
tions, women experience more negative mood changes and are more vulnerable to 
stress (29,31,32). Furthermore, anger, sadness and irritability are the most commonly 
reported symptoms during the luteal phase in women with a premenstrual dysphoric 
disorder, suggesting that a proportion of women are more vulnerable to hormonal 
fluctuations (33). It might be hypothesized that some BPD features, such as extreme 
emotional instability and reactivity, are associated with cyclical hormone changes. 
Therefore, studies with clear operationally-defined periods of the menstrual cycle 
are needed in order to accurately differentiate between the effects of estradiol and 
progesterone, not only on psychophysiological stress reactivity, but also on the emo-
tional, cognitive, and behavioral functioning of healthy women and women at high 
risk for psychopathology. 
Hormonal contraception is another factor associated with negative effects on emo-
tional, cognitive and behavioral properties. One of the most progressive developments 
in recent contraception policy has been the development of long-acting reversible 
contraception (34), such as implants or progesterone releasing intrauterine devices. 
Although the advantages of using an LNG-IUD are indisputable regarding its efficacy, 
safety, and local and rapid reversible nature, significant discontinuation rates have 
also been reported (35,36). Chapter 6 provides important experimental evidence that 
the LNG-IUD exerts robust systemic influences. We observed significantly elevated 
cortisol responses and a down-regulation of adrenal cortex function in healthy women 
using the LNG-IUD. Unfortunately, the design of the studies reported in Chapter 6 did 
not permit an assessment of whether the observed systemic physiological influences 
of LNG-IUD are associated with mood disturbances or emotional lability. Hence, 
taken together with the emerging evidence that progesterone influences the risk and 
severity of mood and anxiety disorders, and the rapidly increasing number of women 
using the LNG-IUD, the possibility that the LNG-IUD might impose a clinically-
significant risk needs to be evaluated in large population-based observational studies. 
Although the side effects of hormonal contraceptives in general have been largely 
underreported, awareness of the adverse effects is important for both patients using 
hormonal contraceptives and for prescribing physicians. Satisfaction and continua-
tion rates might be improved if health care professionals had access to more detailed 
research on side effects, and therefore could provide improved counseling. 
Considering that the high prevalence of affective disorders, and increased stress 
sensitivity, in women is partly attributed to both endogenous and exogenous hor-
monal factors, we need to improve our understanding of these complex relationships. 
The challenge in understanding the significance of the vast array of stress reactivity 
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and hormone fluctuations for women’s health and health care rests not so much in 
assessing the influence of each sex and stress hormone in isolation, but rather in un-
derstanding how these hormones interact throughout the course of the reproductive 
cycle. Improved knowledge of how stress hormones interact with sex hormones to 
contribute to stress resilience or vulnerability, and ultimately how such an interaction 
might contribute to etiology of stress-related disorders, might help offer new targets 
for therapies. Finally, women have the right to know the consequences of the hor-
monal changes that their body goes through during their lifetime, including sufficient 
facts to make an informed decision regarding choice of contraceptive method, and 
further research is vital to ensure this.
In conclusion, our investigation of different factors regarding cognitive processing 
and psychophysiological stress response provide evidence that:
- maladaptive personality traits are important factors in understanding the relation-
ships between fundamental personality characteristics and cognitive processing 
during acute psychosocial stress, in both women with and without personality 
disorder;
- the 5-HTTLPR genotype is significantly associated with the cortisol response to 
acute psychosocial stress;
- the physiological response to acute psychosocial stress differs between groups 
with distinct personality psychopathology whereas the subjective mood distur-
bance response does not;
- distinct hormonal contraceptive methods have contrasting effects on physiologi-
cal reactivity to acute psychosocial stress in healthy women;
- ACTH stimulation of the adrenal cortex elicits gonadotropin release in healthy 
premenopausal women.
While these explorations add important clues towards a more comprehensive under-
standing and coherent picture of stress induced sensitivity in women, it is apparent 
that sex hormones play an important role, and interact with a variety of factors, 
including fundamental personality traits, personality pathology, genetic factors, and 
environmental influences, to regulate physiological reactivity and adaptation to 
stress, and thereby women’s individual well-being.
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summAry
Background and aims
Many of the stressors of our daily lives are psychological in nature and often socially 
oriented. Psychosocial stress is a reaction to a real or interpreted threat to the integrity 
of an individual that manifests itself by biochemical, physiological, cognitive and be-
havioral changes. It is commonly accepted that individuals vary markedly in the way 
they react to a challenging natural environment, or to complex social interactions. 
It is also widely acknowledged that these individual differences might have impli-
cations for behavior and health outcomes. According to the stress-diathesis theory, 
individual differences in reactivity to stressful events are dependent on personality 
characteristics that might either buffer, or be a predisposing risk factor, for emotional 
upheaval and ultimately risk of developing psychiatric decompensation. Considering 
that maladaptive emotional control is a significant burden in women with personal-
ity disorders, the aim of this thesis (described in chapter 1) was to investigate how 
stress regulation in women is modified by personality disorders through quantitative 
assessments of their psychophysiological response to acute psychosocial stress. We 
assessed cognitive appraisal and psychophysiological responses during a standard-
ized psychosocial stress procedure, the Trier Social Stress Task (TSST). The TSST was 
conducted according to the original protocol reported by Kirshbaum et al. (1993) 
consisting of a preparation period, a free speech task and a verbal mental arithmetic 
task, each lasting 5 minutes. The TSST was performed in front of a two-member panel 
that maintained affectively neutral facial expressions throughout the procedure and 
provided the participant with no verbal or non-verbal feedback. We also examined 
genetic and hormonal factors that might contribute to the biology underlying physi-
ological stress reactivity in women.
The studies were carried out at the department of Psychotherapy of the Riagg 
Rijnmond (Schiedam, The Netherlands) and the department of Psychiatry of the Eras-
mus University Medical Center (Rotterdam, The Netherlands). Study subjects were 
recruited among women with DSM-IV Axis II diagnosed personality psychopathol-
ogy, who were under outpatient treatment at the department of Psychotherapy of 
the Riagg Rijnmond. Patients were considered ineligible to participate if they had a 
comorbid diagnosis of bipolar disorder, schizophrenia, current major depression, or 
had used psychotropic medication within the previous 9 months. The control group 
consisted of healthy adult women of reproductive age who were recruited from the 
community through local advertisements. Eligibility requirements for healthy controls 
included the absence of any DSM-IV Axis I or Axis II diagnoses, as well as no ongoing 
or previous psychiatric or psychological treatment. Questionnaires were completed 
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by all participants, yielding information on symptoms of psychopathology, childhood 
trauma, attachment, positive and negative affect, and general health.
All women participated in a psychosocial stress test during which heart rate and 
skin conductance level (SCL) were measured continuously, and salivary cortisol levels 
and subjective mood disturbance were measured at regular intervals. In addition, the 
serotonin transporter gene-linked polymorphic region (5-HTTLPR) and glucocorticoid 
receptor genotyping was performed in order to examine the association of candidate 
genetic factors on HPA axis reactivity to psychosocial stress. Cognitive appraisal was 
assessed during the anticipation period, directly before the performance of the stress 
task. 
An additional study was performed in a cohort of healthy women with identical 
eligibility requirements as for the control group in the main TSST study. Low-dose 
(1µg) intravenous adrenocorticotropic hormone (ACTH) was administered in order 
to dissect the influence of stress on female reproductive physiology (gonadotropin 
release). We measured the concentration of hair cortisol to determine whether the 
laboratory-based assessments of HPA axis functioning during acute stress would also 
be confirmed by studying long-term cortisol exposure under naturalistic conditions. 
findings
In chapter 2, we examined the direct and indirect impact of attachment insecurity 
and temperament on the cognitive appraisals of acute psychosocial stress in a female 
sample consisting of healthy women and women with a personality disorder. In addi-
tion, the mediating role of maladaptive personality traits was taken into account. Our 
findings showed that positive affectivity was directly linked to secondary appraisal 
of acute psychosocial stress confirming the earlier suggestions that positive affectiv-
ity buffers against stress. Furthermore, we found that maladaptive personality traits 
mediated the negative impact of both attachment anxiety and negative affectivity on 
primary appraisal of acute psychosocial stress. Most importantly, this pattern of as-
sociations applied equally to women with personality disorder and healthy controls, 
confirming the importance of maladaptive personality traits for understanding the 
contribution of individual characteristics on cognitive appraisals of acute psychoso-
cial stress.
Considering the growing evidence of a potential association between the serotonin 
transporter gene-linked polymorphic region (5-HTTLPR) and HPA axis functioning, 
chapter 3 describes the outcome of our study designed to investigate how the HPA 
axis response to psychosocial stress is moderated in women by 5-HTTLPR genotype. 
In addition, we examined whether this association was moderated by the 5-HTTLPR 
interaction with experienced early life stress. We found that women carrying two 
copies of the long (LL) version of the 5-HTTLPR displayed exaggerated cortisol re-
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sponses to psychosocial stress compared women with at least one copy of the short 
(SL or SS) allele. This association did not change when a potential interaction of 
5-HTTLPR genotype and early life adversity was taken into account. Our findings 
demonstrate the complex association between the 5-HTTLPR and cortisol reactivity 
to psychosocial stress, for which additional studies will be required to further clarify 
the relationships between genetic predisposition and stress sensitivity.
In chapter 4, we investigated whether the psychophysiological stress response dif-
fers as a function of personality disorder diagnosis. We compared subjective mood 
disturbance, heart rate, SCL, and salivary cortisol responses to psychosocial stress in 
women with cluster C personality disorder (CPD) and borderline personality disorder 
(BPD). Both CPD and BPD patients reported a similar burden of subjective mood 
disturbance after performing the TSST. However, only BPD patients demonstrated 
reduced baseline cortisol levels with a blunted cortisol and heart rate response to 
the TSST. In addition, BPD patients exhibited a generalized increase of SCL. No sig-
nificant differences in baseline or TSST reactivity of cortisol, heart rate, or SCL were 
observed between CPD patients and healthy controls. Therefore, we concluded that 
BPD patients have a distinct psychophysiological responsivity to psychosocial stress, 
indicating a potentially distinct underlying biology. 
Although the use of hormonal contraception among women is increasing annually, 
our knowledge about the effects of contraception on stress-induced physiology in 
women is, remarkably, very limited. In particular, data on long-acting contracep-
tives such as the progestin releasing intrauterine device (LNG-IUD) is almost entirely 
unexplored. Therefore, in chapter 5, we investigated the effects of hormonal contra-
ception on female stress physiology. We found that women using the LNG-IUD had 
an exaggerated salivary cortisol response to the TSST, compared to women using 
combined oral contraceptives and natural cycling women. Heart rate responses were 
also significantly potentiated during the TSST in women using a LNG-IUD. After 
ACTH challenge, women using the LNG-IUD or combined oral contraceptives had a 
blunted salivary cortisol response compared to naturally cycling women. In line with 
the TSST findings, women using the LNG-IUD had significantly elevated levels of hair 
cortisol. Although the LNG-IUD has been widely reported to function with negligible 
systemic effects, our findings suggest that LNG-IUD contraception induces a centrally-
mediated sensitization of both autonomic and hypothalamic-pituitary-adrenal (HPA) 
axis responsivity. We concluded that large population-based observational studies 
are urgently warranted to evaluate the potential risk of the LNG-IUD for developing 
mood and anxiety disorders.
Previous studies in postmenopausal women have demonstrated that the gonadotro-
pin response to adrenal stimulation is highly estrogen-dependent, and significantly 
potentiated by progesterone. In chapter 6, we investigated the effects of acute stress 
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on gonadotropin release in premenopausal women. We have examined this effect in 
3 independent groups defined by their differential use of hormonal contraceptives: 
1) women having a natural menstrual cycle, 2) women using oral contraceptives 
(combination estrogen/progestin), and 3) women using an LNG-IUD. With this study 
design, we were able to further dissect the hormonal context by which adrenal cortex 
activity mediates gonadotropin release. Our results confirmed a permissive function 
of estradiol and demonstrated that acute stimulation of adrenal steroids, most likely 
cortisol, mediates gonadotropin release.
In chapter 7, the main results and conclusions of this thesis were presented and 
discussed. We have gained further insight into the psychophysiological responses to 
stress, and defined important determinants that influence these responses in women 
with and without personality disorder. We showed that when exposed to a challeng-
ing situation, cognitive perceptions of stress are strongly and directly influenced by 
emotional dysregulation, and indirectly by varying influences of attachment style and 
temperament. Furthermore, we provided evidence that maladaptive personality traits 
are important factors in understanding the relationships between attachment, tempera-
ment and mentalization capacity during acute psychosocial stress, not only in clinical 
samples, but also in the general population. Another important finding was the role of 
genetic factors in the physiological response to stress in women of reproductive age. 
We found that women with the LL genotype of the 5-HTTLPR polymorphism demon-
strated significantly higher salivary cortisol responses to psychosocial stress compared 
to women with at least one copy of the S allele. Furthermore, our data indicated that the 
physiological stress response differs as a function of the subtype of personality disorder. 
Although women suffering from either BPD or CPD exhibited similar levels of mood 
disturbance in response to psychosocial stress, patients with BPD demonstrated signifi-
cant attenuations of cortisol and heart rate reactivity compared to patients with CPD or 
healthy controls. Moreover, our findings indicated that the pattern of blunted cortisol 
and heart rate reactivity to psychosocial stress was specific to patients with BPD, rather 
than simply a consequence of emotional vulnerability in personality psychopathology. 
Regarding the impact of sex hormones, we found that distinct hormonal contraceptive 
methods have contrasting effects on endocrine reactivity to acute psychosocial stress. 
Compared to natural cycling women, women using an LNG-IUD exhibited a robust 
potentiation of the salivary cortisol response during the TSST, whereas women using 
combination estrogen-progestin contraception showed a blunted cortisol response. 
Similarly, women using the LNG-IUD showed significantly higher concentrations of 
hair cortisol than naturally cycling women. Lastly, our data demonstrates that acute 
stimulation of adrenal steroid production, most likely cortisol, mediates enhanced 
gonadotropin release in healthy premenopausal women. 
145
Taken all together, these explorations of varying determinants of psychophysiologi-
cal responses to psychosocial stress provide important clues in establishing a more 
comprehensive understanding of stress induced sensitivity in women of reproductive 
age with and without personality psychopathology. Considering that stress sensitiv-
ity is frequently investigated as a vulnerability marker for both mental and physical 
health problems, we argue that circulating sex hormone levels should be taken into 
consideration while examining the responses to psychosocial stress in women.
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Achtergrond en doelstellingen
Veel van de stressoren die we in ons dagelijks leven ervaren zijn psychologisch van 
aard en vaak sociaal van oorsprong. Psychosociale stress kan worden gedefinieerd als 
een reële of een ervaren bedreiging van de psychische integriteit van een individu die 
gepaard gaat met biochemische, fysiologische, cognitieve en gedragsmatige veran-
deringen. Het is algemeen geaccepteerd dat individuen aanzienlijk verschillen in de 
wijze waarop zij reageren op hun omgeving of op complexe sociale interacties. Ook 
is het algemeen aanvaard dat deze individuele verschillen gevolgen kunnen hebben 
voor gedrag en gezondheid. Volgens het stress-kwetsbaarheidsmodel zijn individuele 
verschillen in reactiviteit op stressvolle gebeurtenissen afhankelijk van persoonlijk-
heidskenmerken. Persoonlijkheidskenmerken kunnen bij stress een beschermende 
factor zijn voor emotionele ontregeling of, in geval van kwetsbaarheid, emotionele 
ontregeling juist faciliteren. Uit het model volgt dat hoog kwestbare individuen onder 
invloed van stressoren psychiatrische ziekten kunnen ontwikkelen. 
Het doel van dit proefschrift is de stressgevoeligheid te onderzoeken bij vrouwen 
met en zonder persoonlijkheidsstoornis door hun psychofysiologische reacties op 
acute psychosociale stress te bestuderen. We onderzochten (hoofdstuk 1) de ’cogni-
tive appraisals’ (subjectieve evaluatie van ernst van de stressor en de eigen weerbaar-
heid ertegen) cognitieve ”appraisals” en de psychofysiologische responsiviteit tijdens 
een psychosociale stressprocedure, de Trier Sociale Stress Taak (TSST). De TSST is 
uitgevoerd volgens het oorspronkelijke protocol zoals opgesteld door Kirshbaum et 
al. (1993). Het stressprotocol bestaat uit een voorbereidingsperiode, een opdracht 
voor een fictief sollicitatiegesprek en een verbale hoofdrekentaak van elk 5 minuten. 
De TSST werd uitgevoerd ten overstaan van een tweeledig panel dat gedurende de 
hele procedure geen enkele gezichtsuitdrukking toonde of (non)verbale feedback gaf. 
Daarnaast onderzochten we de genetische en hormonale factoren die een rol spelen 
in de fysiologische stressreactiviteit van vrouwen.
De studies werden uitgevoerd op de afdeling Psychotherapie van de Riagg Rijnmond 
(Schiedam, Nederland) en de afdeling Psychiatrie van Erasmus Universitair Medisch 
Centrum (Rotterdam, Nederland). In deze studies hebben wij twee steekproeven van 
vrouwelijke proefpersonen onderzocht. De ene steekproef bestond uit ambulante 
patiënten met persoonlijkheidspsychopathologie, die op de afdeling Psychotherapie 
van Riagg Rijnmond in behandeling waren. Patiënten met een comorbide diagnose 
van een bipolaire stoornis, schizofrenie of depressie, of die in de afgelopen 9 maan-
den psychotrope medicijnen hadden gebruikt, waren uitgesloten van deelname. De 
andere steekproef bestond uit gezonde volwassen vrouwen van vruchtbare leeftijd 
(18-46 jaar). Voor deze laatste steekproef werd geworven onder de algemene bevol-
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king door het plaatsen van lokale advertenties. Criteria voor deelname van gezonde 
proefpersonen waren: geen DSM-IV as-I of as-II diagnose hebben en niet onder 
psychiatrische of psychologische behandeling zijn of ooit geweest zijn.
Gedurende de psychosociale stressprocedure werd van alle vrouwen de hartslag en 
het huidgeleidingsniveau continu gemeten en werden met regelmatige tussenpozen 
cortisolniveaus in speeksel bepaald en werd de subjectieve veranderingen in de 
gemoedstoestand gemeten door gebruik van een korte vragenlijst. Het serotonine 
transporter gen promoter polymorfisme (5-HTTLPR) werd bepaald om de rol van 
deze genetische factor op de reactiviteit van de hypothalamus-hypofyse-bijnier (HPA) 
as op psychosociale stress te onderzoeken. De cognitieve appraisal werd beoordeeld 
tijdens de voorbereidingstijd, direct vóór de uitvoering van de stress taak. Bij alle 
proefpersonen werd een selectie van vragenlijsten afgenomen, gericht op het meten 
van symptomen van psychopathologie, jeugdtrauma, gehechtheidsstijl, positieve en 
negatieve affectiviteit en algemene gezondheid. Om de effecten van stress op de 
vrouwelijke fysiologie (gonadotropine vrijlating) te onderzoeken werd een aanvul-
lende studie uitgevoerd waarbij gezonde vrouwen met verschillende anticonceptie 
methode een lage dosis (1µg) adrenocorticotropic hormoon (ACTH) intraveneus 
toegediend kregen. Tot slot hebben we de cortisolconcentratie in het haar van de 
gezonde vrouwen bepaald. Dit om te onderzoeken of de laboratorium bevindingen 
betreffende de effecten van anticonceptie op de HPA as reactiviteit overeenkomen 
met de cortisolconcentraties gedurende een langere periode tijdens normale ambu-
lante omstandigheden.
Bevindingen
We hebben de directe en de indirecte gevolgen van een onveilige gehechtheidsstijl 
en van temperament op de cognitieve appraisal van acute psychosociale stress onder-
zocht in een steekproef van gezonde vrouwen en vrouwen met een persoonlijkheids-
stoornis (hoofdstuk 2). Daarbij werd rekening gehouden met de modulerende rol van 
niet-adaptieve persoonlijkheidstrekken. Uit onze bevindingen bleek dat positieve 
affectiviteit direct gekoppeld is aan secundaire appraisals van acute psychosociale 
stress. Deze bevinding bevestigt de al eerder gesuggereerde beschermende rol van 
positieve affectiviteit tegen stressoren. Bovendien vonden we dat niet-adaptieve per-
soonlijkheidstrekken de effecten van zowel de aan gehechtheid gerelateerde angst 
als de negatieve affectiviteit op de primaire appraisal van acute psychosociale stress 
medieren. Dit patroon van associaties gaat op voor zowel de gezonde vrouwen als 
voor vrouwen met persoonlijkheidspsychopathologie. De bevindingen suggereren 
dat niet adaptieve persoonlijkheidstrekken belangrijke factoren zijn om het effect 
van individuele kenmerken op cognitieve appraisals van acute psychosociale stress 
beter te begrijpen.
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In hoofdstuk 3 hebben we onderzocht of de reactiviteit van de HPA as op psycho-
sociale stress wordt gemoduleerd door de 5-HTTLPR in een groep van vrouwelijke 
proefpersonen. Bovendien onderzochten we of deze associatie beïnvloed wordt door 
de interactie van de 5-HTTLPR en het hebben meegemaakt van een jeugdtrauma. In 
tegenstelling tot de bekende literatuur, vonden we dat vrouwen die twee exemplaren 
van de lange (LL)-allelen van de 5-HTTLPR dragen een hogere cortisolrespons op 
psychosociale stress lieten zien dan vrouwen met ten minste één kopie van de korte 
(SL of SS)-allelen. Verder veranderde deze waargenomen associatie niet significant 
wanneer de interactie tussen 5-HTTLPR and jeugdtrauma werd meegerekend. Onze 
bevindingen laten de complexe associatie zien tussen de 5-HTTLPR en de cortisol 
reactiviteit op psychosociale stress. Er zijn meer studies onder vrouwen nodig om de 
relatie tussen genetische aanleg en stress gevoeligheid verder te verduidelijken.
Ook is onderzocht of de psychofysiologische stressrespons op psychosociale stress 
verschilt per soort persoonlijkheidspsychopathologie (hoofdstuk 4). We vergeleken 
de subjectieve gemoedstoestandverandering, hartslag, huidgeleiding en cortisol-
responsen op psychosociale stress bij vrouwen met een cluster C persoonlijkheids-
stoornis (CPD) of een borderline persoonlijkheidsstoornis (BPD). Zowel CPD als BPD 
patiënten lieten meteen na het uitvoeren van de stresstaak een vergelijkbare toename 
in subjectieve gemoedstoestandverandering zien. Echter, patiënten met BPD lieten 
zowel een lagere baseline van cortisolniveaus zien als een lagere cortisol en hartslag 
reactiviteit op de TSST. Daarnaast lieten patiënten met BPD verhoogde niveaus van 
huidgeleiding zien. Er zijn geen significante verschillen in baseline of reactiviteit van 
cortisol, hartslag of huidgeleiding op de TSST waargenomen tussen CPD patiënten en 
gezonde vrouwen. We vonden dus dat BPD patiënten, in tegenstelling tot de CPD 
patiënten, een andere psychofysiologische responsiviteit op psychosociale stress 
hebben, wat een verschillende onderliggende biologie van de psychopathologie 
suggereert.
Hoewel het gebruik van hormonale anticonceptie onder vrouwen jaarlijks groeit, is 
onze kennis over de effecten van anticonceptie op stress-geïnduceerde fysiologie bij 
vrouwen zeer beperkt. Met name de effecten van langdurig gebruik van voorbehoeds-
middelen (zoals een hormonaal spiraal, geplaatst in baarmoeder; LNG-IUD) zijn 
onbekend. Wij onderzochten daarom de impact van hormonale anticonceptie op de 
vrouwelijke stressfysiologie (hoofdstuk 5). We vonden dat vrouwen die een LNG-IUD 
gebruikten een significant hogere cortisolrespons lieten zien in reactie op de TSST, 
vergeleken met vrouwen die een gecombineerde orale anticonceptie (pil) gebruikten 
en vrouwen met een natuurlijke menstruele cyclus. Ook de hartslag was aanzienlijk 
verhoogd tijdens de TSST bij vrouwen die een LNG-IUD gebruikten. Na de ACTH test 
lieten vrouwen met een LNG-IUD en vrouwen die de pil gebruikten een verlaagde 
cortisolrespons zien vergeleken met vrouwen met een natuurlijke menstruele cyclus. 
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In overeenstemming met de TSST bevindingen lieten vrouwen met een LNG-IUD 
aanzienlijk verhoogde niveaus van haarcortisol zien vergeleken met vrouwen met 
een anticonceptie pil of een natuurlijke menstruele cyclus. Onze bevindingen zijn 
een sterke aanwijzing dat een LNG-IUD een systemisch werkingsmechanisme heeft, 
terwijl de bijsluiters van dit type anticonceptie een lokale werking suggereren met 
verwaarloosbare systemische bijwerkingen. 
Studies onder postmenopauzale vrouwen concludeerden dat de gonadotropine 
reactie op bijnierstimulatie zeer estradiolafhankelijk is en significant gestimuleerd 
wordt door progesteron niveaus. Wij onderzochten de effecten van acute stress op de 
afgifte van gonadotropinen in een steekproef van premenopausale vrouwen (hoofd-
stuk 6). We hebben dit effect onderzocht in drie onafhankelijke groepen die waren 
gedefinieerd op basis van gebruik van hormonale anticonceptie: 1) vrouwen met een 
natuurlijke menstruatiecyclus, 2) vrouwen die orale anticonceptie gebruikten (com-
binatie oestrogeen/progestageen) en 3) vrouwen die een LNG-IUD gebruikten. Met 
dit studiedesign konden we de effecten van de hormonale context en de stimulatie 
van bijnierschors op de gonadotropinenrespons verder ontrafelen. Onze bevindingen 
bevestigen een belangrijke rol van estradiol en tonen aan dat acute stimulatie van 
bijniersteroïden, hoogstwaarschijnlijk cortisol, de afgifte van gonadotropinen beïn-
vloeden.
discussie en conclusies
Het proefschrift geeft meer inzicht in de psychofysiologische reacties op stress en de 
meest bepalende factoren die van invloed zijn op deze psychofysiologische reacties 
bij vrouwen met en zonder persoonlijkheidspsychopathologie (hoofdstuk 7). We 
toonden aan dat wanneer vrouwen worden blootgesteld aan een stressvolle situatie, 
de betekenis van de cognitieve perceptie van stress wordt versterkt door de invloed 
van emotionele disregulatie, en indirect door de invloeden van gehechtheidsstijl en 
temperament. Bovendien bewijzen we dat niet-adaptieve persoonlijkheidstrekken 
belangrijke factoren zijn om inzicht te krijgen in de relaties tussen gehechtheidsstijl, 
temperament en mentalizerend vermogen tijdens acute psychosociale stress, niet 
alleen binnen de klinische populatie, maar ook onder de algemene bevolking. Een 
andere belangrijke vaststelling is de rol van genetische factoren in de stressfysiolo-
gie bij vrouwen. We hebben aangetoond dat vrouwen met het genotype LL van de 
5-HTTLPR-polymorfisme aanzienlijk hogere cortisolreacties op psychosociale stress 
hebben dan vrouwen met ten minste één kopie van het S-allel. Bovendien laten we 
zien dat de fysiologische stressrespons verschilt per persoonlijkheidspsychopatho-
logie. Hoewel vrouwen die lijden aan BPD of CPD een overeenkomstige gemoeds-
toestandverandering vertonen als gevolg van psychosociale stress, laten patiënten 
met BPD een aanzienlijk lagere cortisol- en hartslagreactiviteit zien ten opzichte 
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van patiënten met CPD of gezonde vrouwen. Bovendien tonen deze bevindingen 
aan dat dit patroon van verlaagde cortisol- en hartslagreactiviteit op psychosociale 
stress specifiek is voor patiënten met BPD in plaats van eenvoudigweg een gevolg van 
emotionele kwetsbaarheid bij de persoonlijkheidpsychopathologie. 
Met betrekking tot de invloed van geslachtshormonen vonden we dat verschil-
lende hormonale anticonceptie verschillende effecten hebben op de fysiologische 
responsiviteit op acute psychosociale stress. Vergeleken met vrouwen met natuurlijke 
menstruele cyclus, lieten vrouwen die een LNG-IUD gebruikten een grote toename 
van de cortisolrespons zien in reactie op de TSST, terwijl vrouwen die een combinatie 
anticonceptie gebruikten een verlaagde cortisolrespons lieten zien. Ook bleek dat 
vrouwen die een LNG-IUD gebruikten aanzienlijk hogere concentraties van haarcor-
tisol hadden dan vrouwen met een natuurlijke menstruele cyclus. Tot slot laten onze 
gegevens zien dat acute stimulatie van bijniersteroïden, hoogstwaarschijnlijk cortisol, 
de afgifte van gonadotropinen beïnvloeden bij gezonde premenopauzale vrouwen.
Samengevat zijn deze studies belangrijke stappen in het verkrijgen van inzicht in 
een meer omvattend en samenhangend beeld van stressgevoeligheid bij vrouwen van 
vruchtbare leeftijd met en zonder persoonlijkheidspsychopathologie. Omdat stress-
gevoeligheid vaak is onderzocht als een kwetsbaarheidsfactor voor zowel mentale als 
fysieke gezondheidsproblemen, stellen we dat er bij vrouwen rekening moet worden 
gehouden met geslachtshormoonniveaus bij onderzoek naar de psychofysiologische 
reacties op psychosociale stress.
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Ik zie mijn promotietraject als een lange reis. Voor mijn vertrek las ik verschillende 
verslagen en luisterde ik naar reisverhalen. Zo kreeg ik een idee van wat ik te zien zou 
krijgen, proeven en ervaren. Ik werd gewaarschuwd voor bergen werk, geattendeerd 
op de gevaarlijke hoeken en gaten, en ook gewezen op zeeën van mogelijkheden. 
Uiteraard werd ik ook geïnformeerd over de moeilijkheidsgraad van de trail, gevolgd 
door een grote prijs, wat alle inspanning doet vervagen. Ik zie mijn proefschrift als het 
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Er zijn 3 belangrijke ingrediënten die mijn avontuur, de voldoening en het succes 
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en de proefpersonen, en anderen die (on)verwacht mijn pad kruisten. Zij maakten 
met hun ervaringen, inzichten, wel of niet in samenwerking mijn reis rijker en turbu-
lenter; en 3) de ‘backpack’,  mijn basis met mijn normen en waardesysteem, kennis 
en ervaring. 
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afwijken. Ik waardeer dat jullie mij de mogelijkheid hebben gegeven om onbekende 
gebieden te kunnen verkennen. Jullie hebben mij alle nodige bouwstenen aangereikt, 
niet alleen voor een volmaakte reis maar ook voor het schrijven van mijn reisverslag, 
mijn proefschrift. Ik kijk voldaan en trots terug op een verrijkende en leerzame reis. 
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uit om te proeven en te ervaren. In een onbekend land ben ik dankbaar als ik begeleid 
wordt door een ‘local’.  Mijn speciale dank gaat naar professoren Dr. Elisabeth van 
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was voor mij een bijzondere bestemming, niet zozeer als een plek, maar als een 
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soortgelijk wetenschapsvirus ook bestaat en ik vrees dat ik daar zelf mee besmet ben.
